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1 INTRODUCTION  
1.1 Historical background and definition of clinical neuropsychology 
Clinical neuropsychology represents an important field of expertise within psychology and 
found its origin in the 18th century, when Franz Josef Gall (1758-1828) aimed to link scull 
formations with personality traits. During the following decades, technical, medical, political 
as well as social changes led to a rapid development of this area of expertise. In the 21st 
century clinical neuropsychology is seen as self-contained subarea of the cognitive 
neurosciences including university chairs, associations and peer reviewed journals 
(Goldenberg, 2007). As a scientific discipline clinical neuropsychology aims to understand the 
central nervous mechanisms underlying human behavior and perception (Hartje & Poeck, 
2006). For this purpose, methods and findings from classical psychology, neurology, 
neuroanatomy and neurophysiology are brought together. As an interdisciplinary 
intersection between psychology and medicine, the importance of clinical neuropsychology 
is growing due to increasing age of the general population and an increasing incidence of 
brain diseases. For prognosis as well as for therapy of a brain disease and its symptoms, valid 
diagnostic during the course of the disease is highly relevant. 
Consequently, a major field of work for neuropsychologists represents diagnostics i.e. 
registration and description of cognitive and affective impairments after brain damage 
(Sturm, Herrmann, & Münte, 2007). To answer specific diagnostic questions regarding the 
actual functional state, the course of disease or patient-oriented treatment plans, 
information from neurological, neuro-radiological and electrophysiological assessments 
need to be integrated. In addition, standards for objective diagnostics, mainly oriented to 
those of clinical/psychological diagnostics, need to be set. For correct planning of an 
assessment and valid interpretation of the results, basic knowledge about psychological test 
theory as well as functional-anatomic relationships are necessary (Hartje & Poeck, 2006). 
Neuropsychological assessment focuses on basic and higher perception performance, 
memory, attention and sensory-motor functions as well as particular educational and job 
dependent performance. In addition, the patieŶt’s affeĐtiǀe status and personality are 
evaluated (Hartje & Poeck, 2006). The second major field of work is neuropsychological 
therapy of brain damage associated functional disturbances. Depending on the severity of 
brain damage, the duties of a neuropsychologist range from early rehabilitation, with 
1 INTRODUCTION 
10 
training of language and orientation, to longer scheduled treatment in several rehabilitative 
phases with the ultimate goal to reintegrate the patient into his social and professional life 
(Sturm et al., 2007). The attendance in highly structured inpatient rehabilitation is often 
followed by ambulant consultations of a neuropsychologist, regularly with a focus on coping 
with the underlying brain affecting disease and its impact on social and professional life.  
The duties of a clinical neuropsychologist in working fields such as ambulant diagnostics, 
rehabilitation or consultation are well characterized in the literature. However, attention is 
rarely drawn on the scope of work in a neurosurgical context. To date there is a lack of 
published recommendations on the characterization of external requirements and 
specifications of diagnostic questions in this special field of interest. In addition, clinical 
research on particular topics of this field is rare.  
The present work seeks to describe and define the requirements for neuropsychological 
diagnostic in emergency hospitals treating patients with intracranial tumors. The aim is to 
validate current methods and to establish a reliable neuropsychological assessment routine 
for patients undergoing awake surgeries. In addition, a specific diagnostic method for the 
very special context of intraoperative diagnostics in awake craniotomy is supposed to be 
introduced and evaluated. 
 
1.2 Intracranial tumors  
Intracranial tumors are defined as neoplasm inside of the bony scull (Münte & Herrmann, 
2007). They can be roughly discriminated based on the origin of their tissue as primary and 
secondary brain tumors (Poeck & Hacke, 1998). Primary brain tumors can emanate from 
various sources such as neurons and glial supporting tissue (gliomas), meninges 
(meningiomas), the pituarity gland, germ cells or from congenital malformations like 
dysembryoplastic neuroepithelial tumors (Poeck & Hacke, 2006). Secondary brain tumors 
refer to tumors of the scull bone and metastases with an origin in other body parts.  
The incidence for intracranial tumors is estimated to 15 newly diagnosed adults per 100.000 
inhabitants per year (Poeck & Hacke, 2006). The prevalence amounts 50 patients per 
100.000 inhabitants. The portion of brain tumors in tumor diseases ranges between 7-9% 
whereas primary brain tumors represent only 5% (Poeck & Hacke, 2006). With increasing 
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age, the risk of acquiring a brain tumor raises (Robert Koch-Institut / Gesellschaft der 
epidemiologischen Krebsregister in Deutschland e.V., 2013). Malignant brain tumors are 
found more often in men. An extensive description of the medical and biological properties 
of brain tumors can be found in Berlit (2006) or Hacke and Poeck (2006). 
Tumors can be classified according to their histological profile into benign and malignant 
neoplasms (Poeck & Hacke, 2006). For classification of brain tumors the scheme provided by 
the world health organization (WHO), which differentiates four grades of malignancies, is 
widely used (Louis et al., 2007). These grades characterize the biological growth behavior of 
the tumor considering factors such as cell density or necrosis and provide the estimated time 
of survival as shown in Table 1 (Berlit, 2006). Here, the degree of anaplasia of cells is one 
important criterion for determination of malignancy of a tumor (Röther, 2006). Anaplasia of 
cells refers to the regression of mature cells back to undifferentiated cells, which leads to a 
loss of structural and functional differentiation (for further information see Röther, 2006). 
This can lead for example to deformed cell nuclei, giant cells and disturbed patterns of 
orientation of the cells to one another (Weinberg, 2013). As a result, tumors emerging from 
the same cell type can be classified into tumors of different WHO grades depending on the 
anaplasia of the cells and the other histological parameters/characteristics (Louis et al., 
2007; Weinberg, 2013). An example for a tumor consisting of astrocytes (astrocytoma) and 
its different nomenclature according to its histological profile and allocation to a WHO grade 
is provided in Table 1. It is common to divide gliomas into low and high grade gliomas (LGG, 
respectively HGG) due to their different biological behavior. 
 
Table 1: Histological classification of  primary brain tumors according to the WHO-scheme 
WHO Grade Dignity Estimated survival time Exemplary tumor entity  
I benign >5-(50) years pilocytic astrocytoma 
II semi-benign 3-5 years diffuse astrocytoma 
III semi-malignant 2-3 years anaplastic astrocytoma 
IV malignant 6 months (to 2 years) glioblastoma multiforme 
Note. WHO = world health organization  
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Only 15-20% of all primary gliomas are classified as LGG, which refers to a WHO grade of I or 
II (van Loon et al., 2015). Their mean incidence in Europe is approximately 1/100.000 
persons per year (van Loon et al., 2015). LGGs show a tendency for transformation of their 
cells from former benign status (grade I or II) to more and more malignant portions 
(anaplastic transformation). For instance, this transformation from an astrocytoma grade II 
to an anaplastic astrocytoma grade III or even a glioblastoma multiforme (GBM; highest 
graded astrocytoma) affects about 79% of the patients initially diagnosed with a LGG (Shaw 
et al., 2002). These so called secondary GBMs are more common in younger patients (Ohgaki 
& Kleihues, 2009). In cohorts of higher age metastases and malignant gliomas dominate 
(Röther, 2006). Here for example GBMs without former history of a low grade astrocytoma 
can be found (Berlit, 2006). 
Medical treatment of intracranial tumors consists currently of a neurosurgical operation, 
radiation and/or chemotherapy. Depending on the tumors’ histology and its localization 
inside the brain, these methods are combined and if necessary repeated. For some cases of 
benign tumors, like most meningiomas or some cases of pilocytic astrocytoma, one surgery 
is sufficient to prevent the tumor from growing back again and the patient is considered as 
cured. The prognosis is completely different in semi-benign and malignant gliomas, where 
despite repeated surgeries, radiation and chemotherapy, a recurrence of the tumor cannot 
be impeded. For LGGs, due to their slow growth rate and small rate of symptoms in 
neurological exams, in the past a ͞ǁait-and-see͟ appƌoaĐh was employed until symptoms 
manifested and a surgery was inevitable (Shields & Choucair, 2014). Today for the treatment 
of LGGs an early operation is recommended to prevent infiltration and anaplastic 
transformation, including evidence for a prolonged overall survival (Shields & Choucair, 
2014).  
Due to these differences between gliomas and other primary and secondary brain tumors 
regarding biological behavior (f. e. infiltrating vs. non-infiltrating), treatment (operation, 
chemo- and radiotherapy) and the resulting difference in their iŵpaĐt oŶ the patieŶt’s 
cognitive, psychological and physical wellbeing, this work will mainly focus on gliomas.  
For tumors located near or in so called eloquent areas (areas specialized for dedicated 
functions like for instance language or motor function where resection would induce 
permanent deficits) the surgery can be done under awake conditions to minimize the risk of 
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permanent impairment. This approach of an awake craniotomy is mainly used in glioma 
patients and described in detail in the following section. 
 
1.3 Awake craniotomies and brain mapping 
In the 1930s, Wilder Penfield’s approach of stimulating the exposed brain surface with 
electric currents during surgeries for epilepsy paved the way for awake craniotomies. By 
directly evoking responses to focal electrical stimulation of different cortical targets, this 
approach aimed at identifying eloquent motor areas to preserve respective cortex areas 
where stimulation elicited observable reactions (Penfield & Boldrey 1937). The resulting map 
of the huŵaŶ ͞hoŵuŶĐulus͟ aligŶed to the ďƌaiŶs suƌfaĐe oŶ the loĐatioŶ of the ŵotoƌ aŶd 
sensory areas is the most popular result of this work (Snyder & Whitaker, 2013). Years later, 
Ojemann optimized the technique and the rating of the intraoperative tasks (Whitaker & 
Ojemann, 1977). In 1992, Berger introduced direct cortical stimulation (DCS) to map 
language and motor functions on the exposed cortex during resections of intracranial 
tumors (Berger & Ojemann, 1992). Since then, DCS based brain mapping became the 
standard method for mapping brain functions in neurosurgery worldwide (Mandonnet, 
2011). Despite major technical improvements of preoperative functional imaging it is still not 
possible to predict the resectability (risk of permanent impairment) of a given brain area 
with high reliability (Ius, Angelini, Thiebaut de Schotten, Mandonnet, & Duffau, 2011). 
Therefore, DCS based brain mapping remains the gold standard procedure for tumor 
resection in eloquent areas.  
In general, the formal course of an awake craniotomy following an awake-awake-awake 
protocol can be described as follows: The patient is prepared with the routine monitoring 
devices for medical functions and lightly sedated, but still able to speak, react and move. 
After analgesia of the patients scalp works, it is incised and the subjacent skull is opened 
with a drill and a saw. Finally, the dura mater is incised and stitched to the sides. After that, 
the neurosurgeon uses a pin shaped electronic probe and applies short electric impulses, 
which can either disturb, inhibit or elicit neuronal function in a small area (transient virtual 
lesion) (Duffau, 2011a). Simultaneously with the stimulating electric current, which lasts only 
for seconds, the patient is asked to execute a specific task like picture naming. If task 
execution is disturbed or not feasible for the patient, the site is considered with positive 
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response to DCS. In consequence, such sites are regarded as functionally essential and will 
not be removed (Duffau, 2011b). To increase the reliability of DCS positive results, the gold 
standard to date is to stimulate a brain site for three times and to spare it, if all stimulations 
led to disturbances in the monitored function (Duffau, 2011a). Behavioral reactions are 
often visualized by applying sterile paper numbers and letters on the brain surface, which 
represent the different patient reactions to DCS. The result is an individual map of the 
patieŶts’ fuŶĐtioŶs on his brains surface as shown in Figure 1. After to cortical mapping the 
resection of the tumor is initiated (Talacchi, Santini, Casartelli et al., 2013). Stimulation on 
subcortical white matter tracts is used for further resection with the goal to identify the 
deep functional limits of the resection (Duffau, 2011b). In awake surgery and DCS the 
neuropsychological diagnostic has the responsibility to ensure the mapping of functions 
located near the tumor and monitor these functions during the tumor resection. Alterations 
of the assessed functions are recorded and reported to the neurosurgeon. In addition, the 
neuropsychologist has the responsibility to ensure the patients’ compliance and well-being. 
Details of the intraoperative neuropsychological diagnostic are described in the section 
͞intraoperative diagnostics͟ below.  
 
 
Figure 1: Intraooperative image of a brain’s surface. Sterile paper number tags indicate different brain sites 
stimulated with DCS. The tags correspond to the patient’s behavior in reaction to DCS. Left side (C): Mapped 
cortex before any resection, tumor is marked with an asterisk (*). Right side (D): Completed resection of the 
tumor with spared functional areas in the resection cavity indicated by number 40 and 50 (with kind permission 
taken from Duffau, 2005). 
 
In contrast to the former approach, the patient is deeply sedated until brain mapping can 
start during an asleep-awake-asleep protocol. Mapping is performed during the awake state 
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and the patient is narcotized before and after this procedure. This approach is not used in all 
clinics, due to the risk of non-compliance caused by deep sedation and the need for 
intubation (Talacchi, Santini, Casagrande et al., 2013). 
The objective of an awake craniotomy is to balance the oncological outcome (improve the 
survival of the patient) and the functional outcome (preserve quality of life) (Klein, Duffau, & 
Witt Hamer, 2012; Yordanova, Moritz-Gasser, & Duffau, 2011). For this balancing between 
maximizing the tumor resection and minimizing permanent neurological deficits Duffau 
iŶtƌoduĐed the teƌŵ „onco-functional balance͟ (Duffau & Mandonnet, 2013). 
Maximization of the survival time can be achieved by expanding the resection even beyond 
the visible tumor borders (Duffau, 2011c; Yordanova et al., 2011). This reduces tumor 
infiltrated brain tissue and therewith a recurrence and the potential for anaplastic 
transformation (Duffau, 2011c; Yordanova et al., 2011). Studies document the positive 
correlation between overall survival time and the extent of resection (Berlit, 2006). 
However, an aggressive resection bears the risk of permanent functional loss, which can 
ultimately reduce the patieŶt’s quality of life (Giovagnoli, 2005). Minimizing such risks of 
permanent deficits can be achieved by sparing functional areas during the resection with the 
help of a functional brain map, as provided by DCS in awake craniotomy (Duffau, 2011c). 
Usually, the resection is stopped when no more tumor tissue is apparent by visual inspection 
and a safety margin of 1 or 2 cm around the former tumor is resected (Berlit, 2006). A more 
aggressive approach was introduced by Duffau’s gƌoup, suggesting that resection should be 
stopped when reaching functional borders like for example eloquent subcortical pathways 
(Talacchi, Santini, Casagrande et al., 2013). According to this group, the greater extent of 
resection increases the overall survival time without decreasing the cognitive and physical 
wellbeing of the patient (Bello et al., 2011; Duffau, 2009b; Duffau & Mandonnet, 2013). 
Despite these promising results, theƌe is ͞Ŷot eŶough data to ǀalidate this stƌategǇ to date͞ 
and future studies on feasibility, reproducibility and safety are mandatory (Talacchi, Santini, 
Casagrande et al., 2013).  
A good intraoperative detection of the functional borders is only possible when patient 
selection, preparation, intra-operative diagnostic and postoperative outcome evaluation 
follow a high diagnostic standard. Here, the central role of neuropsychological diagnostics 
becomes evident. Because cognitive and physical functioning are pivotal for social 
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participation and quality of life (Ownsworth, Hawkes, Steginga, Walker, & Shum, 2009), it is 
one of the main goals of neuropsychological diagnostics in the neurosurgery context to 
support every attempt to preserve these functions. 
 
1.4 Neuropsychological impairments in intracranial tumors 
The effects of an intracranial tumor ͞ǀaƌǇ aĐĐoƌdiŶg to suĐh faĐtoƌs as theiƌ Ŷatuƌe, site, size, 
ƌate of gƌoǁth, aŶd theiƌ tƌeatŵeŶt;sͿ͟ (Lezak, 2012, p. 333). The most common 
consequences of an intracranial tumor are neurological deficits and (neuro-) psychological 
changes of intellect and personality.  
Several factors regarding the basic neurobiological principles of brain tumors are 
responsible for cognitive impairment. All brain tumors share an increase of the intracranial 
pressure due to their mass effect inside the scull. In case of slow growing tumors, the brain 
is able to tolerate their growth in some parts by shrinkage of the ventricles and compression 
of the brain tissue. This process can continue over years before any signs of an increased 
intracranial pressure or neuronal malfunction become evident (Poeck & Hacke, 2006). Due 
to constant pressure on the brain tissue, cerebral perfusion decreases and relative oxygen 
shortage occurs. In addition, newly built vessels lack a blood-brain-barrier in some tumors. 
As a consequence, the surrounding brain tissue may store liquid and thus swells. This 
mechanism is known as tumor induced edema of the brain. On the long run, shortage of 
oxygen, as well as edema, disturb routine neuronal communication leading to impairments. 
Overall, cognitive decline increases with edema and tumor size and a higher WHO grade 
(Talacchi, Santini, Savazzi, & Gerosa, 2011; Taphoorn & Klein, 2004). In addition, depending 
on the kind of tumor, the borders between tumor and healthy brain tissue are to a greater 
or lesser extent differentiated. In particular low grade gliomas (LGG; primary brain tumors 
with low WHO grade) tend to grow along cerebral fibers and infiltrate large areas of brain 
tissue without causing a clear mass effect for a longer period (Duffau, 2011b). The extent of 
infiltration of healthy brain tissue and resulting degeneration of neuronal communication 
also contributes to cognitive impairment (Bosma et al., 2007; Taphoorn & Klein, 2004). In 
addition, every third brain tumor patient experiences epileptic seizures, often as an initial 
symptom (Poeck & Hacke, 2006). About 65%-85% of patients with LGG do experience 
seizures as general symptom of the disease (Shields & Choucair, 2014). Epileptic seizures 
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hamper cognitive functioning and require medication (Bosma et al., 2007; Correa et al., 
2007; Klein et al., 2001; Klein et al., 2012). However, anti-epileptic medication may have a 
negative influence on attention and executive functions (Klein et al., 2002; Klein et al., 2003). 
Furthermore, radio- and chemotherapy can also lead to a reduced cognitive and physical 
performance status (Correa et al., 2007; Correa et al., 2008; Klein et al., 2002). In summary, 
factors of tumor characteristics, treatment modalities and comorbidities can account for the 
observed variations of cognitive functioning in patients with gliomas over time (van Loon et 
al., 2015).  
Tumor related neurological impairments are movement disorders and hemiparesis, as well 
as sensory deficits and visual disturbances (Poeck & Hacke, 2006). Symptoms caused by 
increased intracranial pressure include headache, deceleration, a general lack of interest as 
well as changes in affect and motivation (Poeck & Hacke, 2006). In addition, cognitive 
symptoms such as disturbances of language, memory, attention, orientation or planning are 
frequently found in patients with intracranial tumors (Klein et al., 2002; Meyers, Hess, Yung, 
& Levin, 2000; Murray et al., 2000; Santini, Talacchi, Squintani et al., 2012; Satoer et al., 
2012; Scheibel, Meyers, & Levin, 1996; Scotland, Whittle, & Deary, 2012; Talacchi et al., 
2011; Taphoorn & Klein, 2004; Tucha, Smely, Preier, & Lange, 2000). The prevalence of 
cognitive decline before treatment (surgery, radio- or chemotherapy) in patients with 
intracranial tumors is shown in Table 2. Only studies applying a neuropsychological test 
battery, a clear definition of patient sample and assessment date were included. Although 
glioma induced impairments can affect all cognitive domains, a substantial portion of 
patients show no signs of cognitive deficits at all (Habets et al., 2014; Klein et al., 2002; 
Meyers et al., 2000; Murray et al., 2000; Santini, Talacchi, Squintani et al., 2012; Satoer et al., 
2012; Scheibel et al., 1996; Scotland et al., 2012; Talacchi et al., 2011; Taphoorn & Klein, 
2004; Tucha et al., 2000).  
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Table 2: Cognitive impairment in patients with brain tumors before treatment in comparison 
with healthy subjects 
 cognitive domains neuropsychological tests 
study impaired most often 
impaired 
impaired most often 
impaired 
Santini, Talacchi, 
Squintani et al., 2012: 
n = 22, gliomas in the 
left hemisphere, 
scheduled for awake 
craniotomy, 
͞preoperative  ͟
37% of the 
patients showed 
deficits in one or 
more domains 
visual-spatial 
memory 
 
59% of the 
patients showed 
deficits in one or 
more tests 
 
visual-spatial 
memory, verbal 
memory, word 
fluency 
 
Talacchi et al., 2011: n 
= 29, gliomas, 1-5 days 
prior to the operation  
 
 
38% of the 
patients showed 
deficits in one or 
more domains 
executive 
functions, 
memory, 
language, gnosis, 
kinetic praxia 
executive 
functions 
79% of the 
patients had 
deficits in at 
least one of the 
tests 
verbal memory, 
visual-spatial 
memory, word 
fluency 
 
Tucha et al., 2000: n = 
139, primary or 
secondary intracranial 
tumors, before 
operation (not further 
specified) 
/ / 
91% of the 
patient had 
deficits in one or 
more tests 
memory, 
attention, 
executive 
functions 
Habets et al., 2014: n= 
62, high grade gliomas, 
week before 
operation 
79% impairment 
in at least one 
domain 
verbal memory, 
attention 
/ / 
Satoer et al., 2012: n = 
28, gliomas in left 
hemisphere, 1-2 
months before the 
operation 
language, 
memory, 
executive 
functions 
/ / / 
Satoer et al., 2014: n = 
45, gliomas in 
eloquent areas 93.3% 
left hemisphere, 1-2 
months before 
operation 
language, 
memory, 
attention, 
executive 
functions 
/ / / 
Note. / = no data available 
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In patients with LGGs, the prevalence of cognitive impairments regarding memory, attention 
and executive functioning range from 19% to 83% (van Loon et al., 2015). Comparing high 
and low grade gliomas, a recent finding by Campanella and colleagues (2015) supports the 
assumption that patients with HGG show lower preoperative cognitive functioning over LGG 
patients. The ability of the brain to compensate for tumor induced neuronal malfunctions 
and to reorganize after lesions is referred to as neuroplasticity (Duffau, 2011b) and 
discussed in detail in section 1.5 Neuroplasticity. In this section, the relationship of tumor 
grade and impairment is also further specified. 
The dimension of surgery induced cognitive impairments cannot be validly estimated since 
the existing literature on the comparison of pre- and direct postoperative cognitive 
functionality is scarce (Klein et al., 2012). Evidence for surgery induced impairments was 
demonstrated in a small cohort study by Reijneveld and colleagues (2001), who evaluated 
which treatment option (wait-and-see vs. surgery) is preferable for patients with LGGs 
regarding cognitive functionality. The cognitive performance of 24 patients with suspected 
LGG (wait-and-see group) was assessed via a neuropsychological test battery and compared 
to the performance of i) patients with operation or ii) biopsy approved LGGs and iii) a control 
group. All groups were matched. Both patient groups showed worse cognitive performance 
relative to the control group. The operated LGG-patients demonstrated more severe 
cognitive decline than the LGG-patients without operation or biopsy. Talacchi and colleagues 
(2011) reported impairments in 76% of the patients after successful surgery on the single 
test level, and in 38% on the domain level. An improvement of cognitive functions only 
occurred in approximately 20% of the patients whereas a worsening was found in 38% 
(single test level). In contrast, Campanella and colleagues (2015) found a significant increase 
in cognitive deficiency rates only for LGG patients directly after the operation but no change 
in HGG patients. Table 3 summarizes all studies comparing cognitive functioning in patients 
with intracranial tumors before and after the operation using extensive neuropsychological 
test batteries. It remains an open question why cognitive functioning improves directly after 
surgery in some cases but declines in others.  
In general, the patients’ individual physiological response to an intracranial operation has 
to be taken into account (Talacchi et al., 2011). Some patients develop postoperative edema 
and infarction around the resection cavity, which can account for cognitive and sensory-
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motor decline (Poeck & Hacke, 2006). On the other hand, reduction of the tumors’ mass 
effect can improve the formerly existent impairments spontaneously (Tucha et al., 2003). In 
addition, the brain’s ability to adapt to lesions before the operation (neuroplasticity) can 
differ between patients. For example, patients with higher preoperative adaption to the 
tumor (as often seen in LGG patients) tend to have fewer direct postoperative deficits 
despite removal of eloquent areas (Desmurget, Bonnetblanc, & Duffau, 2007). 
Depending on the tumor type (LGG or HGG), the changes in cognitive functionality across 
time can differ significantly. As shown in Table 3, only few studies are available comparing 
cognitive functioning in the long-term follow-up with a comprehensive neuropsychological 
test battery. For instance, Santini and colleagues (2012) reported a rate of 45% of patients 
with a decline in cognitive functioning, whereas improvement is reported in 5% of the 
patients. Predominantly executive and language functions were affected. In approximately 
one third of the patients, no changes in the assessed cognitive functions were found. While 
60% of LGG patients were able to return to work, this was only the case in 10-20% of HGG 
patients (Armstrong et al., 2016). 
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Table 3: Cognitive impairment in patients with brain tumors after surgery in comparison 
with preoperative results 
study 
cognitive domains single neuropsychological tests 
    
Talacchi et al., 2011: n = 29, 
gliomas, 3-7 days 
postoperatively 
21% 
 
24%  
memory 
38% 
visuo-motor 
pace with 
alternation 
24% 
memory 
Habets et al., 2014: n= 36, 
high grade gliomas, 5 weeks 
after operation before any 
treatment 
17% verbal 
memory, 15% 
attention, 15% 
psychomotor 
function 
(total 23%) 
24% visuo-
construction, 
21 % verbal 
memory, 
18% 
attention 
(total 49%) 
/ / 
Satoer et al., 2014: n = 45, 
gliomas in eloquent areas 
93.3% left hemisphere, 1-2 
months before operation 
and 3 months 
postoperatively 
language memory 
categorical 
fluency 
free verbal recall 
Satoer et al., 2012: n = 28, 
gliomas in left hemisphere, 
3-4 months after the 
operation 
language, 
executive 
functions 
/ 
39% 
word fluency, 
visuo-motor 
pace with 
alternation 
21% 
free verbal recall 
Santini, Talacchi, Squintani 
et al., 2012: n = 22, patients 
with glioma in the left 
hemisphere, scheduled for 
awake craniotomy, follow-
up data obtained 3–6 
months postoperatively (if 
possible) 
45%  
executive 
functions, 
memory 
5% 
 
 
54% 
word fluency, 
attention, 
working 
memory, 
verbal 
memory, 
picture naming 
18% 
 
 
Note.  = decreased functionality;  = increased functionality; / = no data available 
 
When evaluating the number of impaired patients, the following considerations have to be 
taken into account. First, there is no consensus on how to assess cognitive impairment in 
patients with intracranial tumors (van Loon et al., 2015). Following this, the information 
about the number of impaired patients depends, beside tumor characteristics, on the time 
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point of assessment (before/after the operation and course of the disease), different patient 
samples (first diagnosis, recurrence), different neuropsychological assessment methods 
(selection of tests, evaluation focus like test-specific or domain-specific analysis) and 
different criteria for impairment. In addition, reports of missing data or participation bias of 
subjects are often missing in the literature so far. Moreover, the different rates on 
postoperative cognitive improvement or decline can be explained by several factors, along 
with different methods for assessment and criteria of impairment classification. First, the 
postoperative assessment time points differ between studies and some included also 
patients with passed radio- and/or chemotherapy (for example Satoer et al., 2012). Second, 
the tumor type is crucial for the course of cognitive functioning. In case of tumors with no 
recurrence, like most meningiomas, postoperative cognitive impairment remains stable or 
can be increased by neuropsychological rehabilitation and therapy (Meskal, Gehring, Rutten, 
& Sitskoorn, 2016). In case of slow growing lesions like LGGs, time also allows rehabilitation 
of cognitive deficits but tumor growth will subsequently lead to deficits again. In case of 
malignant (primary) brain tumors only a short time period for recovery exist. Their fast 
progressive tumor growth makes additional treatment such as chemo- or radiotherapy 
necessary, which are known to negatively influence cognitive performance. Moreover, their 
recurrence leads to inevitable cognitive decline (Bosma et al., 2007; Correa et al., 2007; 
Correa et al., 2008; Klein et al., 2002). Third, the type of surgical approach (tumor 
extirpation under intubation narcosis or awake craniotomy) might have a significant 
influence, especially on functions like language and sensory-motor processing, because 
cognitive and physical functions can be protected under awake craniotomy (see chapter  1.3 
Awake craniotomies and brain mapping).  
 
1.5 Neuroplasticity 
The concept of neuroplasticity describes the brain’s ability to rearrange cerebral 
organization following injuries to restore functioning of neuronal networks (Desmurget et 
al., 2007). Neuroplasticity can also take place in healthy individuals due to learning of new 
abilities (Thomas & Baker, 2013). The underlying biological mechanisms at a microscopic and 
macroscopic scale, such as modulation of synaptic efficiency, neurogenesis or functional 
redundancies, are currently investigated in many studies (Duffau, 2011c). It is known that 
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some of these mechanisms allow changes of neuronal functioning within minutes to hours 
(short-term remodeling) while other types require several days to months before reaching a 
new functional state (medium- or long-term remodeling) (Duffau, 2011c). Based on fMRI 
studies, a hierarchical model of reorganization with three steps of functional redistribution 
in patients with intracranial tumors was suggested: In a first step remaining functional areas 
within the tumor are determined, in a second step, neuroplastic mechanisms redistribute 
eloquent areas around the tumor tissue and finally, if compensation is still insufficient,  
fuŶĐtioŶal ĐoŵpeŶsatioŶ ďǇ ͞ƌeŵote aƌeas ǁithiŶ the lesioŶed heŵispheƌe aŶd/oƌ 
ĐoŶtƌalateƌal hoŵologs͟ is established (Desmurget et al., 2007). 
Following the time course of a brain tumor disease, three intervals for possible 
compensation can be defined: i) preoperative functional compensation, ii) intraoperative 
functional reshaping and iii) postoperative functional compensation. For the preoperative 
phase of compensation the temporal pattern of the lesion (acute vs. slow-growing) was 
identified as a central factor for neuroplasticity (Desmurget et al., 2007). Functional 
compensation is higher in slow growing lesions such as LGGs over acute lesions caused by 
stroke. LGGs grow approximately 4 mm per year and within 8 years, most patients do not 
show any neurological or neuropsychological impairments due to neuronal adaption 
(Desmurget et al., 2007). Acute and slow growing lesion types seem to differ with respect to 
their pattern of reorganization: the recruitment of remote brain areas in the ipsi- and 
contra-lesional hemisphere is much more efficient in slow growing than in acute lesions 
(Desmurget et al., 2007). In addition to the previously described fMRI studies, intraoperative 
DCS studies confirmed the hierarchical model of reorganization and its postulated three 
steps of organization of eloquent areas especially for sensory-motor and language sites 
(Duffau, 2011c). Furthermore, the assumption of short-term remodeling and immediate 
intra-surgical plasticity triggered by the resection itself could be observed by DCS 
assessment for the first time (Desmurget et al., 2007). With the help of DCS, brain regions 
which cover similar functions can be identified (redundant sites). Subsequently, the site 
which is infiltrated by the glioma can be resected and the functional transfer to the second, 
intact site can be observed (Duffau, 2011c). Postoperatively, neuroplastic adaptions can be 
supported by specific rehabilitation (Duffau, 2011c; Zucchella, Capone et al., 2013).  
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The integration of the existing knowledge about neuroplasticity led to two main therapeutic 
implications. First, based on the results of a study by Ius and colleagues (2011), a map of 
resectability was generated for WHO °II gliomas which indicates the probability of eloquent 
areas within tumor affected structures with the goal to preoperatively estimate the 
expected extent of the resection. A high probability of functional areas within the tumor 
mass was found in the primary motor and somatosensory cortex and emphasizes the 
importance of dedicated intraoperative diagnostic for sensory-motor functions (Ius et al., 
2011). In a complementary approach, Duffau (2011c) proposed a list of cortical areas where 
surgical removal should induce only transient deficits and would allow full postoperative 
recovery. These areas included, among others, the supplementary motor area (SMA), the 
insula or primary somatosensory areas (Duffau, 2011c). Second, knowledge regarding the 
time course of neuroplasticity enables a staged neurosurgical approach (Talacchi, Santini, 
Casagrande et al., 2013; Talacchi, Santini, Casartelli et al., 2013). Factors like the resection 
itself, postsurgical rehabilitation and/or regrowth of the residual tumor could result in 
additional functional reshaping (Duffau, 2011c). If eloquent areas are found within the 
tumor, allowing only an incomplete glioma resection, modern neuro-oncology recommends 
a waiting period for further neuroplastic changes and a second surgery several months or 
years after the first. Animal studies confirmed a better outcome for such a staged 
neurosurgical approach relative to a single complete resection (Duffau, 2011c; Martino, 
Taillandier, Moritz-Gasser, Gatignol, & Duffau, 2009; Robles, Gatignol, Lehéricy, & Duffau, 
2008).  
Because neuroplasticity is difficult to investigate, only sparse information about predictors 
and limitations of the plastic potential is accessible to date. One limiting factor seems to be 
the subcortical connectivity via white matter fibers. A minimum of connecting white matter 
tracts needs to be preserved to enable postoperative recovery (Ius et al., 2011). So far, there 
is only evidence for patterns of subcortical plasticity involving the altered use of preserved 
white matter tracts, but Ŷo eǀideŶĐe foƌ ďuildiŶg Ŷeǁ tƌaĐts ;͞ƌeǁiƌiŶg͟Ϳ in humans (Duffau, 
2009a). Neurosurgery could potentially harm necessary white matter connections and 
thereby lead to permanent neurological impairments. This again emphasizes the importance 
of awake craniotomies and suitable intraoperative diagnostic of functional areas as 
described in chapter 2.2.3.2 Intraoperative diagnostics.  
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2 METHODOLOGICAL BACKGROUND AND CONSIDERATIONS 
2.1 Neuropsychological assessment in intracranial tumors 
Neuropsychological approaches in intracranial tumors primarily focus on diagnostics with 
the goal to help optimizing medical treatment stages for the individual needs of patients 
;͞personalized therapeutic management͟Ϳ (Duffau, 2014). At the beginning of the inpatient 
stay and before the operation, the main concern regards the patieŶt’s current cognitive 
status. Prior to treatment, the goal of the neuropsychological assessment is to establish a 
cognitive profile providing a first evaluation of the status of the most important cognitive 
and sensory-motor functions. In contrast to standard neurologic examinations, deficits are 
often diagnosed by in-depth neuropsychological assessment (Duffau, 2014). This profile 
provides the physicians with an overview of the patient’s ability to understand questions and 
instructions and cooperate. In addition, cognitive deficits can be seen as indicators of the 
functional-neuroanatomical relationship between the tumor and the surrounding brain 
tissue. Many patients benefit from neuropsychological education and explanation of their 
symptoms. This way, the compliance for the following treatments can be increased (Díaz et 
al., 2009). For clinical as well as research purposes, the initial baseline assessment is crucial 
for all conclusions drawn from the following assessment time points. Comprehensive 
intraoperative neuropsychological diagnostic supports the neurosurgeon’s decisions 
regarding the resection and therewith helps to maintain the patient’s cognitive and physical 
status as well as quality of life. Follow-up diagnostic enables planning of rehabilitation and 
assessment of rehabilitation achievements. In addition, reliable and valid diagnostic is 
necessary for outcome evaluation. This influences the impact of surgical techniques such as 
awake craniotomy compared to intubation narcosis and also the need for the evaluation of 
side effects of radio- or chemotherapy. 
In the following sections, basic principles of neuropsychological assessment, methodological 
quality criteria and diagnostic requirements resulting from patient care in the context of 
neurosurgery are discussed.  
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2.1.1 Neuropsychological diagnostics 
To describe complex cognitive performance, it is necessary to establish theoretical 
assumptions of the underlying cognitive constructs which are often not directly observable 
(Lezak, 2012). Well-established cognitive constructs are evidence based, and for example 
recommended by the guidelines for neuropsychological diagnostic of the German society of 
neuropsychology (Leitlinien zur neuropsychologischen Diagnostik der Gesellschaft für 
Neuropsychologie (GNP; Gauggel & Sturm, 2005) and can be found in the existing standard 
text books of clinical neuropsychology (Hartje & Poeck, 2006; Lezak, 2012; Sturm et al., 
2007). Basic functions such as concentration, orientation to time and working memory as 
well as higher cognitive functions such as reasoning or planning are defined. Single functions 
for similar constructs can be grouped into cognitive domains. For instance the domain 
language is composed of reading, picture naming and understanding written and acoustic 
information (Satoer et al., 2012). Other common domains are attention, memory and 
executive functions (Lezak, 2012; Schnider, 2008; Taphoorn & Klein, 2004). There is no strict 
assignment of discrete cognitive functions to cognitive domains. This can be explained by the 
fact that particular functions often contribute to more than one domain (Lezak, 2012). In 
additioŶ, ͞It is typically unclear, and in most cases impossible to demarcate a distinctive 
ďouŶdaƌǇ ǁheƌe oŶe fuŶĐtioŶ stops aŶd the otheƌ ďegiŶs.͟ (Lezak, 2012, p. 25). Similar 
problems emerge when assigning neuropsychological tests to discrete functions since test 
performance often engages several cognitive functions. Consequently, assignment of tests is 
commonly carried out according to major functional areas of response. However, such 
assignment differs in complexity among different tests which strongly call upon several 
functions (Lezak, 2012). The Trail making test part B is an example for a complex assignment 
of a test (Tombaugh, 2004). The TMT-B aims to assess visuo-motor speed and divided 
attention, but captures also visual scanning, attention and cognitive speed (Tombaugh, 
2004). Due to this, the TMT-B can be applied as a tool for assessment of different domains 
such as attention or visuo-motor functions. In summary, the absence of any consensus on 
the distinction of cognitive domains or assigned functions for neuropsychological diagnostics 
might hamper valid estimation of the prevalence of cognitive deficits in patients with brain 
lesions. 
Compilations of neuropsychological tests, so called test batteries, aim to investigate, with at 
least one neuropsychological test, the most important domains of cognition such as 
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language, visuo-motor speed, visuo-perception, attention and memory (Satoer et al., 2014; 
Taphoorn & Klein, 2004). An average assessment time for a comprehensive 
neuropsychological test battery in patients with intracranial tumors is one hour or more 
(Bosma et al., 2007). The final result of this assessment is a neuropsychological performance 
profile, characterizing the patieŶt’s stƌeŶgths aŶd deficits (Taphoorn & Klein, 2004). 
Diagnostic test instruments of a battery are taken from other settings such as intelligence 
diagnostics (f. e. digit span from Wechsler batteries) as well as pools of tests explicitly 
dedicated to neuropsychological testing (f. e. the Five Point Test) (Lezak, 2012). For practical 
reasons, a selection of short single tests is usually preferred over one extended test. This 
allows for taking breaks without compromising test results. Suggestions of a gold standard 
for diagnostics in the setting of a neurosurgical emergency hospital can be found in the 
existing literature (Reijneveld et al., 2001; Taphoorn & Klein, 2004), some of which refer to 
tests being successfully applied in patients with intracranial tumors (Satoer et al., 2014). 
However, a major drawback is the lack of validation of many cognitive tests for the use in 
patients with brain tumors. Furthermore, a standardized implementation of diagnostic tests 
would be mandatory to guarantee sufficient validity. Chapter 2.1.2 of this thesis focuses on 
the description of evaluation criteria for the quality of diagnostic test instruments. 
In some instances, particularly in research settings with low resources or patients with 
strong impairments, short cognitive screening tools might be more appropriate than 
comprehensive test batteries. With an average assessment period of approximately 10 
minutes, they are very efficient. However, one drawback is the lack of a differentiated 
cognitive performance profile as cognitive screening tools often assess cognitive functions or 
constructs via a single item to generate a sum score for global cognitive functioning. This 
might significantly affect both the sensitivity and specificity of the assessment. Specifically, 
the use of screening tools always bears the risk of false negatives (i.e., erroneously 
classifying patients as unimpaired), which can be avoided by using a comprehensive test 
battery. Another percentage of patients is misclassified as impaired by screening tools but 
does not show cognitive impairment in a comprehensive test battery (i.e., false positives). 
Consequently, the aim of the first publication included in this thesis (Becker, Steinmann et 
al., 2016) focuses on the validity of different screening methods and their potential for 
clinical and research application. 
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The two most common cognitive screening tools in the field of intracranial tumor patients 
are the Mini Mental Status Exam (MMSE) (Folstein, Folstein, & McHugh, 1975; Kessler, 
Denzler, & Markowitsch, 1990) and the Montreal cognitive assessment (MoCA) (Nasreddine 
et al., 2005). The MMSE was designed to screen for patients with a high probability of 
Alzheiŵeƌ’s disease ;ADͿ. The MoCA represents a later, more sensitive advancement which 
aims at identifying patients with mild cognitive impairment as a first stage of AD, which 
might be missed by the MMSE. Consequently, the MMSE consists of easier items and is more 
prone to ceiling effects in the sum score in patient groups other than AD (Tombaugh & 
McIntyre, 1992). The MMSE includes tasks for orientation, attention/concentration, 
language functions, construction, verbal learning and recall (Malloy et al., 1997). It is not 
suitable for the assessment of cognitive deficits such as executive functions, abstract 
thinking, judgment, problem solving and visual perception (Malloy et al., 1997; Meyers & 
Brown, 2006; Meyers & Wefel, 2003; Nasreddine et al., 2005; Shibamoto et al., 2008; Smith, 
Gildeh, & Holmes, 2007). Thus, additional testing is recommended to cover executive 
functioning (Folstein, 1998). The MoCA evaluates visuospatial/executive functions, naming, 
verbal memory (immediate and delayed recall), verbal fluency, attention, abstraction, and 
orientation. It was previously validated in patients with intracranial tumors (Olson, Tyldesley 
et al., 2011). Although it was initially designed for patients with an early state of dementia, 
current studies show a clear advantage over the MMSE also in neuro-oncological patients 
(Bernstein, Lacritz, Barlow, Weiner, & DeFina, 2011; Olson et al.; Olson, Tyldesley et al., 
2011; Olson, Chhanabhai, & McKenzie, 2008). To overcome the limitations of established 
tools in the field of (neuro-) psychology with respect to sensitivity and specificity, new tools 
are validated against established tools. A recently published screening tool is the Brief 
Cognitive Status Exam (BCSE), as part of the Wechsler Memory Scale – Fourth Edition 
(Petermann & Lepach, 2012). The first publication included in this thesis represents the first 
validation of the BCSE in patients with intracranial tumors and provides a differentiated 
analysis of its use for this patient group (see chapter 3.1). 
 
2.1.2 Quality criteria for diagnostic tools  
The test quality is usually defined by standard criteria, including test objectivity, reliability 
and validity (Moosbrugger & Kelava, 2012b). In addition, a psychological test instrument can 
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be evaluated in terms of its performance as a classifier for a certain function such as 
cognitive impairment (i. e. impaired vs. non-impaired). In psychological and medical 
contexts, metrics like sensitivity and specificity are preferred to assess the validity of a 
diagnostic instrument. The main criteria and selected methods for their quantification are 
described in more detail in the following section. 
 
2.1.2.1 Objectivity  
A test is considered as objective, if data is collected in an unbiased fashion and therefore 
independent of test instructor, scorer and interpreter (Moosbrugger & Kelava, 2012a). 
AĐĐoƌdiŶg to the diffeƌeŶt steps of a test pƌoĐeduƌe ;adŵiŶisteƌ test, sĐoƌe tested suďjeĐt’s 
performance, interpret results), objectivity can be differentiated into three sub aspects 
termed implementation, evaluation and interpretation objectivity (Amelang, Zielinski, 
Fydrich, & Moosbruger, 2002). During each step of a test procedure the examiner might 
have an influence on the final test result/score of a tested subject (Amelang et al., 2002). To 
ensure independence of the final test result from the examiner, most test manuals provide 
specific and detailed instructions on how to administer, score and interpret the test (Strauss, 
Sherman, Slick, & Spreen, 2006). According to classical test theory, the final test result ;͞ǆ͟Ϳ 
of a tested subject is thought to be the suŵ of a tƌue sĐoƌe ;͞t͟Ϳ aŶd aŶ eƌƌoƌ ;͞e͟Ϳ eǆpƌessed 
iŶ the foƌŵula ͞ǆ = t + e͟ (Strauss et al., 2006). The MeasuƌeŵeŶt eƌƌoƌ ͞e͟ can be defined as 
͞fluĐtuatioŶ iŶ sĐoƌes that ƌesults fƌoŵ faĐtoƌs ƌelated to the ŵeasuƌeŵeŶt pƌoĐess that aƌe 
iƌƌeleǀaŶt to ǁhat is ďeiŶg ŵeasuƌed͟ ;Urbina, 2004, p. 117). From this view, standardization 
of each step of a test procedure aims to minimize variance of the error in the final test result 
due to different examiners, scorers and test situations (Beauducel & Leue, 2014; Strauss et 
al., 2006).  
In more detail, implementation objectivity refers to the grade of independence of the test 
results from systematic or unsystematic variations of behavior of the examiner during test 
implementation. Behavior of the examiner can lead to variations in the performance of a 
tested subject and in consequence to variations of the final test result (Lienert & Raatz, 
1998). Implementation objectivity can be achieved by providing clear instructions on the 
conditions under which the test should be performed, such as (written) instruction for the 
tested subject, help f. e. by cuing or rules for termination in the handbook (Moosbrugger 
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& Kelava, 2012b). As a result of this standardization, the implementation conditions should 
not vary between assessments (Lienert & Raatz, 1998) and the tested person is assumed to 
be the only source of variance in the assessment situation (Moosbrugger & Kelava, 2012b).  
Evaluation objectivity refers to the numerical or categorical evaluation of the recorded test 
performance of a tested subject according to dedicated rules (Lienert & Raatz, 1998). This 
can be achieved by providing the investigator with a standardized protocol and scoring sheet 
for each subject and consistent rules for scoring of test performance in the test manual 
(Lienert & Raatz, 1998). The final result of the scoring/evaluation procedure is the raw score 
of the tested subject (Lienert & Raatz, 1998). Evaluation objectivity is perfect in case of items 
ǁith a Đleaƌ ͞ĐoƌƌeĐt͟ oƌ ͞ǁƌoŶg͟ aŶsǁeƌ ;f. e. WeĐhsleƌ Digit “Ǉŵďol TestͿ (Lienert & Raatz, 
1998; Sherman, Brooks, Iverson, Slick, & Strauss, 2011). Lower evaluation objectivity is 
obtained for tests with a subjective component during scoring (f. e. Rey-Osterrieth Complex 
Figure, Aachener Aphasie Test or verbal fluency tasks) (Sherman et al., 2011). Most 
handbooks provide examples with clearly assigned scoring, however, regularly there is test 
performance which is not covered by such examples and in consequence, scoring is not 
possible without ambivalence (Lienert & Raatz, 1998). 
Interpretation objectivity refers to the grade of independence of the interpretation of raw 
scores of a test from the interpreting person, which must not be necessarily the examiner or 
scorer of the test (Lienert & Raatz, 1998). Most handbooks provide clear rules for 
interpretation of raw scores to achieve interpretation objectivity (Moosbrugger & Kelava, 
2012a). Absolute interpretation objectivity is given where norm charts or criterions for 
definition of aberrations are available (f. e. raw scores are assigned to percentile ranks or 
classified by a cutoff score) (Lienert & Raatz, 1998; Moosbrugger & Kelava, 2012a). In this 
case, identical raw scores of different test subjects will result in the same interpretation 
result. Loǁeƌ iŶteƌpƌetatioŶ oďjeĐtiǀitǇ is fouŶd iŶ ͞ĐliŶiĐal appƌoaĐhes͟ ǁheƌe test ŵateƌial 
needs interpretation of the examiner (f. e. projective tests) (Amelang et al., 2002).  
Objectivity, reliability and validity are strongly related factors, where objectivity is a basic 
requirement for the others (Beauducel & Leue, 2014). Quantification of implementation, 
evaluation and interpretation objectivity is possible by assessing the degree of concordance 
between two or more investigators and is referred to as interrater reliability (Margraf, 
Maier, & Pschyrembel, 2012). Due to the substantial overlap of the concepts of objectivity 
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and reliability (see also Amelang et al., 2002) some authors outline statistical quantification 
of objectivity in the section/chapter on objectivity and do not introduce the term interrater 
reliability (f. e. Amelang et al., 2002; Lienert & Raatz, 1998; Moosbrugger & Kelava, 2012a). 
Contrariwise, other authors introduce interrater reliability in the section on reliability and do 
not address the topic objectivity in detail (Sherman et al., 2011; Strauss et al., 2006). 
For this work, we followed a suggestion of Amelang and colleagues (2002) classifying the 
above outlined aspects of implementation, evaluation and interpretation objectivity 
ƋualitatiǀelǇ as ͞pƌeseŶt͟ oƌ ͞aďseŶt͟ afteƌ ƌeǀieǁ of a tests handbook. Statistical 
quantification of objectivity in the form of interrater reliability will be assigned to the section 
͞reliability͟ according to Sherman and colleagues (2011) (see also Margraf et al., 2012; 
Strauss et al., 2006). 
 
2.1.2.2 Reliability 
ReliaďilitǇ ƌefeƌs to ͞the oǀeƌall ĐoŶsisteŶĐǇ of a ŵeasuƌe and can be defined in several ways, 
including consistency within itself (internal consistency reliability), consistency over time 
(test-retest reliability), consistency across alternate forms (alternate form reliability), and 
consistency across raters (inteƌƌateƌ ƌeliaďilitǇͿ͟ (Strauss et al., 2006, p. 10). The 
afoƌeŵeŶtioŶed aspeĐts of ƌeliaďilitǇ ͞ĐoŶtribute to an overall assessment of a particular 
test’s ƌeliaďilitǇ, ǁhiĐh is siŵplǇ aŶ estiŵate of the degƌee to ǁhiĐh a test is fƌee fƌoŵ 
ŵeasuƌeŵeŶt eƌƌoƌ͟ ;Sherman et al., 2011, p.874). The term measurement error refers to 
͞e͟ iŶtƌoduĐed iŶ section 2.1.2.1. OďjeĐtiǀitǇ. ͞ReliaďilitǇ ĐoeffiĐieŶts are influenced by test 
characteristics (e. g., length, item type, item homogeneity), sample characteristics (e.g., 
saŵple size, ƌaŶge oƌ ǀaƌiaďilitǇͿ͟ aŶd a tests ͞ĐlaƌitǇ͟ ;Strauss et al., 2006, p.10), which 
refers to aspects of objectivity in implementation and evaluation as outlined above. 
Most important for the present work are the test-retest reliability (comparison of test 
scores of the same subject during two assessment times) and the interrater reliability 
(assessing the degree of agreement between two or more raters). A statistical method for 
quantification of test-retest reliability is the correlational analysis of test raw scores between 
the two time points of assessment (Sherman et al., 2011). The resulting correlation is 
referred to as retest reliability coefficient (Sherman et al., 2011). Statistical methods for 
quantification of interrater reliability include for instance correlational analysis (Amelang et 
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al., 2002; Lienert & Raatz, 1998; Sherman et al., 2011), Kendall's coefficient of concordance 
(Moosbrugger & Kelava, 2012a), percent of agreement and kappa (Sherman et al., 2011). 
 
2.1.2.3 Validity 
Validity can be defined as the degree of accordance between the attribute measured by the 
test and the attribute it claims to test for (Lezak, 2012; Sherman et al., 2011). Factors that 
can affect validity in an individual assessment are for instance ͞deǀiatioŶs fƌoŵ staŶdaƌd 
adŵiŶistƌatioŶ, uŶusual testiŶg eŶǀiƌoŶŵeŶts, aŶd ǀaƌiaďle oƌ pooƌ eǆaŵiŶee ĐoopeƌatioŶ͞ 
(Sherman et al., 2011, p. 886). There are several aspects of validity by which test scores can 
be classified (Urbina, 2004). The most common model of validitǇ is the ͞tƌipaƌtite ŵodel͟ 
whereby validity is divided into three core components (content-related, criterion-related 
and construct validity) (Sherman et al., 2011). Two components of validity are of particular 
interest for this work. The construct validity can be estimated by addressing convergent and 
divergent validity (Moosbrugger & Kelava, 2012b). Convergent validity indicates the degree 
of accordance between the test and the results from other tests for similar constructs. 
Contrariwise, divergent validity aims to investigate whether a test measures one specific, 
distinguishable trait. Therefore, for instance low correlations are expected with tests that 
measure other constructs.  
Criterion validity is given, if successful conclusions on a criterion outside the test situation 
can be drawn from the behavior of the subject during the test situation (Sherman et al., 
2011). This can be operationalized by concurrent validity (the relationship between test 
result and a criterion at the same time point) and predictive validity (prognosis of a future 
value of the construct) (Lezak, 2012; Moosbrugger & Kelava, 2012a). Quantification of both 
is generally carried out by correlational analysis (Moosbrugger & Kelava, 2012a). In addition, 
classification accuracy statistics such as positive and negative predictive values (predicting 
the presence or absence of specific diagnoses based on test scores) are also used to 
determine the validity of test scores (Sherman et al., 2011). These are described in detail in 
section 2.1.2.4 Measures of test performance. 
Ecological validity is of particular importance for neuropsychological diagnostics. It refers to 
the ability of a neuropsychological test to predict behavior in everyday life such as returning 
to work, benefit from rehabilitation, independent living, or managing finances (Lezak, 2012). 
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Ecological validity is especially important for essential functions determining quality of life 
such as communication abilities or mobility. Achievement of high ecological validity is often 
limited by the test procedure itself because test situation and requirements do not 
completely match daily demands (Chaytor & Schmitter-Edgecombe, 2003). For instance, a 
quiet environment for the test might allow good performance, but a high noise level at work 
or home environment might still prevent sufficient participation in everyday situations 
(Lezak, 2012).  
 
Factors limiting validity 
Validity of test results will vary upon the field of application of a test (spectrum of usage and 
population) (Lezak, 2012; Sherman et al., 2011). An example for this is the use of a screening 
iŶstƌuŵeŶt eǆpliĐitlǇ desigŶed to disĐƌiŵiŶate patieŶts ǁith Alzheiŵeƌ’s disease fƌoŵ eldeƌlǇ 
depressed peƌsoŶs. The pƌediĐtiǀe ǀaliditǇ ŵaǇ ďe loǁeƌ ǁheŶ it’s used foƌ the puƌpose of 
identifying young traumatic brain injury patients who are likely to benefit from rehabilitation 
(Lezak, 2012). Similarly critical can be seen the use of the MMSE in clinical study trials: the 
test ǁas eǆpliĐitlǇ desigŶed foƌ diagŶosis of Alzheiŵeƌ’s disease ďut is fƌeƋueŶtlǇ used foƌ 
determination of side effects in clinical trials (for further discussion see publication one of 
this thesis).  
As outlined above ;see seĐtioŶ ͞NeuƌopsǇĐhologiĐal diagŶostiĐs͟Ϳ, one test can address 
several cognitive constructs. In consequence, a test can vary with respect to validity for the 
measurement of different constructs (Lezak, 2012). Validity measures/ results will be lower 
when assessing psychological constructs that highly fluctuate, such as executive functioning 
(Strauss et al., 2006). Lower validity results are also expected for populations that show a 
high response variability, such as patients with brain disorders (Strauss et al., 2006). 
 
2.1.2.4 Measures of test performance: Sensitivity and Specificity 
Many neuropsychological tests, particularly screening instruments, provide the investigator 
with a binary classification of the tested person for a distinct attribute (condition of interest 
(Strauss et al., 2006). Regarding cognitive function, this refers to the classification of being 
cognitively impaired or unimpaired. To attest the quality of a new instrument, well 
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established tests for similar purposes can be used as external classifiers (so called gold 
standard) (Strauss et al., 2006).  
Sensitivity and specificity are statistical measures for the performance of a binary 
classification test (Moosbrugger & Kelava, 2012a). Sensitivity refers to the proportion of 
subjects with the condition of interest determined by the gold standard who are correctly 
classified as such by a test (true positive rate, see Table 4) (Strauss et al., 2006). Specificity 
refers to the proportion of subjects without the condition of interest determined by the gold 
standard who are correctly identified as condition negative by the new test (true negative 
rate) (Strauss et al., 2006).  
Sensitivity and specificity have a negative relationship making independent optimization of 
both at the same time impossible (Lezak, 2012). A highly sensitive test (liberal diagnosis) will 
classify almost all impaired persons as impaired, but will also classify many healthy persons 
as impaired (low specificity) (Lezak, 2012). In contrast, a very highly specific test 
(conservative diagnosis) will inevitably miss a considerable rate of impaired subjects (low 
sensitivity). The relationship between sensitivity, specificity and their corresponding 
classification errors (i.e. false positives or negatives) is exemplified in Table 4. It depends on 
the concrete context of a test’s appliĐatioŶ hoǁ ĐoŶseƌǀatiǀe oƌ liďeƌal a diagŶosis should ďe 
assigned. Accordingly, false negative results can be preferred over false positive results and 
vice versa. For cognitive diagnostic purposes in the clinical context, a false positive 
classification can lead to more expensive, unnecessary and perhaps exhausting treatment 
for the patient. In case of awake craniotomy, a false positive test result would indicate the 
tested site as functionally necessary. In consequence, this site would be spared at the cost of 
optimizing the resection of tumor tissue. A false negative classification can result in a missed 
chance for rehabilitation or the removal of functionally necessary brain sites in awake 
craniotomy.  
The respective probability that a subject with a positive or negative classification result (by 
the test) has the true condition is expressed as positive or negative predictive value (PPV and 
NPV) (Fawcett, 2006), by Strauss and colleagues (2006) referred to as positive and negative 
predictive power. PPV refers to the probability that an individual with a positive test result 
has the condition of interest (Strauss et al., 2006). PPN refers to the probability that an 
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individual with a negative test result does not have the condition of interest (Strauss et al., 
2006). 
 
Table 4: Cross-table of classification results of a binary test and selected measures of test 
quality 
  True condition 
(as determined by gold standard) 
 
  condition positive condition negative  
C
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test 
outcome 
positive 
true positive 
false positive  
(Type I error) 
positive predictive value 
(PPV) 
= true positive / 
test outcome positive 
test 
outcome 
negative 
false negative  
(Type II error) 
true negative 
negative predictive value 
(NPV) 
= false negative/ 
test outcome negative 
  true positive rate 
(Sensitivity) 
= true positive / 
condition positive 
true negative rate 
(Specificity) 
= true negative / 
condition negative 
Accuracy 
= true positive + true 
negative / 
total population 
 
An effective method for evaluation of the performance of a diagnostic test is the calculation 
of receiver operating characteristics (ROC) and their visualization by ROC-curves (Park, Goo, 
& Jo, 2004). For each cutoff score sensitivity and specificity are calculated. The 
corresponding values of sensitivity and 1-specificity (false positive rate, FPR) are displayed in 
the ROC-curve (for an example see Figure 2). Each discrete point on the graph is called 
operating point (Park et al., 2004). ROC-curves can be used to determine an optimal cutoff 
score. To set a cutoff score for classification in a ROC-analysis, a cutoff score with an optimal 
balance between sensitivity and specificity is desirable (Moosbrugger & Kelava, 2012b). This 
point, at which the sum of sensitivity and specificity is at its peak, can be calculated (Youden-
Index, Youden, 1950). In case of severe consequences following a false negative classification 
over a false positive classification, it might be useful to lower the cutoff score relative to the 
original Youden-Index. However, a verification of the classification is necessary in any case. 
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In addition, ROC-curves allow to assess the performance of a test independently of the 
cutoff score (Park et al., 2004). The most popular indicator for this purpose is the area under 
the ROC curve (AUC). The AUC can be interpreted as average value of sensitivity for all 
possible values of specificity. It ranges between 1 (perfect accurate test) and 0.5 (test results 
are pure chance as illustrated by the diagonal D in Figure 2 on the right side) (Park et al., 
2004). 
 
  
Figure 2: Exemplary Receiver operating characteristic curves (ROC). Left: Empirical ROC curve with discrete 
points (dots) in a plot of test sensitivity (y-axis) versus its false positive rate (FPR; x-axis) obtained at each cutoff 
level. Estimation of AUC (area under curve) by nonparametic approaches is possible. Right: Fitted or smooth 
ROC curves that are estimated with the assumption of binormal distribution, parametric estimation of AUC is 
possible. Curve A represents a perfect test (AUC = 1) and curve D a test with diagnostic performance of chance 
(AUC = .5). Test B has a higher AUC and a better overall diagnostic performance than C (taken with kind 
permission from Park et al., 2004). 
 
2.2 Requirements for neuropsychological diagnostics in the neurosurgical 
emergency hospital  
To illustrate the special requirements for neuropsychological diagnostics in the neurosurgical 
setting, the course of a glioma disease in an exemplary case patient is described in the 
following sections.  
 
2.2.1 The patients 
Patient A was at work when a sudden epileptic seizure let him fall unconsciously from his 
chair and injured his facial bones on the right side. After a few minutes, he slowly gained 
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consciousness, but felt disoriented and was unable to speak or properly understand the 
accident that injured his face. He was brought to the emergency hospital by an ambulance 
immediately.  
In the vast majority of cases, the inpatient stay at the hospital starts unexpected. Many 
patients are brought to the emergency clinics since they complain about neurological and 
neuropsychological symptoms or experience an unexpected seizure like patient A. The 
medical routine diagnostic consists of a neurological examination, computer tomography 
(CT) and/or magnet resonance imaging (MRI). If a tumor is detected, a contemporary surgery 
is recommended in most cases to reduce further tumor growth, prevent seizures and initiate 
following treatment such as radio- and/or chemotherapy. 
Factors such as the unexpectedness of the seizures, unfamiliar medical diagnostics and the 
diagnosis of a brain tumor can be perceived as highly threatening by the patient and may 
lead to subjective loss of control (Adelbratt & Strang, 2000; Perks, Chakravarti, & Manninen, 
2009). In addition, the suggested treatment of an operation on the open skull, can be 
frightening and highly stressful for the patient (Goebel, Strenge, & Mehdorn, 2012; Perks et 
al., 2009). Consequently, it is crucial to preserve physical and mental functions beyond the 
surgery to the best possible degree since their impairment can strongly decrease subjective 
quality of life (Shields & Choucair, 2014). Diaz and colleagues (2009) identified proper 
information sharing during the initial inpatient stay as a key factor to decrease anxiety levels 
of glioma patients. However, cognitive deficits induced by the brain tumor often hamper 
correct application of neuropsychological diagnostic tools and hinder communication about 
the diagnostic procedure and its goals. In addition, patients with intracranial tumors are 
often easily exhausted, which prevents extensive information sharing and assessment over 
several hours.  
In summary, neuropsychological diagnostic in the setting of the neurosurgical hospital needs 
to be adapted to the needs of highly stressed and emotionally vulnerable patients (Habets et 
al., 2014). In addition, most patients show motor and language impairments combined with 
a reduced general state of health making additional adaptions of a test battery necessary.  
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2.2.2 The setting 
Patient A was administered to the intensive care unit. He underwent CT and MRI scans and 
was finally diagnosed with a tumor in his left temporal lobe, one day after the initial epileptic 
seizure. He felt uncomfortable with the medial equipment attached to him. Lacking any 
medical background, it was hard for him to understand the information given by the 
physicians. He was worried about ignoring possible early signs of the tumor. The physicians 
recommended an operation on his brain within two days. However, the surgery bore the risk 
of severe persisting language deficits rendering speaking and understanding impossible.  
In the setting of an emergency hospital, time is critical. Due to the early operation time point 
only a few days after hospital admission, neuropsychological diagnostic competes with 
several other time consuming diagnostics and educational appointments. In addition, the 
requirement of a trained neuropsychologist renders an extensive neuropsychological 
expensive. Consequently, many hospitals cannot afford to assess all patients with a 
comprehensive neuropsychological test battery. Therefore, they use cognitive screening 
instruments to identify patients in need for further assessment. This holds also for research 
trials on new medications for the treatment of intracranial tumors.  
In summary, the amount of neuropsychological diagnostic is often restricted by low 
resources such as budged and diagnostic time, which contradicts the overall high diagnostic 
demand. 
 
2.2.3 Examination purposes and approaches  
The specific disease and its treatment in the emergency hospital account for particular 
questions, which need to be addressed by the neuropsychological diagnostic. The diagnostic 
course can be considered along the different treatment stages of preoperative, 
intraoperative and postoperative diagnostic. In the following, the different diagnostic steps 
are outlined. 
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2.2.3.1 Preoperative diagnostics  
2.2.3.1.1 Cognitive status diagnostic 
Patient A was registered for a preoperative neuropsychological status diagnostic. This has to 
be carried out at the intensive care unit since he was not allowed to leave the bed and 
health monitoring devices, due to his injuries and high risk of additional seizures.  
Assessment of a patieŶt’s cognitive status aims at providing a cognitive profile for the most 
important functions such as language, executive functions, visuo-perception, visuo-motor 
speed and memory and should include a screening of the current emotional state (Goebel, 
Kaup, Wiesner, & Mehdorn, 2013). Additionally, basic data about a patient’s socio-
professional life such as employment, hobbies and activities should be assessed, because 
functionality in these areas are predictors for a patient’s subjective quality of life 
(Giovagnoli, 2005). This information can be used to adjust a treatment strategy to a patient’s 
individual needs (Duffau, 2014; Goebel et al., 2013). Comprehensive patient education about 
further treatment options and possible risks for impairment can rely on the cognitive 
assessment. In addition, the cognitive status before any treatment serves as baseline for 
further evaluation of treatment impact (Duffau, 2013). In most cases, the preoperative 
status diagnostic can be performed with a comprehensive neuropsychological test battery 
as described in chapter 2.1.1 Neuropsychological diagnostics. The test compilation can be 
tailored to the physical impairments of a patient: For instance, in case of a hemiparesis, this 
can be achieved by excluding tests that require intact motor ability of the dominant hand. 
Screening tools (see above) represent an alternative to a comprehensive neuropsychological 
test battery in significantly impaired or exhausted patients. Most screening tools provide a 
sum score for global cognitive functioning and allow a global classification into ͞impaired͟ 
ǀs. ͞non-impaired͟. However, they cannot provide valid information on the performance of 
distinct cognitive domains due to their brief extent. 
Neuropsychological assessment of Patient A was successfully performed on the intensive 
care unit. However, the neuropsychological test battery had to be reduced. Tests which 
relied on fast drawing were not used, as the patient had to stay in bed. The assessment 
revealed impaired verbal memory, semantic word fluency and verbal comprehension as well 
as increased anxiousness. An additional functional MRI located the patient’s language 
functions in direct vicinity to the tumor. This raised the question whether the operation 
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should be performed under local anesthesia or intubation narcosis. An evaluation of his 
eligibility for an awake craniotomy was requested. 
For patients with intracranial tumors within eloquent areas, an additional 
neuropsychological appointment is necessary to assess their eligibility for an operation 
under local anesthesia (awake craniotomies). An awake craniotomy can represent a highly 
stressful and potentially traumatic procedure for the patient and therefore makes a careful 
preoperative patient selection mandatory (Nossek et al., 2013). Especially in the context of 
awake craniotomy, a cognitive profile of deficits and resources is helpful to estimate a 
patient’s intraoperative resilience and compliance. In addition, the cognitive baseline profile 
provides information on tasks which should be assessed during awake craniotomy to 
prevent further impairment (for details see chapter 2.2.3.2 Intraoperative diagnostics) 
(Duffau, 2013). If awake surgery is done in functional areas for sensory-motor function, the 
cognitive baseline profile is complemented by a sensory-motor baseline assessment as 
explained in publication two included in this thesis (Becker, Jehna, Steinmann et al., 2016).  
 
2.2.3.1.2 Patients’ eligibility for an awake craniotomy  
The initial selection criterion for patients to undergo awake craniotomy is a medical decision 
based on structural MR-images. If functional cortical areas or white matter tracts are 
assumed to be located close to the tumor, an awake craniotomy should be considered 
(Nabavi et al., 2009). Functional MRI (fMRI) can be used to verify the location of eloquent 
areas relative to the tumor and provides additional information on the functional-
neuroanatomic relationship between the tumor and surrounding brain structures (Nabavi et 
al., 2009). Unfortunately, fMRI based functional maps are prone to errors due to altered 
brain perfusion near the tumor and cannot replace intraoperative DCS mapping (Duffau, 
2011a, 2011c). For concrete surgery planning, diffusion tensor imaging (DTI) and computer 
based virtual reconstruction of white matter fiber tracts (tractography) is frequently used 
(Bello et al., 2011). This method was introduced by Catani and colleagues (2002) as ͞in vivo 
disseĐtioŶ͟ aŶd allows a preoperative clear visualizations of the white matter structures near 
the tumor (Bello et al., 2011; Catani et al., 2002; Catani & Thiebaut de Schotten, 2008). 
Figure 3 displays examples for this visualization method, showing tumors growing in the 
frontal lobe near the pyramidal tracts. DTI uses diffusion characteristics of water molecules, 
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which differ in grey and white matter. Water molecules will diffuse more rapidly in the 
direction aligned with the internal structure and slower perpendicular to the preferred 
direction. This causes a preferential direction of diffusion along the direction of white matter 
fibers. Diffusion preference can be measured, reconstructed and color coded for the whole 
brain by special analysis software. Further steps of analysis calculate probabilities for the 
course of the tracts and finally allow visual reconstruction of the most likely pathway of 
white matter tracts (probabilistic tractography; Behrens et al., 2003). Deterministic 
approaches rely on the concrete measured main direction of diffusion inside of a voxel and 
stop when certain cancellation criteria are reached (Pierpaoli, Jezzard, Basser, Barnett, & Di 
Chiro, 1996). Both methods strongly depend on the applied analysis methods/models and 
software, which can result in different visualizations of the same white matter tracts in the 
same patient (Bürgel et al., 2009). In addition, the computed visualizations may significantly 
deviate from the in vivo arrangement (Bello et al., 2011). 
 
 
Figure 3: Tractography of the corticospinal tracts (red). In the left hemisphere, the pyramidal tract is running in 
close proximity to a tumor (in light blue) in the peri-rolandic area. The two corticospinal tracts are overlayed on 
coronal and axial maps of fractional anisotropy (anisotropy: preference for molecules to diffuse in an direction 
dependent manner, opposed to isotropic i. e. identical diffusion in all directions) (with kind permission taken 
from Duffau, 2011b, p. 68). 
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A detailed overview of large white matter tracts and their (cognitive) functions was provided 
by Catani and colleagues (2008) in the so called ͞DTI tractography atlas͟. In the individual 
patient, a visualization of white matter tracts by DTI based tractography can help to clarify 
the operating strategy and facilitate an estimation of functional impairment caused by 
surgery. Despite major improvements of the technique in the last decade, these 
visualizations are still estimations of individual white mater arrangement in a patients’ actual 
brain. DTI tractography exhibits measurement errors caused by visualization algorithms 
and/or by tumor specific factors such as impeded measurement of diffusion due to peri-
tumoral edema. Thus, DTI tractography cannot replace but rather complement 
intraoperative DCS (Duffau, 2011b).  
After initial MRI- and DTI-based selection the rationale of an awake craniotomy is discussed 
with the patient and if necessary, additional baseline assessment for mapping purposes is 
performed during a special preparation appointment. Nossek and colleagues (2013) 
evaluated failed awake craniotomies. They identified the role of patient preparation during 
the preoperative phase as crucial factor for the patient’s cooperation and avoidance of 
intraoperative complications (Nossek et al., 2013). From the neuropsychological perspective, 
the aim of the preparation appointment is an estimation of the patient’s functional and 
psychological eligibility for awake craniotomy. In addition, tasks for intraoperative 
diagnostics are practiced during the preparation appointment (Talacchi, Santini, Casagrande 
et al., 2013).  
 
2.2.3.1.2.1 Functional eligibility  
Functional eligibility refers to a patient’s cognitive and physical state of health and the 
requirements on this functionality for an awake craniotomy. Both aspects of functionality 
are mandatory for successful awake craniotomy.  
Prior to the preparation appointment, the neuropsychological status diagnostic provides 
data on the patient’s cognitive functionality such as the ability to speak, understand, 
concentrate and execute commands necessary for successful realization of an awake 
craniotomy. Specifically, the patient’s language has to be fluent enough to express himself in 
a reliable manner. Further, he must be able to communicate alterations in cognitive and 
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physical functions, dizziness, pain and other discomfort during the operation. Verbal 
comprehension is highly important as the patient needs to understand instructions, 
reassurance attempts and questions correctly. Memory functions are mandatory to ensure 
correct recall of information and advice given prior to surgery. Attention is important to 
understand and follow all the necessary tasks. Intact visual functions are mandatory if 
pictures need to be named intraoperatively.  
Explicit exclusion criteria for awake craniotomy regarding cognitive functionality do not exist 
to date. However, Picht and colleagues (2006) as well as Nabavi and colleagues (2009) give a 
first orientation: Patients scoring below 23 points in the MMSE and a failure rate above 50% 
in standardized language tasks where excluded in their studies. Apart from that, they 
emphasize inhibited, apathic and disorganized behavior patterns as predictors for 
intraoperative noncompliant behavior and therewith exclusion criteria for an awake 
craniotomy. In a study by Santini and colleagues (2012), patients with 30% or more errors in 
a standardized picture naming task, were excluded from awake surgery. Other authors 
excluded patients at a 10% or >25% error cutoff (Santini, Talacchi, Squintani et al., 2012; 
Talacchi, Santini, Casagrande et al., 2013). A high failure rate in picture naming is assumed to 
interfere with a reliable interpretation of intraoperative test results. This is due to the fact 
that speech disturbances after DCS cannot be traced back to the exclusive effect of DCS. 
Alternatively, the naming disorder caused by the initial aphasia itself may have caused the 
effect. This might result in an increase of the false positive rate during cortical stimulation. 
Beside cognitive functionality, physical functionality is the other essential category for 
preoperative evaluation. Since the procedure will often last for several hours and is 
exhausting, a moderate to good general health status is necessary to face an awake 
craniotomy (Talacchi, Santini, Casagrande et al., 2013). Santini and colleagues (2012) defined 
a Karnofsky performance scale of >70% as a possible inclusion criteria. Moreover, if sensory-
motor functions are mapped during the awake surgery, a sufficient functionality in these 
categories is mandatory. Severe motor and sensory impairments hinder differentiated 
evaluation during the operation and represent exclusion criteria for awake operations in 
these cases.  
Preservation of sensory-motor and language functions are the most frequent reasons to 
undergo an awake craniotomy (Duffau, 2011d). Despite this fact, a standardized and reliable 
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assessment of sensory-motor functions in awake craniotomy is not established to date. As a 
consequence, no standardized guidelines for exclusion criteria are available. The second 
study of this thesis (Becker, Jehna, Steinmann et al., 2016) describes an approach to design 
an efficient and feasible assessment tool for this context in detail.  
If sensory-motor function is a focus of awake craniotomy, a detailed sensory-motor baseline 
is assessed to supplement the cognitive baseline profile. Similar to cognitive assessment, 
sensory-motor baseline testing serves as the reference point for further appraisal of a 
patient’s functions i) in the operating room for mapping purposes, ii) after the surgery for 
evaluation of outcome and iii) later on for follow-up after rehabilitation. In patients with 
language impairments, the sensory-motor baseline assessment represents a valuable 
opportunity to assess the ability to understand the commands and carry out the tasks 
accordingly. In addition, the risk of impairments in sensory-motor function during and after 
the surgery should be discussed with the patient. The individual social and professional life 
defines subjective limits for impairments. For instance, loss of fine motor skills bears a high 
risk for reduction of subjective quality of life for a passionate musician while other patients 
might tolerate such impairments (Duffau, 2009b). Figure 3 shows an example of a patient 
with a high risk of functional impairment, requiring detailed preoperative information. The 
pyramidal tracts, necessary for motor functions, are running in direct neighborhood to the 
tumor. In this case, the patient needs to be prepared for possible motor impairment during 
and after the operation. This ensures clear agreement on tolerable impairments and reduces 
the risk of unexpected intraoperative deficits.  
A detailed description of sensory-motor tasks for awake craniotomy is presented in the 
second publication included in this thesis (Becker, Jehna, Steinmann et al., 2016). The use of 
other tasks is explained in section 2.2.3.2 Intraoperative diagnostics. 
 
2.2.3.1.2.2 Psychological eligibility 
Awake craniotomy is highly demanding for a patieŶt’s psychological stability and coping 
mechanisms. Talacchi and colleagues (2013) summarized the importance of a good eligibility 
evaluation as follows: ͞Although aǁake ĐƌaŶiotoŵǇ is geŶeƌallǇ ĐoŶsideƌed to ďe ǁell 
tolerated, complications such as emotional distress and agitation are reported and lead to 
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loss of control, the need for more sedation, and failure of the mapping project. Once the 
patient has been given a detailed description of the procedure and provided his fully 
informed consent, the decision to operate will depend on whether he can be reasonably 
expected to be cooperative. Failure rates due to agitation vary from 2 to 8%, but are not 
sǇsteŵatiĐallǇ ƌepoƌted ;“ahjpaul, ϮϬϬϬͿ.͟ (p. 212). First suggestions for criteria regarding 
psychological eligibility in awake craniotomy were provided by Santini and colleagues 
(2012). Anxiety, the attitude to pain, depression and capacity for self-control were assessed 
in their pilot study. Fear of pain and anxiety were found to be possible warning signs for a 
failure of the awake craniotoŵǇ due to patieŶt’s iŶĐoŵpliance. To date, there are no other 
clinical articles available addressing the psychological eligibility of patients scheduled for 
awake craniotomy. Due to the absence of empirical data, the appraisal of psychological 
eligibility is mainly based on the clinical experience of the neuropsychologist. During 
inpatient stay, there are several opportunities to collect data for this rating. First, behavioral 
monitoring during cognitive assessment provides valuable information on a patient’s ability 
to tolerate frustration and remain compliant under stressful situations. Second, a 
preparation appointment provides further opportunity for behavioral monitoring and 
evaluation. During a detailed discussion of the operating procedure and risks, the patient is 
confronted with highly emotional topics that can be used to test psychological coping 
abilities. Third, explicit discussion of anticipation and fear provides additional valuable 
information on psychological eligibility for the procedure. A patient’s emotional stability and 
functionality can be considered sufficient, if one can assume that he is able to undergo 
awake craniotomy with high compliance and reasonable emotional distress.  
 
Patient A underwent evaluation for physical and psychological eligibility for awake 
craniotomy. He fulfilled basic criteria of language and sensory-motor function and was 
expected to undergo the procedure with high compliance. 
He understood the rationale for an awake craniotomy and agreed on the procedure. 
However, he felt nervous about being conscious during the drilling of his skull and resection 
of the tumor. His motivation for an awake surgery was to preserve his ability to speak and 
understand to the best possible degree. The baseline assessment of his sensory-motor and 
language functions showed a high performance, enabling a good differentiation between 
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baseline and new impairments during the operation. His general state of health assessed 
with the Karnofsky Performance Status was rated 70-80%. The operation was scheduled for 
the next day. 
 
2.2.3.2 Intraoperative diagnostics 
The key functions of a neuropsychologist during intraoperative diagnostics can be 
summarized as follows: i) performing the neuropsychological testing, i.e., requesting the 
patient to perform tasks under DCS and ii) accurate interpretation of the various 
disturbances induced by DCS (Duffau, 2011a).  
Representative tasks to map motor functions involve the request to move facial muscles, 
arms, hands, fingers or legs. Sensory assessment is commonly performed by touching the 
patient’s extremities and recording his feedback. The elaborate work of Chacko and 
colleagues (2013) provides a summary of possible events under awake craniotomy that need 
to be taken into account by the neuropsychologist. This includes for instance deceleration of 
movement, weakness and delayed response (Chacko et al., 2013). Their findings emphasize 
the value of a distinction between elicitation of aa function and its inhibition in response to 
DCS (Mandonnet, 2011). In case of evocative stimulation, the patient might for instance 
report muscle twitches or sensations. In case of inhibition, changes in movement’ quality 
during motor task performance can be observed (Mandonnet, 2011).  
To date, there is no literature available on the comparison of different motor tasks for 
intraoperative diagnostic. This holds also true for intraoperative alterations of cognitive and 
motor functionality and their ability to predict a postoperative long-term outcome. The 
reviewed literature revealed a large variety of methods used for intraoperative mapping of 
sensory-motor functions across different institutions (Duffau, Capelle, Denvil, Sichez, 
Gatignol, Taillandier et al., 2003; Whittle, Borthwick, & Haq, 2003). In addition, the applied 
methods covered mainly semi-standardized or unstandardized tasks and rating systems. 
Even more critical, in most cases baseline and postoperative assessment differed from 
intraoperative assessment methods (Duffau, Capelle, Denvil, Sichez, Gatignol, Taillandier et 
al., 2003; Whittle et al., 2003). Thus, comparison of results between institutions is hampered 
and valid conclusions on the advantages of awake craniotomy relative to intubation narcosis 
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are difficult to draw (Talacchi, Santini, Casagrande et al., 2013). This topic was addressed in 
the second publication of this thesis (Becker, Jehna, Steinmann et al., 2016). 
In case of language mapping, tasks are presented simultaneously with DCS. Naming of 
objects presented on a screen is one of the most common tasks that was already used by 
Whitaker and Ojemann (Talacchi, Santini, Casagrande et al., 2013; Whitaker & Ojemann, 
1977). Figure 4 illustrates an example of a presentation slide for awake cortical mapping. The 
patient is requested to read a seŶteŶĐe ;͞This is a…͟Ϳ aŶd suďseƋueŶtlǇ Ŷaŵe the presented 
target object. A picture is usually presented for 4 seconds and the patieŶt’s response is 
recorded (Talacchi, Santini, Casagrande et al., 2013). The electrical impulse is usually applied 
to the ďƌaiŶ’s suƌfaĐe ǁith piĐtuƌe oŶset (Talacchi, Santini, Casagrande et al., 2013).  
 
 
Figure 4: Example picture from a picture naming task for awake craniotomy. 
 
Language impairments during DCS range from naming disturbances to complete speech 
arrest (Talacchi, Santini, Casartelli et al., 2013). A systematical evaluation of the 
characteristics and distribution of naming errors during cortical mapping with DCS was 
presented in 2010 by Corina and colleagues (2010). They differentiate six common types of 
errors and were able to provide neurosurgeons with a preoperative map of possible errors at 
different locations of resection (Corina et al., 2010). Beside object naming, other language 
tasks such as word generation (verbal fluency), speech comprehension and reading are used 
for intraoperative diagnostics (Giussani et al., 2010).  
Although mapping of language functions is already performed since four decades, the 
standardization of intraoperative tasks other than naming, is still in its infancy (Rofes, Aguiar, 
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& Miceli, 2015). Recently, several publications addressed this issue and made first proposals 
for intraoperative selection and combination of language tasks by taking the tumor location 
and the presumed language deficits into account (Coello et al., 2013; De Witte, Satoer, Colle 
et al., 2015; De Witte, Satoer, Robert et al., 2015, De Witte & Mariën, 2013, 2013; Rofes et 
al., 2015; Rofes & Miceli, 2014). Future studies on the predictive validity of different types of 
errors might provide information about the likelihood of permanent language dysfunction 
after resection of a critical site and its impact on the patieŶt’s life. For instance, Moritz-
Gasser and colleagues (2012) found a significant positive correlation between the speed of 
lexical access and later return to professional life.  
Beside language and sensory-motor functions, other (cognitive) functions might also be 
located in the vicinity of the tumor. Within the last years, the research interest on higher 
order cognitive functions has substantially grown and valuable information about their 
functional-neuroanatomic location in the human brain was gained (Duffau, 2011b). 
Furthermore, case reports and small cohort studies report promising approaches for 
intraoperative evaluation of calculation, visual perception, spatial cognition, memory, 
executive functions and singing (Duffau et al., 2002; Duffau, 2010, 2011d; Wager et al., 
2013). However, methods for intraoperative diagnostic of these functions are still in the 
experimental stage.  
Independent of the intraoperative tasks, awake craniotomy aims to preserve functional 
tissue around or in the tumor. There is evidence that functional tissue can be subdivided into 
compensable and essential areas (Desmurget et al., 2007). Compensable areas support 
(cognitive) function. After resection, only transient disturbances are induced. Contrariwise, 
essential areas are primarily necessary for a particular function and cannot be resected 
without permanent deficits (Desmurget et al., 2007). Resection of essential areas should 
therefore be avoided. According to the gold standard, a cortical site is considered as 
essential when functional disturbances can be elicited three times by DCS (Duffau, 2011a). 
At first glance, it seems intuitive to distinct between essential and compensable brain areas 
and to follow the rationale of sparing essential areas. However, the relation between DCS 
induced disturbances and postoperative functionality is not linear. For instance, DCS of the 
posterior part of the SMA, elicits positive motor responses and its resection leads to 
immediate postoperative deficits such as hemiparesis, akinesia and mutism (Rutten & 
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Ramsey, 2011). These symptoms typically resolve within several months, during which a 
functional transfer to the contralateral SMA takes place (Rutten & Ramsey, 2011). This 
example emphasizes the importance of future integrative research on resectability of areas 
and their neuroplastic adaption for successful awake craniotomy, with the general aim to 
maximize resection while minimizing the risk of permanent deficits.  
In summary, intraoperative decisions with respect to the resection of an area rely on i) valid 
and sensitive intraoperative diagnostic with appropriate tasks, ii) a valid decision strategy 
(three positive responses to DCS) and iii) the integration of knowledge about neuroplasticity. 
Specifically, phenomena such as a delayed manifestation of a deficit, fast recovery of initially 
inhibited functions by dynamical short-term plasticity and late recovery due to biological 
long-term plasticity complicate intraoperative decisions for resection (Mandonnet, 2011). 
Future research on the predictive validity of intraoperative responses to DCS during specific 
tasks is urgently required.  
 
Patient A underwent awake craniotomy with mapping and monitoring of language and 
sensory-motor functions. Due to intraoperative language disturbances, functional areas that 
were infiltrated by the tumor were preserved to avoid permanent functional loss.  
 
2.2.3.3 Postoperative diagnostics 
Patient A recovered quickly from the awake craniotomy. During the first days after the 
surgery, he showed medium impairments of language comprehension and word fluency, but 
symptoms improved until discharge. A specialized rehabilitation institution for language 
therapy was suggested according to his cognitive status diagnostic (with the focus on 
language) five days after the operation. Further improvement of language functions was 
determined in the follow-up neuropsychological assessment two months after the surgery. 
Ambulant neuropsychological therapy was initiated and stepwise vocational reintegration 
followed. 
Directly after the operation, the diagnostic of language deficits is highly important. Early 
detection of language disturbances allows the early start of language rehabilitation which 
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significantly improves the outcome (Frommelt, 2010). If applicable, a second status 
diagnostic could quantify the immediate operative outcome and might help to find a suitable 
rehabilitation clinic (Duffau, 2013). Targeted rehabilitation of sensory-motor functions in 
patients with intracranial tumors is also initiated early after surgery, but needs to be well 
balanced to avoid adverse side effects due to overuse (Xerri, 2011). 
During the time course of the disease, repeated neuropsychological diagnostic helps to 
quantify multiple outcomes (operative long-term outcome, effects of radio- and/or 
chemotherapy and rehabilitation) and provides a data set for further planning of 
therapeutical support. For most patients, return to normal social life and work are most 
important goals. With the help of personalized therapeutic strategies over years, these goals 
are achievable, particularly for LGG patients (Duffau, 2013). Finally, there is evidence that 
cognitive decline precedes visual signs of tumor recurrence on MR-images (Klein et al. 2012; 
Meyers et al. 2000), further underlying the importance of a comprehensive follow-up 
diagnostic.  
From a scientific perspective, regular neuropsychological follow-up assessments provide 
information on the brain’s adaption to a lesion and its potential for neuroplasticity. 
Simultaneously acquired MRI-data can provide insight into structural correlates of functional 
alterations. The acquired data should include information about the patient’s sensory-motor 
and cognitive functionality as well as quality of life in addition to the overall survival time. 
This integrative and patient- oriented approach allows valid comparison for example 
between surgical procedures (awake vs. asleep craniotomies) or evaluation of the impact of 
intraoperative methods such as MRI, ultrasound or neuro-navigation. In addition, clinical 
studies investigating novel treatment options such as chemotherapeutic drugs use repeated 
cognitive follow-up assessments to determine side effects on wellbeing and cognition. 
Unfortunately, they often use screening tools instead of comprehensive test batteries 
(Folstein et al., 1975; Meyers & Brown, 2006; Meyers & Wefel, 2003; Patel & Mehta, 2007). 
 
2.3 Research questions and study aims  
The above discussed literature revealed substantial gaps in the clinical diagnostic process for 
glioma patients. The overall aim of the studies included in the present thesis was to improve 
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pre-, intra- and postoperative neuropsychological diagnostics. To this end the following 
research questions and specific aims were addressed: 
I. The setting of emergency hospitals and the available resources in clinical research do often 
not allow for a comprehensive neuropsychological evaluation of cognitive functions. 
Therefore, the first main question was whether an excellent cognitive screening instrument 
might be able to substitute a comprehensive neuropsychological test battery, especially in 
the context of preoperative cognitive assessment. Consequently, the first publication 
(Becker, Steinmann et al., 2016) investigated whether the recently published screening tool 
BCSE has overcome the limitations of the MMSE and MoCA and represents a valid tool for 
patients with intracranial tumors. 
II. In the context of awake craniotomy, expert consultation as well as a review of the existing 
literature revealed the lack of a feasible and standardized tool for pre-, intra- and 
postoperative assessment of sensory-motor function. The second publication (Becker, Jehna, 
Steinmann et al., 2016) therefore sought to develop a standardized diagnostic tool for such a 
setting and evaluate its feasibility in glioma patients eligible for awake craniotomy.  
III. As previously described, the evaluation of postoperative outcome provides valuable 
information on the consequences of the resection. Research on neuroplasticity based on 
large cohort studies or randomized trials is difficult or impossible to conduct. Consequently, 
case reports on patients with a unique disease constellation provide valuable information. 
Therefore, the third publication (Becker, Jehna, Larsen, Synowitz, & Hartwigsen, 2016) 
investigated pre- and postoperative basic cognitive and language function in a patient with a 
congenitally absent left hemisphere and a HGG to elucidate plastic changes in the 
reorganized brain  
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3 EMPIRICAL STUDIES 
3.1 Publication I - Cognitive screening in patients with intracranial tumors: 
Validation of the BCSE 
 
This section presents the first publication (Becker, Steinmann et al., 2016). Here we 
investigated whether the recently published screening tool BCSE has overcome the 
limitations of the MMSE and MoCA and represents a valid tool for patients with intracranial 
tumors. 
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Abstract This study presents the ﬁrst validation of the
Brief Cognitive Status Exam (BCSE) against two other
screening tools for cognitive impairment in patients with
intracranial tumors. 58 patients and 22 matched healthy
controls completed the BCSE, the Mini Mental State
Examination (MMSE) and the Montreal Cognitive
Assessment (MoCA). Patients were additionally tested
with a comprehensive neuropsychological battery. Based
on this assessment, they were classiﬁed as cognitively
impaired or unimpaired on ﬁve cognitive domains. Anal-
yses revealed a comparable feasibility of the BCSE relative
to the MoCA and the MMSE, but a smaller range of
assessed functions (e.g., no correlation with the domain
visual-spatial functions). The ability to separate patients
and healthy controls was extremely poor for BCSE and
MMSE (sensitivity of 38.6 % and less), but moderate for
MoCA (sensitivity 68.97 %). Detection of cognitive
impairment in patients was worst with BCSE (sensitivity
37 %; MoCA 92.9 %, MMSE 44.4 %) as compared to
neuropsychological testing. Moreover, prediction of cog-
nitive outcome was also worst for the BCSE (AUC = .713,
NPV = 50 %). An optimal cut-off of 50.5 increased the
results slightly. In summary, the BCSE showed good fea-
sibility but no sufﬁcient results in separating healthy indi-
viduals from patients or detecting cognitive impairment in
patients. Consequently, as a screening measure, we would
recommend the MoCA instead of the BCSE. However,
since even the MoCA failed to detect cognitive impair-
ment, our study supports the view that reliable results could
only be obtained with a comprehensive neuropsychological
battery.
Keywords Screening instrument  Neuropsychological
diagnostic  Intracranial tumor
Introduction
Intracranial tumors refer to any solid neoplasm inside the
bony skull. Their growth can alter normal brain function
and cause symptoms like increased intracranial pressure,
neurological deﬁcits, epileptic seizures and (neuro-) psy-
chological changes. Common treatment for intracranial
tumors includes neurosurgical operations, chemotherapy
and/or radiotherapy. These treatments, as well as the
growth of the intracranial tumor mass and possible inﬁl-
tration of brain tissue are likely to account for the fre-
quently reported reduced cognitive abilities in this patient
group [1–8].
Cognitive performance relies on intact sensory and
motor abilities and several discrete functions. They are
typically assessed during neuropsychological examinations
that consider multiple domains representative for both
hemispheres, including memory, attention, orientation,
speech and executive functions [8]. Precise identiﬁcation of
(even minor) cognitive impairments is on one hand
important for clinical patient management since it
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determines further treatment options like cognitive and
social rehabilitation. Moreover, cognitive impairment is a
predictor of recurrence and survival [3, 9] and is associated
with an overall decrease in quality of life and execution of
activities of daily living [10, 11]. On the other hand,
identiﬁcation of cognitive impairment is particularly
important for research studies that include cognitive status
as an outcome measure, for example in evaluation of
treatment effects and side effects [8, 9, 11, 12]. The current
gold standard recommends a comprehensive neuropsy-
chological test battery with a duration of at least one hour
for assessment of cognitive domains [13]. However, com-
prehensive testing is very costly as it necessitates trained
personal, test rooms, testing materials and time. Therefore,
many clinical trials rely on short screening tools like the
MMSE [12, 14–16]. However, it is questionable whether
cognitive screening instruments represent valid alternatives
to comprehensive neuropsychological test batteries in some
settings and patients [12, 15, 17]. As one of the few studies
considering a comparison of screening tools against the
gold standard of a comprehensive neuropsychological test
battery, Olson and colleagues [18] compared the screening
tools MMSE and MoCA [19] in patients with intracranial
tumors (n = 58). They reported a sensitivity of only
61.9 % for the MoCA and 19 % for the MMSE and a
speciﬁcity of 94.4 % for the MMSE (MoCA 55.6 %) rel-
ative to a 3-4 h neuropsychological assessment battery.
Further analysis failed to reveal any cut-off score where
satisfying detection of cognitive impairment in this popu-
lation was possible and further investigations of the MoCA
in this collective were recommended. Hence, valid alter-
native screening tools for detection of cognitive decline are
desirable. The need for studies involving new, alternative
screening tools was further stressed by the results of a
previous study in acute stroke patients that demonstrated an
underestimation of cognitive impairment for the MoCA
compared to a neuropsychological assessment [20].
The novel screening instrument BCSE [21] might rep-
resent a promising tool for this purpose. However, to the
best of our knowledge, this test has not been compared to
the gold standard of a test battery to date. Consequently,
the validity and diagnostic properties of the BCSE to
identify cognitive impairment in patients with intracranial
tumors remain to be determined.
The primary goal of this study was to explore whether
the BCSE is a superior alternative for neuropsychological
screening as compared with the MoCA and MMSE in
patients with intracranial tumors. A validation of this novel
tool was mandatory since this test has not been used in
patients with intracranial tumors so far. Therefore, our ﬁrst
aim was to examine the feasibility and convergent validity
of the BCSE in comparison to the established screening
instruments MoCA and MMSE.
Secondly, we aimed at providing a comprehensive
comparison of the sensitivity and speciﬁcity and other
diagnostic properties of the BCSE relative to MoCA and
MMSE. Particularly, we examined whether the BCSE
would be more reliable than the older screenings in (i) de-
tecting patients with intracranial tumors versus healthy
subjects and (ii) detecting cognitive impaired subjects in a
patient cohort asserted by the gold standard of a compre-
hensive neuropsychological test battery covering several
cognitive domains.
The neuropsychological test battery in our study was
conceptualized as a German version of the cognitive
domains suggested by Olson and colleagues [18] but was
considerably shorter in terms of assessment time. This was
mandatory to reduce the inﬂuences of exhaustion, selection
bias and split assessment that was reported previously [18].
Thereby, we aimed to reduce the dropout rate and gain
complete neuropsychological proﬁles for each patient.
Methods
Screening-instruments
The BCSE, as part of the Wechsler Memory Scale—Fourth
Edition [21], is a screening tool to assesses basic cognitive
functions: orientation to time, incidental recall, mental
control, planning/visual perceptual processing, inhibitory
control, and verbal productivity. The necessary assessment
time ranges between 7 and 11 min. To the best of our
knowledge, only one previous study evaluated the BCSE
[22] by comparing it with the MMSE in patients with mild
cognitive impairment (MCI) or dementia and healthy
controls. The BCSE provided a better sensitivity in patients
with Alzheimer’s dementia. However, it was less speciﬁc
in correctly distinguishing older adults with MCI from
healthy controls. The present study should thus represent
the ﬁrst validation of the diagnostic properties of the BCSE
in patients with intracranial tumors.
The MoCA evaluates cognitive functions in about
10 min [19]. Current studies show a clear advantage over
the MMSE also in neuro-oncological patients [6, 23, 24].
The MoCA provides a relatively higher sensitivity com-
pared to the MMSE [19, 24–26] and is less affected by
ceiling effects [27] as it includes more demanding tasks
[19]. However, speciﬁcity was lower than in MMSE [19,
23, 25, 26]. It was previously validated in patients with
intracranial tumors [24].
The MMSE [14, 28] assesses cognitive functions also in
about 10 min. The MMSE is often used in patients with
intracranial tumors [2, 29, 30], although it has not been
systematically validated in these patients to date [16, 29].
Moreover, application in patient groups other than
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dementia has been criticized [30] as it demonstrated a
relatively low validity [12, 16, 19, 26, 31].
Feasibility analysis
We assessed admission time and subjective perceived tol-
erability and strain for each screening instrument. For the
latter, we modiﬁed the ranges of a visual analogue scale
(VAS) [32] from ‘‘not at all tolerable’’ (0) to ‘‘very toler-
able’’ (10) and respectively from ‘‘not at all exhausting’’
(0) to ‘‘very exhausting’’ (10). In addition, patients had to
state which screening tool they would prefer. For subjec-
tive validity, they were asked which of the screening tools
was best in measuring their perceived changes due to the
disease.
Cognitive domains
Table 1 displays the applied test battery, which was based
on two previous studies (see Online Resource 1 for pro-
cedure of assessment) [7, 10]. Both used comprehensive
neuropsychological test batteries and assigned tests to
particular domains. In the study by Satoer and colleagues
[7], lexical word ﬂuency was assigned to the domain lan-
guage. In contrast, semantic word ﬂuency was assigned to
the domain ‘‘memory’’ in the present study since areas
involved in executive and verbal functions seem to support
semantic word ﬂuency, but contribute less to this task than
temporal (i.e., memory related) regions [33]. Indeed, neu-
roimaging studies revealed stronger activation in the left
hippocampal areas than in the dorsolateral pre-frontal
cortex for semantic word ﬂuency [34].
Subjects
All eligible patients scheduled for routine neuropsycho-
logical examination between April 2013 and July 2014
were pre-screened for study participation. The control
group was recruited among relatives and matched to the
patient group in terms of age, years of education and
gender (for detailed information see Online Resource 1).
Statistical analysis
The data analyses were carried out with the statistical
package for social sciences (SPSS) Version 21…0 and
MedCalc V.12.2.1.0. For a detailed description of the sta-
tistical analysis concerning the preliminary analysis
including feasibility and validity see Online Resource 1.
We referred to the cut-off scores reported in the
respective manuals for group deﬁnition of cognitive status
variables in the screening tools. All subjects reaching lower
scores were labeled as ‘‘cognitively impaired.’’ In case of
the MMSE, we used\26 as cut-off [14]. For the MoCA
and the BCSE, we used the standard cut-off scores of\27
or the percentile rank of\15, respectively [19, 21].
In the test battery, cognitive impairment was assumed
when at least one domain was indicative of impairment [1,
43]. For each domain, we obtained a z-score following the
procedure outlined by two previous studies, for details see
Online Resource 1 [1, 44].
In a ﬁrst step, we calculated sensitivity, speciﬁcity,
positive predictive value (PPV), negative predictive value
(NPV) and diagnostic accuracy (DA) in detecting patients
with intracranial tumors among healthy controls for the
BCSE, MoCA and MMSE. Secondly, we tested these
screening tools against a neuropsychological test battery. In
each case, receiver operating characteristic (ROC) curves
were constructed. The area under the curve (AUC) was
calculated for each ROC curve as a measure of test accu-
racy. Statistical signiﬁcances of the differences between
AUCs were assessed with a non-parametric approach [45].
Optimal cut-off values were derived at ROC coordinate
points where both sensitivity and speciﬁcity were opti-
mized using the Youden Index [46]. In addition, we again
calculated sensitivity, speciﬁcity, PPV, NPV and DA for
the three screenings at these optimal cut-off scores.
Results
Subjects
In this prospective study trial, 58 patients participated before
or after (n = 5) their neurosurgical operation (for details see
Online Resource 2: Flowchart of the recruitment process).
Sample characteristic are shown in Table 2. 58 patients
(50 % female) aged 27–80 (M = 58.03; SD = 13.94)
completed the whole assessment in 75–115 min; two of
them completed only the screening instruments due to fati-
gue and exhaustion (1 of them only MoCA). Results
regarding the prevalence of cognitive impairment are dis-
played in Online Resource 2.
The healthy, matched control subjects (n = 22) did not
reveal any differences in age, gender or education (for
details see Online Resource 2). Overall, the control group
had signiﬁcantly higher scores on each screening tool than
the patient cohort.
Preliminary analysis
Analysis of feasibility
Assessment time for all three tools varied between 2 and
21 min (BCSE: Md = 8, range 4–15; MMSE: Md = 5,
range 2–15, MoCA: Md = 10, range 3–21). The perceived
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strain of the BCSE (Md = 3, range 0–9) differed signiﬁ-
cantly from the MMSE (Md = 1, range 0–9; z = -3.817,
p = 0.000). The subjective tolerability was signiﬁcantly
higher for the BCSE (Md = 9.5, range 5–10) than the
MoCA (Md = 9, range 0.5–10; z = -2.053, p = 0.038).
The screening tools were judged as equally appropriate by
the patients (X(2)
2
= 0.304, p = 0.899), but the MoCA was
signiﬁcantly more often rated as the screening tool which
can ‘‘detect actual problems’’ (32.8 %, n = 19), the
MMSE was preferred by 5.2 % (n = 3), the BCSE by
17.2 % (n = 10) (X(2)
2
= 12.063, p = 0.003).
Analysis of validity
The BCSE correlated with the MMSE (r = 0.475,
p = 0.000) and the MoCA (r = 0.485, p = 0.000). It
showed signiﬁcant correlations with the domains speech
(r = 0.388, p = 0.000), attention and visuo-motor speed
(r = 0.302, p = 0.002), memory (r = 0.378, p = .000)
and executive functions (r = 0.351, p = 0.000), but no
correlation with visual-spatial functions (r = 0.070,
p = 0.473). Detailed results for MoCA and MMSE are
displayed in Online Resource 2.
Main analysis: diagnostic properties of BCSE
Distinguishing patients from healthy controls
TheMoCA revealed the highest sensitivity, while speciﬁcity
was higher for MMSE and MoCA. Both tools classiﬁed
100 % of the control group as cognitively unimpaired, as
compared with 81.8 % according to the BCSE. Best PPV
was shown for MMSE and MoCA, best NPV and best
diagnostic accuracy (DA) for the MoCA (Table 3). The
AUC was highest for MoCA (0.848), but signiﬁcant dif-
ferences were only found between MoCA and BCSE.
Table 1 Neuropsychological test battery
Domain/test Cognitive abilities Description
Language
Subtests of the Aachener Aphasie Test (AAT, [35])
Token test Verbal comprehension Pointing to and manipulating geometric forms on verbal
command
Naming Word ﬁnding Naming Objects, colors and complex activities
Written language Verbal academic skills Writing to dictation and reading aloud
Language comprehension Auditory and reading
comprehension
Finding the object/scene out of three distracting stimuli
Lexical word ﬂuency [36] Phonological ﬂuency Producing words beginning with a given letter within 2 min
Attention and visuo- motor speed
Digit Span [37] Attention and working memory Immediate repetition of digits forward and in reverse order
Trail-making test part A (TMT-A, [38]) Visuo-motor speed Connecting 25 encircled numbers
Memory
Memo-test [39] Immediate and delayed verbal
memory
Learning 10-item wordlist within ﬁve repetitions, recall after
15 min
Rey-Complex-Figure-Test (CFT, [40])
delayed recall
Implicit visual–spatial memory Reproduction of the copied ﬁgure from memory
Semantic word ﬂuency [36] Semantic memory Naming animals within two minutes
Executive functions
Five-point test (FPT, [41]) sub score
productivity
Figural ﬂuency Production of patterns by connecting dots within rectangles
within three minutes
Trail-making test part B (TMT-B, [38]) Cognitive ﬂexibility, visuo-
motor speed
Connecting 25 encircled numbers and letters in alternating
order
Semantic alternating categorical word
ﬂuency [36]
Flexibility of verbal ﬂuency Naming sports and fruits alternating within two minutes
Visuo-spatial functions
Visual Object and Space Perception battery (VOSP, [42])
Object decision Object perception Detecting silhouettes of a real object among fantasy drawings
CFT [40] copy Visual–spatial processing Copying a complex ﬁgure
AAT Aachener aphasie test; CFT Rey-complex-ﬁgure-test; FPT Five-point test; TMT-A Trail-making test part A; TMT-B Trail-making test part
B; VOSP Visual object and space perception battery
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Table 2 Sample characteristics
patient cohort (N = 58)
Variable n %
Mean age in years M = 58.03 (SD = 13.94)
range = 27–80
Sex
Female 29 50
Male 29 50
Education (highest level)
Elementary school 26 44.8
Junior high school 17 29.3
University entrance diploma 11 19.0
University degree 3 5.2
No graduation 1 1.7
Current employment status
Currently employed/in education 37 64.0
Retired 17 29.3
Housekeeper/unemployed 4 6.9
Pre-morbid intellectual level/IQa M = 110.25 (SD = 10.80)
range = 82–137
Karnofsky Performance Status 0-100 (n = 47) M = 87.13 (SD = 13.54)
range = 50–100
Previous neurosurgical treatment
None 47 58.8
First recurrence after initial operation 10 12.5
Second recurrence 1 1.3
WHO grading
WHO I 15 29.9
WHO II 9 15.5
WHO III 7 12.1
WHO IV 20 34.5
No WHO grading
Malignant tumor (Metastases) 4 6.9
Benign tumor (Schwannoma) 1 1.7
No histopathological reportb 2 3.4
Tumor-histological diagnosis
Meningioma 15 25.9
Astrocytoma 10 17.2
Glioblastoma multiforme 20 34.5
Other 11 19.0
No histopathological report 2 3.4
Tumor-lateralization
Right 23 39.7
Left 24 41.4
Other (e.g. multiple or medial) 11 19.0
Main tumor-localization
Frontal 20 34.5
Temporal 11 19.0
Parietal 11 19.0
Occipital 2 3.4
Multiple 8 14.0
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Distinguishing patients with cognitive decline
from unimpaired patients
The full protocol could not be applied to all patients: Pri-
ority was given to tests that were most relevant to the
preparation and evaluation of the operative procedure,
which accounts for ﬂuctuating number of patients per
domain (see [1]). 48.1 % (n = 26) of the patients were
classiﬁed as unimpaired and 51.9 % (n = 28) as impaired
in at least one domain (see Online Resource 2).
MoCA showed better sensitivity than MMSE at the
respective cut-off scores, indicating higher speciﬁcity
(Table 4). At the optimal cut-off score, sensitivity was
highest for MoCA and speciﬁcity was highest for MMSE.
Regarding cognitive impairment in the neuropsychological
test battery, the AUC for MoCA was highest. A signiﬁcant
difference between two ROC curves was found for MoCA
and BCSE.
Discussion
This is the ﬁrst study comparing the BCSE with the MoCA
and the MMSE in terms of feasibility and diagnostic
properties in patients with intracranial tumors. With respect
to the feasibility of the BCSE in patients with intracranial
tumors, we experienced that assessment time of the BCSE
was similar to the estimated time provided in the manual
and lay between MMSE and MoCA. All screening tools
were perceived as hardly straining, highly tolerable and
equally appropriate. The signiﬁcantly higher strain of
BCSE and MoCA in comparison with MMSE probably
reﬂects higher demands on executive functions and mem-
ory in both tests. Additionally, the BCSE was rated as more
tolerable than the MoCA, which might explain why the
MoCA, as the subjectively most difﬁcult tool, was signif-
icantly more often judged as the screening tool that could
‘‘detect the actual problems’’.
As expected, we found medium but signiﬁcant correla-
tions between the BCSE and the two other screening tools
(r = 0.475–0.485). While the BCSE was the only screen-
ing that failed to show a signiﬁcant relationship with visuo-
spatial functions, this test showed low signiﬁcant correla-
tions with all other domains. This can be explained by the
lack of the BCSE in assessing visuo-spatial functions. As
this is the ﬁrst study investigating the BCSE in the popu-
lation of patients with intracranial tumors, our results
remain to be replicated in future studies. A detailed dis-
cussion of the results of MoCA and MMSE can be found in
Online Resource 3.
Distinguishing patients and healthy controls
One of our main goals was to examine the BCSE‘s ability
to correctly distinguish patients with an intracranial tumor
from healthy individuals. It should be kept in mind, how-
ever, that the screening tools were not constructed to
address this speciﬁc issue.
Regarding the speciﬁcity of the tools, it should be noted
that the control group was correctly classiﬁed as
Table 2 continued
Variable n %
Basal ganglia, cerebellum and adjacent structures 6 10.3
M arithmetic mean; SD standard deviation; WHO World health organization
a Estimated via the socio-demographic equation [47, 48]
b One patient suffered from a meningioma of the falx cerebri (radiological report), but died under the
surgery. One patient declined a surgery and was diagnosed with gliomatosis cerebri (radiological report)
Table 3 Diagnostic properties
distinguishing patients from
healthy controls (manual
cut-off)
AUC SD P Sensitivity Speciﬁcity PPV NPV DA
BCSE 0.699 0.0638 0.0018 38.6 81.82 84.6 34.0 50.6
MoCA 0.848 0.0409 \0.0001 68.97 100 100 55.3 77.5
MMSE 0.826 0.0463 \0.0001 28.07 100 100 33.9 47.4
Comparison of AUC z p
MoCA-BCSE 1.966 .0493*
MMSE-BCSE 1.611 0.1072
MMSE-MoCA -0.356 0.7218
AUC area under the curve; BCSE Brief Cognitive Status Exam; DA diagnostic accuracy; MMSE Mini
Mental State examination; MoCA Montreal cognitive assessment; NPV negative predictive value; P prob-
ability; PPV positive predictive value; SD standard deviation;  test statistic: z value; * signiﬁcant with
P\ .05
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unimpaired with 100 % by MMSE and MoCA. Surpris-
ingly, the BCSE considered four of them as impaired. With
respect to the very low speciﬁcity in detecting cognitive
impairment (see below), we assume that this outcome is a
false positive classiﬁcation. The ability to correctly identify
those individuals who have been classiﬁed as tumor
patients (i.e., the sensitivity) was extremely poor for BCSE
(38.6 %), but also for the MMSE with even less sensitivity.
The best, but still moderate sensitivity was achieved for the
MoCA (68.97 %). Better results were obtained for the
probability that the tested person was a patient (i.e.,
impaired) based upon a positive score (PPV), which was
considerably higher for all screenings (BCSE 84.6 %,
MoCA 100 %, MMSE 100 %). In contrast, the NPV
probability of a valid negative test result (i.e., unimpaired)
was very low (B55.3 %). Overall, diagnostic accuracy
favored the MoCA. ROC-analysis revealed low AUC for
BCSE, while AUCs for MMSE and MoCA were good
(0.826 and 0.848). Although no signiﬁcant differences
(only in tendency) were found between the AUCs of
MoCA and MMSE, our results suggest that the MoCA
seems to be the best alternative in clinical screening situ-
ations because it demonstrated the highest sensitivity.
However, it should be noted that it still misses one third of
ill patients, indicating that it should not serve as the sole
criterion for assuming a brain disease and initiating further
diagnostic.
Detecting cognitively impaired patients
Our second main goal was to examine the ability of the
BCSE to correctly identify those patients who have been
classiﬁed as cognitively impaired according to the current
gold standard of a comprehensive neuropsychological test
battery. When the cut-offs provided by the manuals were
used, the BCSE showed extremely low abilities to detect
impaired individuals (37 %). The best alternative screening
tool was the MoCA (92.9 %). Considering the speciﬁcity,
the BCSE’s ability to detect cognitively unimpaired indi-
viduals among patients with an intracranial tumor was
moderate but similar to the results of the MoCA (MoCA
61.5 %; BCSE 65.4 %). The best alternative screening for
this purpose was the MMSE (92.3 %). Converging results
were reported by other authors comparing MMSE and
MoCA in different and similar patient populations [18, 19,
26, 49]. For the BCSE, the poor results need to be further
explored in future studies.
Finally, prediction of cognitive outcome was worst for
the BCSE (AUC = 0.713) compared to the other screening
tools. Hence, with respect to the negative predictive value
(NPV), results from BCSE were in poor agreement with the
neuropsychological test battery as patients with a BCSE
score above PR 15 were likely to meet neuropsychological
criteria for cognitive impairment after comprehensive
evaluation (NPV = 50 %). Conversely, patients classiﬁed
as impaired by the BCSE (score\ PR15) had a probability
of 52.6 % to be diagnosed as impaired by the test battery.
The best alternative screening tool here againwas theMoCA
with clearly superior results (NPV = 88.9; PPV = 72.2).
Importantly, examination of different cut-off scores lead
to the conclusion that only in case of the BCSE the use of
an optimal cut-off increased both sensitivity and speci-
ﬁcity, indicating that the use of the stratiﬁed norms leads to
substantial misclassiﬁcation of patients with intracranial
tumors. Despite this improvement, the values remained far
below the diagnostic ability of MMSE and MoCA.
In summary, the BCSE is as feasible as the MoCA or the
MMSE in patients with intracranial tumors, but seems to
Table 4 Diagnostic properties
of cognitive impairment
according to
neuropsychological test battery
AUC SD P Manuals cut-off J sens spec PPV NPV DA
BCSE 0.713 0.0747 0.003 PR 15 % 37.0 65.4 52.6 50.0 50.9
MoCA 0.895 0.0412 \0.000 \26 0.503 92.9 61.5 72.2 88.9 77.8
MMSE 0.845 0.0547 \0.000 \26 0.516 44.4 92.3 85.7 61.5 67.9
Comparison of AUC z p
MoCA-BCSE 2.133 0.033*
MMSE-BCSE 1.426 0.154
MMSE-MoCA -0.730 0.47
Optimal cut-off
BCSE \51/50.5 0.439 59.3 84.6 80.0 66.7 72.7
MoCA \24/23.5 0.632 78.6 84.6 84.6 78.5 81.5
MMSE \28/27.5 0.625 74.1 88.5 87.0 76.7 81.1
AUC area under the curve; BCSE Brief Cognitive Status Exam; DA diagnostic accuracy; J Youden’s J;
MMSE Mini Mental State examination; MoCA Montreal cognitive assessment; NPV negative predictive
value; p probability; PPV positive predictive value; PR percentile rank; SD standard deviation; sens
sensitivity; spec speciﬁcity;  test statistic: z value; * signiﬁcant with p\ .05
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lack the assessment of visuo-spatial functions. In addition,
compared to MoCA and MMSE, it showed the lowest
diagnostic qualities in several areas and therefore cannot be
recommended as a screening tool for cognitive status in
these patients. This also holds true for clinical trials, as our
results identiﬁed the MoCA as the screening tool with best
PPV and NPV and again did not favor the BCSE. Never-
theless, for clinical as well as research settings it should be
kept in mind that screening tools usually underestimate the
amount of cognitive deﬁcits and the effect of treatment on
cognition in comparison with a comprehensive neuropsy-
chological test battery.
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3.2 Publication II - The sensory-motor profile awake - A new tool for pre-, intra-, 
and postoperative assessment of sensory-motor function 
 
This section presents the second publication (Becker, Jehna, Steinmann et al., 2016). In this 
publication we sought to develop a standardized diagnostic tool for awake craniotomy and 
evaluate its feasibility in glioma patients.  
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Objectives: Awake  craniotomy is  a  well-established  procedure in surgery of intracranial tumors  in
eloquent areas.  However,  sufficiently standardized  instruments  for the  assessment  of sensory-motor
function  before,  during  and  after  the  operation  are currently  lacking, despite  their importance  for  eval-
uation  of operative outcome.
Patients and methods:  To address  this issue,  we designed a  standardized  assessment  tool  (the “sensory-
motor profile awake  scale”;  SMP-a). The final scale consists  of three motor sections  (face,  arm  and  leg)
assessing  both  gross and fine motor skills and  one  sensory  section.  It  differentiates  between six  grades
of impairment  and  its tasks are  applicable  for intraoperative  continuous  monitoring  of  sensory-motor
functions  and supporting  processes.  We analyzed  the  data  of 17 patients  with  intracranial tumors  eligible
for  awake  craniotomy who  were  preoperatively  assessed with  the  SMP-a.  In addition, we present an
exemplary  case.
Results:  Our  data  support  the  assumption  that the SMP-a  is feasible  in patients  eligible  for  awake  cran-
iotomy, even in patients with  symptoms  of mild  aphasia  or  more  severe  sensory-motor  deficits  caused  by
tumor recurrence.  The exemplary  case  demonstrates  the  feasibility of repeated  measures  with  the  SMP-a
in a  tumor  patient, including  the  adaption  of tasks to  the  individual requirements  of an intraoperative
setting.
Conclusion:  This  exploratory  study  suggests that  the  SMP-a  might  be  a feasible  rating  scale in patients
with  intracranial  tumors.  The flexibility  of the  scale  enables individual adaption,  but preserves  the  stan-
dardized scoring system to allow  comparison between assessment  dates,  patients  and,  hopefully  in the
future,  institutions.  However,  future  studies  are  mandatory  to provide data  on the  instrument’s diagnostic
properties  with  respect  to feasibility, objectivity,  validity  and  reliability.
©  2016  Elsevier B.V.  All  rights  reserved.
1. Introduction
Awake craniotomies are usually considered in  patients with
intracranial tumors located in  or near motor areas to prevent
cortical and/or subcortical damage which might lead  to perma-
nent neurologic deficits [1–5].  Direct cortical stimulation (DCS)
∗ Corresponding author at: Department of Neurosurgery, University Hospital
Schleswig−Holstein, Arnold−Heller−Straße 3, D−24105 Kiel, Germany.
E-mail addresses: Juliane.becker@uksh.de (J. Becker),
margit.jehna@medunigraz.at (M.  Jehna), Elisabeth.steinmann@uksh.de
(E. Steinmann), Maximilian.Mehdorn@uksh.de (H.M. Mehdorn),
Michael.Synowtiz@uksh.de (M.  Synowitz), hartwigsen@cbs.mpg.de
(G. Hartwigsen).
and mapping supports the surgeon with real-time intraoperative
information and this way accounts for individual variability of
cortical organization and neuroplastic changes [2,6]. The neuro-
surgeon must be aware of a  wide range of possible intraoperative
changes (e.g. slowing of movements, weakness, dysarthria or
delayed response) since they guide the decision for resection [7].
A suitable tool for intraoperative monitoring should account for
all these changes and support the neurosurgeon with valid and
standardized that is, easy-to-interpret information during the oper-
ation.
So far, the available literature on  awake craniotomy in motor
eloquent areas provides either no information on the methods used
to  monitor endangered functions, or  is  restricted to the assessment
of somatosensory and motor evoked potentials or  unstandard-
http://dx.doi.org/10.1016/j.clineuro.2016.05.022
0303-8467/© 2016 Elsevier B.V. All rights reserved.
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Table  1
Rating scale for the assessment of complex sensory-motor functions in brain tumor patients undergoing awake craniotomy (sensory-motor profile awake; SPM-a).
SMP-a  preoperative  intraoperative  postoperative
face severe impairment medium impairment no/slight impairment notes
frown  forehead 0 1 2 3 4 5
blink  eyes 0 1 2 3 4 5
wrinkle nose 0 1 2 3 4 5
kissing  lips 0 1 2 3 4 5
laughing  mouth 0 1 2 3 4 5
mouthwash 0 1 2 3 4 5
poke  tongue out 0 1 2 3 4 5
hand  and arm
hand:
fine
motor
skills
rock 0 1 2 3 4 5
scissor 0 1 2 3 4 5
paper 0 1 2 3 4 5
well 0 1 2 3 4 5
finger tapping (oscillating) 0 1 2 3 4 5
strength: shake hands 0 1 2 3 4 5
rotate  wrist 0 1 2 3 4 5
flex  elbow 0 1 2 3 4 5
lift  shoulder 0 1 2 3 4 5
leg
lift  knee slightly 0 1 2 3 4 5
adduct  and abduct foot 0 1 2 3 4 5
move  toes 0 1 2 3 4 5
strength: press foot against hand (io) 0 1 2 3 4 5
sensory
face  0 1 2 3 4 5
fingers  0 1 2 3 4 5
arm  0 1 2 3 4 5
leg  0 1 2 3 4 5
toes  0 1 2 3 4 5
(io): first baseline in the operating room.
ized behavioral monitoring [1,8–16]. Evoked potentials provide
only limited reliability and impairments of non-monitored mus-
cles could not be avoided in previous studies [2,13,17–19].  Another
limitation of this technique is  that evoked potentials provide
no information on the direct effects of the DCS as reflected in
continuous voluntary movement during awake craniotomy [2].
The above-cited limitations probably partly result from the fact
that sensory-motor function is  a complex and integrated process,
comprising mobilization itself and several adaptation processes
[20–24]. This might explain why registration of simple muscle
contractions alone is  insufficient for obtaining optimal evalua-
tion [18,25,26]. Behavioral monitoring as alternative assessment
strategy during DCS  might increase the reliability and validity of
sensory-motor assessment [25,27–30]. However, previous studies
solely applied non- standardized or  semi-standardized approaches
of instructing their patients. Moreover, it remains unclear, if and
how baseline assessment of the patients’ functions was done and
how the surgery-induced alterations were rated and reported.
Therefore, inter-study comparability is hardly existent. In addition,
for evaluation of the surgical outcome, previous approaches often
assessed very different functions on variable scales compared to the
monitored and this way protected functions under surgery [29,30] .
Consequently, a valid conclusion on the value of awake craniotomy
appears to be difficult at this time.
Hence, a standardization of the monitoring procedure would be
mandatory to improve intraoperative assessment of sensory-motor
function and provide reliable postsurgical evaluation. However, to
the best of our knowledge, no attempts have been made to adapt
the existing neurological scales for the application in  awake cran-
iotomy so far.
To bridge this gap, we designed a rating scale suitable for this
purpose. By this, we aimed at combining the advantages of existing
neurological scales used for preoperative and postoperative evalu-
ation in this setting (i.e., the Modified Rankin Scale (mRS) [31],  the
British Medical Council Research Scale (MCRS) [32,33],  the Cana-
dian neurological scale (CNS) [34] and the Graded neurologic scale
[35]). Furthermore we  tried to  overcome the following limitations
of the previous scales: (a) lack of practicability: mRS, CNS and Graded
neurologic scale provide rating sections not suitable for intraoper-
ative setting (e.g., flexion of thighs toward trunk with knees flexed
at 90◦; activities of daily living; gait), (b) lack of highly relevant func-
tions: missing fine motor skills and/or sensory functions in  all four
scales, (c) lack of precision in item phrasing or scoring system: i. e. mix-
ing motor and sensory functions (mRS), vague phrasings in scoring
system like “moderate disability, requiring some help” (mRS) or
limitation to  strength (MCRS) and no qualitative assessment of
deceleration or imprecise movements (CNS).
2. Material and methods
The result of our efforts is the “sensory-motor profile awake
scale” (SMP-a) as displayed in Table 1. Whenever possible, we
adopted suitable items and scoring schedules from existing scales
and adapted them for intraoperative settings.
Somatosensory function can be assessed with the SMP-a by
touching the face and extremities and recording the respective
description of the sensation by the patient. The same holds true
for cortical stimulation-elicited dysesthesia reported by  the patient
(see also 11,19,30). Our standardized scoring system (including
an explanation of the grades) is shown in Table 2.  It  consists of
six points covering three steps of impairment. For assessment of
strength and sensory function, the numbers follow a continuum
similar to the MCRS.
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Table 2
Scoring system for  assessment of complex sensory-motor functions with the SPM-a.
Grade of functionality Classification of impairment
severe moderate slight/no
grade 0 grade 1 grade 2 grade 3  grade 4  grade 5
Motor functions no contraction or
muscle
movement
trace of
contraction
visible or
palpable, but no
movement at the
joint
hint towards a
purposeful
movement
visible
uncoordinated
execution of a
purposeful
movement
visible
purposeful
movement
visible, but
deceleration or
imprecise
execution
no deficit,
purposeful
movement
visible, normal
strength
Sensory  functions numbness, no
sensory function
isolated
dysesthesia, but
rest numb
more severe
dysesthesia,
transposed
assignment of
fingers
dysesthesia slight dysesthesia no deficit,
normal sensory
function
2.1. Recommendation for patient preparation and intraoperative
monitoring
In accordance with other authors [36,37], we recommend an in-
depth preparation of the patient to enhance her/his intraoperative
compliance. Special attention should be paid to functions that are
highly important for the patient’s professional and social life [38].
The total number of tasks during surgery might be decreased if
deficits are tolerated or  specific functions are not  endangered. For
a precise baseline assessment, the patient executes the demanded
movements after a  verbal command with and without visual
control and if necessary by imitation (f.  e. aphasic patients or non-
native speakers). In addition, the patient’s report of any changes
during the operation is  explicitly encouraged [39–41]. In our expe-
rience, one should keep in  mind that some tasks might be not
feasible due to restrictions in the operating theater. For instance,
“frown forehead” is  often hindered by  the Mayfield head holder
and local anesthesia and “lift shoulder” might be impossible due to
the positioning of the patient. A well-trained examiner can do  the
whole preparation within 20 min.
Intraoperatively, the baseline-profile or the last noted profile
changes enable a  fast judgment of any alterations at one glance. The
SMP-a is used in  our clinic in  a  surgery mode following the DCS pro-
tocol introduced by Duffau et al. for stimulation of cortical as well as
subcortical areas without additional measurement’ of somatosen-
sory or motor evoked potentials (SSEP/MEP) [42].  For mapping
purposes the cortical stimulation is done simultaneously with the
execution of one task at a  time. The intraoperative selection of the
tasks for each stimulated site strongly depends on the patient’s
individual neuroanatomical structure and the tumors relationship
to functional areas. For  example, during the mapping of areas with
specified functions like motor areas of the hand, the assessment can
focus only on finger tapping. For areas with negative DCS results,
resection can be initiated and a  selection of tasks can be performed
repeatedly until impairments emerge. Then, again, the monitor-
ing may  focus on the altered functions. In accordance with other
authors, we prefer a continuous monitoring of the selected tasks
during mapping and resection [7,25,27,28,30,43].  To date, intraop-
erative data acquisition is  performed in two ways. The first part of
data acquisition focuses on  several time points of interest, including
pre-stimulation assessment, measurement after change of resec-
tion site, before an intraoperative MRI  or at the end of the resection.
This data can be  recorded with different colors or  symbols on the
SMP-a sheet. As extensive mapping as well as continuous monitor-
ing may  generate a lot of information beyond the time points of
interest mentioned above, this additional data is currently noted
on an extra sheet with exact test time and results. This extra data
can  be condensed in a  postoperative neuropsychological operation
report.
Postoperatively, the tasks of the SMP-a can be assessed at dif-
ferent follow-up dates.
2.2. Subjects
We  retrospectively analyzed the data of patients eligible for
undergoing an awake craniotomy (from 2012 to 2015) at the Uni-
versity Hospital, Kiel. We  included patients whose preoperative
assessments took place within one to  five days before surgery
by a  neuropsychologist (J. B.  and E. S.)  with the assessment scale
introduced here. Additional data on language ability and medical
information was taken from the records. Permission for study par-
ticipation was  routinely obtained from all patients during inpatient
stay.
3. Results
3.1. Group analysis
Table 3 displays the subjects’ characteristics (n  = 17, 9 female).
29.4% of the assessed patients had language impairments: all of
these had difficulties in comprehension, four of them in naming
objects. 47.1% of our patients underwent an operation due to tumor
recurrence. All patients were able to  complete the baseline assess-
ment of the SMP-a sufficiently. The results on the preoperative
SMP-a baseline are displayed in Fig. 1. Preoperatively sensory-
motor functions showed no or only slight impairments except for
finger tapping with a medium functional impairment.
3.2. Exemplary case
The 40 year old patient was hospitalized with a  recurrence of an
oligodendroglioma WHO ◦II  in  the left central region (see Fig. 2  part
B). A former partial resection under general anesthesia two years
earlier had induced a spastic hemiparesis of her right body side that
was treated with intensive rehabilitation training.
She was prepared for an awake craniotomy with the SMP-a as
displayed in Fig. 2 on the left side. The assessment revealed con-
siderable deficits in the gross and fine motor functions of  the right
arm and leg. Additionally, corresponding to functional-anatomical
location of the lesions, the patient experienced impairments in sen-
sory functions and reported a lack of “feeling the extremities in the
deep”. The same assessment without visual control (closed eyes)
showed a strong deceleration of the motor functions of the right
hand.
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Table  3
Sample characteristics (N  =  17).
Variable n  %
Mean age in years M =  50.7 (SD =  10.87)
range  =  32–68
Karnofsky Performance Status 0–100 [52] M =  76.8 (SD = 10.9)
range =  40–100
Operation due to tumor recurrence
No  9 52.9
Yes  8 47.1
Tumor-lateralization
Right 5 29.4
Left 12 70.6
Main tumor-localization
Frontal lobe 7 41.2
Central sulcus 2 11.8
Temporal lobe 1 5.9
Parietal lobe 6 35.3
Insula 1 5.9
Tumor-histological diagnosis
Anaplastic Astrocytoma 3 17.6
Glioblastoma 8 47.1
Oligodendroglioma 2 11.8
Diffuse fibrillary Astrocytoma 1 5.9
Anaplastic Oligoastrocytoma 1 5.9
Oligoastrocytoma 1 5.9
Metastases 1 5.9
WHO  classification (n = 16)[53]
Grade 2 4 23.5
Grade 3 4 23.5
Grade 4 8 47.1
Language abilitya
Impaired 5 29.4
Naming impaired 4 23.5
Comprehension impaired 5 29.4
a assessed with the Aachener Aphasie Test (AAT; [54]).
4. Discussion
The existing literature on awake craniotomy provides either no
information on the methods used to monitor endangered func-
tions during the operation, or is  restricted to the assessment of
somatosensory and motor evoked potentials or unstandardized
behavioral monitoring [1,8–16].  While mRS, MCSR, CNS and Graded
neurological scale were used for evaluation of motor functions
before and/or after the operation [17,18,25,27–30,39–41,44–46]
none of them seem to be generally suitable for intraoperative
assessment. These instruments were originally designed for other
clinical cohorts and include impractical tasks like gait. Moreover,
they lack important tasks like  fine motor skills, mix  functional sec-
tions and do not provide a sufficient scoring system for qualitative
changes in motor functions. With the SMP- a, we aimed to over-
come these limitations and combine their benefits like valuable
items and a template for the scoring system. To the best of our
knowledge, our study represents the first attempt to adapt the
existing formal neurological scales for awake craniotomies.
The strengths of the SMP-a are  its standardization of the intra-
operative tasks and its use in the preoperative phase with an in
depth-preparation of the patient and a detailed baseline assess-
ment. This enhances the patient’s intraoperative compliance and
ensures valid data to compare intraoperative and postoperative
changes. Previous studies frequently reported that tumor-induced
impairment of proprioception and/or fine motor skills often allows
normal movements under visual control but reveals deficits with
closed eyes [47].  Such differences can be  assessed with the SMP-a
baseline by comparing task performance with and without visual
control. Thereby, the possibility of missing preoperative impair-
Fig. 1. Grade of functionality measured on the SMP-a for patients eligible for awake
craniotomy (0/1 = severe impairment, 2/3 =  medium impairment, 4/5 = slight/no
impairment; data obtained from 17 patients).
ments might be substantially reduced, which could otherwise
easily be  mistaken for operation outcomes. Since the SMP-a enables
rating of separate functions instead of providing summary scores,
it is  possible to  reduce the intraoperatively used tasks to  the indi-
vidually requirements of the patient’s social and professional life,
while still preserving a  standardized rating (see  also [38,48]). In
addition, the tasks are doable with minimum effort and there-
fore are repeatedly performable. The simple profile character of
the data and repetition of the same task during the operation
(continuous monitoring) allows to notice any changes like posi-
tive and negative effects of DCS as well as short term plasticity
[49].  Given that the SMP-a includes all motor tasks reported in the
main literature on awake craniotomy [7,25,27,28,30] the neuro-
surgeon can be confident to probe all functions located along the
“human homunculus” of one hemisphere [47,50].  Specific intra-
operative events like deceleration or imprecise execution of the
motor tasks [7] are represented in the rating scale of the SMP-a.
The repeated measure of the same tasks after the operation allows
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Fig. 2. Exemplary case. (A) Grade of functionality measured on the SMP-a with and without visual control. The assessment revealed a  considerable latency for movements
requiring an opening of the hand, despite visual control. Additionally, the patient reported numbness of the right side of the forehead as well as a strongly disturbed
proprioception of the right sided extremities. Assessment with closed eyes (dotted line) revealed a  strong increase in deceleration of fine motor skills (0/1 = severe impairment,
2/3 = medium impairment, 4/5 =  slight/no impairment). (B) Preoperative sagittal T2-weighted MRI showing a tumor recurrence in  the (post-) central region. (C) Preoperative
fiber tracking of the pyramidal tract running in close vicinity to  the  tumor.
drawing a differentiated picture of the recovery of the intraopera-
tively monitored functions. By this, a survey of the intraoperative
resection decisions and a  comparison across patients and institu-
tions becomes possible for the first time.
Our preliminary feasibility analysis shows the successful use of
the SMP-a in 17 patients, 8 of them were operated due to  tumor
recurrence and 5 showed aphasic symptoms. Aphasic symptoms
seem to be tolerable for the assessment of motor functions with
the  SMP-a, as it allows imitation of the tasks in case of compre-
hension deficits. For sensory functions, these impairments might
have greater impact as for rating of these functions a reliable
self-disclosure of the patient is  necessary. Future studies should
evaluate the influence of aphasic symptoms on the SMP-a.
Our preliminary data shows more severe impairments in fine
motor tasks especially finger tapping than in facial motor functions
or sensory functions in a cohort of patients eligible for awake cran-
iotomy. These exploratory findings need to be reassessed in future
studies. The presented exemplary case provides an illustration of
the successful implementation of the SMP-a assessment during
the inpatient stay in a patient with preoperative impairments.
Compared to the neurological examination, the SMP-a baseline
assessment revealed additional information useful for the awake
craniotomy, i.e., the impact of visual control and proprioception
on motor functions.” In addition, it shows the applicability of the
SMP-a in a  patient with a  tumor recurrence and thus more severe
impairments as compared to the average awake patient. Future
studies should address observations like a  possible dissociation of
motor function with or without visual control as well as the subjec-
tive feeling of weight before hemiparesis becomes apparent [39] as
potentially useful information for awake craniotomy.
Although our proposed scale is  more structured and compre-
hensive than the available ones, its ease of use during DCS needs to
be  evaluated beyond our subjective experience. A first hint that the
SMP-a might be suitable for continuous monitoring without caus-
ing high exhaustion mimicking paresis is  provided by the study
of Goebel et al. [51] where monitoring was performed with the
tasks of the SMP-a. In addition, a  feasibility study carried out by
an institution not familiar with this scale would be of great value
and might help to improve the SMP-a significantly. Since a  very
limited number of patients is available for awake craniotomies, we
were not  able to provide data on objectivity (inter-rater reliability),
validity (comparison with other neurological scales) or stability
(test-retest reliability) to date. Additionally, the registration of  the
intraoperative monitoring data beyond specific time points via  a  pc
and its collection in  a database would enable further data analysis
on relationships between standardized behavioral monitoring and
different intraoperative variables like stimulation method (e.g., dif-
44 J.  Becker et al. /  Clinical Neurology and Neurosurgery 147 (2016) 39–45
ferent electrode arrangements, frequency and amplitude), changes
in blood pressure or other assessment methods like SSEP and MEP.
We hope that this preliminary study might encourage other
centers to use this scale and provide data for a  multi-center eval-
uation of its quality criteria. Because of the benefits of the SMP-a
mentioned above, we  are confident that the SMP-a represents a sig-
nificant improvement as compared to previous techniques used in
clinical settings so far. Nevertheless, further studies are necessary
to evaluate the clinical relevance of a comprehensive tool like the
SMP-a. These studies should test whether the SMP-a could serve
the ultimately goal to  evaluate outcome in  awake craniotomy and
compare data between institutions.
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Abstract We present the first case report describing a craniot-
omy for a glioblastoma in a patient with hemihydranencephaly
(HHE). Ten years ago our patient had average cognitive and
language functions, indicating very good adaption of his
single right hemisphere. Due to the tumour he developed a
deceleration, deficits in language functions and mild impair-
ments of basic cognitive functions. Further neuroplastic
reorganisations of his right hemisphere in response to the tu-
mour growth are discussed. The favourable postoperative out-
come supported the decision for careful tumour resection in
this patient with HHE.
Keywords Neuropsychological diagnostic .
Hemihydranencephaly . Neurosurgery . Brain tumour .
Hemisphere agenesis
Introduction
Hemihydranencephaly (HHE) describes the condition of one
brain hemisphere being absent due to prenatal vascular com-
plications. So far, only nine cases have been reported in the
literature [10]. The space of the missing hemisphere is filled
with a cyst containing cerebrospinal fluid, minimal residual
neurons, glial tissue and remaining blood vessels [7]. Central
nervous structures fed by the vertebra-basiliar blood system
like the basal ganglia, pons, medulla, cerebellum, meninges
and falx are not affected [10]. Glioblastoma multiforme
(GBM) represents a malignant primary brain tumour affecting
only about 3 of 100,000 adults per year [3]. The growth of a
GBM causes multiple physical and cognitive symptoms and
its treatment with surgery is the first line therapy [2]. The case
we report is the first illustration of a treatment of a GBM in
HHE so far and a follow-up on the probably oldest patient
alive with HHE [12].
Case report
The 48-year-old patient with a known history of HHE
[12] was diagnosed with a GBM in the right frontal lobe
(Fig. 1). The tumour size was about 5.2 × 6.1 cm with
cystic and solid portions and surrounded by oedema in
the apical direction to the tumour. Despite a considerable
deceleration, the patient was awake, oriented and compli-
ant in the neurological examination. He only presented the
formerly diagnosed spastic hemiparesis of the right side.
The patient complained about a loss of physical strength
within the last 4 weeks, but no recent alteration of the
hemiparesis. He had to wear varifocal glasses for about
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4 years. A semi-structured interview for eyesight revealed
new impairments of basic and spatial visual functions af-
ter approximately 2 years [9].
Functional magnetic resonance imaging (fMRI) of the
left foot showed BOLD-signal alterations in areas similar
to that observed in healthy subjects (Fig. 2) [11]. However,
abnormal activation for foot movement was found near the
hand knob in the precentral gyrus. A deterministic
tractography reconstructed the pyramidal tracts in distance
to the tumour-induced oedema (Fig. 2 middle and bottom
rows). The fMRI of language could not be interpreted due
to the patient’s deceleration.
Preoperative cognitive and language ability
The patient complained of perceived personality changes in
the last 7 weeks. Additionally, he reported a decline in mem-
ory functions and recently occurring problems in pronuncia-
tion for the last 3 months. His pre-morbid cognitive functional
level was estimated to be 90 IQ points [6]. A cognitive screen-
ing tool, the Montreal Cognitive Assessment (MoCA) [8],
revealed an overall result of 17 out of 30 points, indicating
mild cognitive impairment (for details, see Table 1). In sum-
mary, the patient showed preoperative impairments in tasks
involving executive functions, attention, verbal fluency, ab-
straction and memory.
In contrast to a previous assessment 10 years previously
[12], the standardised diagnostic of aphasia [5] revealed clear
symptoms of an aphasic disorder and signs of dysarthria (see
Table 2). His spontaneous speech was repeatedly slurred, but
showed no neologisms, semantic or phonematic paraphasic
errors or repeated speech. In summary, the patient had mild
impairments of receptive, expressive and academic verbal
skills.
Surgical procedure
The strategy for microsurgical removal of the mass was to
minimise frontal lobe alteration and associated risk of
neurological deterioration. Therefore, a right-sided supra-
orbital approach was chosen. Insufficient compliance of
the patient prevented an awake craniotomy. After opening
the dura the tumour appeared clearly distinct from the
Fig. 1 Preoperative magnetic resonance imaging (MRI) scans in
transverse and sagittal views showing the defect of the left hemisphere
and the GBM in the right frontal lobe surrounded by oedema (frontal
midline shift about 1.7 cm). Top row: T1-weighted images (voxel size,
1 × 1 × 2 mm ; TR = 7 . 3 7 m s ; TE = 3 . 5 7 6 m s ; f i e l d o f
view= 224 × 224 mm2, flip angle, 8). Middle row: T2-weighted images
(voxel size, 0.43× 0.43× 2.60 mm; TR=5,501 ms; TE= 80 ms; field of
view= 512 × 512 mm2, flip angle, 90). Bottom row: T2-weighted FLAIR
images (voxel size, 0.45× 0.45 × 3 mm; TR= 12,000 ms; TE= 160 ms;
field of view= 512 × 512 mm2, flip angle, 90)
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brain tissue in a grey-bluish (livid) discoloration. The tu-
mour resection proceeded without complications: solid
masses were resected completely and all cystic structures
were opened. No resection beyond the tumour borders
was performed to avoid the high risk of permanent neu-
rological impairment in this patient. There were no intra-
operative pictures available.
Postoperative surgical outcome
MRI with contrast agent revealed minor contrast enhance-
ments at the margin dorso-laterally to the resection cavity
and a bold ring-like enhancement at the right frontal base
indicating small residual tumour parts (Fig. 3). Postoperative
diffusion tensor imaging (DTI) showed that the pyramidal
tracts were passing the rear corona radiate (Fig. 4). The
capsula interna as well as the cingulum were visually intact
on MRI. The right hemispheric arcuate fasciculus and the
inferior fronto-occipital fasciculus (IFOF) could not be
followed to their origin in anterior direction due to oedema.
Our Supplementary Material (ESM 1) displays additional
probabilistic tractography results of main fibre tracts. Aside
from slight subjectively reported postoperative physical weak-
ness (circulatory disturbances, balance), the neurological ex-
am revealed no novel postoperative sensory-motor deficits.
The patient reported no alteration of the hemiparesis in com-
parison to the preoperative impairment and no changes in
hearing and vision [9]. In addition, there were no more signs
of deceleration.
Postoperative cognitive and language ability
Six days after the resection, the patient no longer reported
problems in memory or pronunciation. It also negated
changes in the patient’s ability to concentrate. With 19
Fig. 2 Top row: Functional MRI for movement of the left foot (t-test,
MC) showing BOLD-signal alterations (red) in the cerebellum (bilateral),
right thalamus, right anterior cingulate cortex, right precentral gyrus, and
the right supplementary motor cortex (block designwith six active and six
passive conditions, 96 volumes; voxel size, 3.3 × 3.3 × 3 mm;
TR=2,500 ms; TE= 33 ms; field of view= 224 × 224 mm2; flip angle,
90). Middle and bottom rows: Deterministic tractography results from
diffusion-weighted images for the pyramidal tracts (green; seed: inferior
cerebellar peduncle) in transverse and coronal views (FA-colour-coded
MRI regis tered onto a T1-TFE scan with TR/TE: 7/3.4,
1 × 1 × 1 mm3 voxel size covering 104 slices (field of view, 224 × 224;
32 directions; b value = 1,000 s/mm2; 52 slices; voxel size, 2 × 2 × 2 mm,
no gap; TR= 5,234 ms; TE= 69 ms; field of view= 512 × 512 mm2; flip
angle, 90)
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of 30 points, the postoperative MoCA (alternative version
2) [8] still indicated mild cognitive impairment (Table 1).
In contrast to the preoperative assessment, the patient was
not able to solve the visual-constructive item. On the con-
trary, the clock-drawing-task was easily carried out this
t ime. One er ro r was made in the naming task
Table 1 Preoperative and postoperative assessment results for basic cognitive functioning with the MoCA [7]
Items
preoperative
raw score
postoperative
raw score
max.
Visual-spatial and executive functions 
alternating Trail Making
0 0 = 1
visuo-construction (rectangle)
1 0 1
clock drawing test
2 3 3
Naming 3 2 3
Attention digit span 2 2 = 2
vigilance 0 1 1
serial 7s 2 2 = 3
Language sentence repetition 0 0 = 2
verbal fluency 0 0 = 1
Abstraction 0 2 2
Memory: Delayed recall
free recall 0 1
cued recalla (0) (2) 5
multiple choicea (1) (2)
Orientation 5 5 = 6
wrong item exact date day of the week
Sum Score 
+1 for education fewer than 12 years
17 19 30
Δ pre-post comparison; max. (achievable) maximum score; a not relevant for final sum score
Table 2 Preoperative and postoperative language functions assessed with the Aachener Aphasie Test (AAT [5])
Subtest of AAT Preoperative Postoperative Δ max.
Raw score Classificationa Raw score Classificationa
Token test 35 Impaired 48 Unimpaired ↑ 50
Reading 27 Marginal 29 Unimpaired ↑ 30
Writing to dictation 28 Unimpaired 30 Unimpaired ↑ 30
Naming 106 Impaired 114 Unimpaired ↑ 120
Auditory comprehension 43 Impaired 41 Impaired ↓ 60
Reading comprehension 49 Impaired 47 Impaired ↓ 60
Δ pre-post comparison, max. (achievable) maximum score
a In comparison to other aphasic patients according to the manual of the AAT
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postoperatively. In contrast to the preoperative results, the
patient was able to solve the vigilance item correctly, in-
dicating clear improvement of the deceleration. In addi-
tion, he showed better performance on the assessment of
abstraction and memory. Moreover, the patient exhibited
no more symptoms of dysarthria (spontaneous speech was
no longer slurred and no new aphasic symptoms oc-
curred). Improvements in expressive and academic verbal
skills occurred. Mild impairments of receptive language
were still present (Table 2).
Fig. 3 Comparison of preoperative and postoperative MRI scans Top
row: Preoperative T1-weighted MRI with contrast agents (voxel size,
0.43 × 0.43 × 5). Bottom row: Postoperative T1-weighted MRI with
contrast agents (voxel size, 0.43 × 0.43 × 5) 1 day after the operation
displaying the slightly regressive midline shift. The resection cavity
exhibited hemorrhagic areas, was partially filled with fluid and showed
slight infarctions at the cavity margins (not displayed here)
Fig. 4 Postoperative deterministic
tractography. Top row: Pyramidal
tract (blue, coronal view) and
inferior fronto-occipital fasciculus
(IFOF) (green, transverse view)
displayed on the background of the
colour-coded FA map and selected
by slice filtering. Bottom row, left:
Display of pyramidal tracts (blue)
and IFOF (green) (selected by slice
filtering) in coronal and transverse
view from posterior overlaid on a
T1-weighted MRI scan registered
to the DTI native space. Bottom
row, right: Reconstruction of the
tumour volume (rosy), the
cingulum (pink), pyramidal tracts
(blue) and the right hemispheric
arcuate fasciculus (green). The
tracts were selected by slice
filtering and are marked by arrows
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Immediately after the patient’s release, radio-chemotherapy
according to the Stupp regimen was started [11]. The treat-
ment is not yet completed, but to date well tolerated by the
patient without major changes in cognitive or physical
status.
Discussion
Here, we present the first report of a craniotomy of a right
frontal GBM in a patient with HHE. Despite the high risk
of causing permanent neurological deficits during an intra-
cranial tumour resection in HHE, this case documents an
almost complete tumour resection with a good outcome
regarding language and basic cognitive functions. In con-
trast to the patient’s normal cognitive functionality 10 years
earlier [12], he presented preoperatively with a severe de-
celeration, mild impairments in basic cognitive functions
(memory, attention, executive functions) and mild impair-
ments in receptive, expressive and academic verbal skills.
One might speculate that these new symptoms were tu-
mour induced. The deceleration vanished after tumour re-
section and some basic cognitive functions including lan-
guage functions improved. No severe cognitive deficits
emerged postoperatively.
Cognitive performance in HHE is generally judged as rel-
atively normal, independent of which hemisphere is affected
[1, 10]. This is explained by the fact that already in utero, no
corresponding hemisphere is present for a longer time period
and the full Bfunctional potential of a single cerebral
hemisphere^ might be able to develop [4, 10]. HHE can be
considered as the earliest time point for a cerebral lesion in-
ducing neuroplastic changes, which likely differ from the ob-
served reorganisations in patients with hemispherectomy [10]
or patients with intracranial tumours. To date, however, it
remains unclear whether patients with HHE show further plas-
tic changes after additional lesions and how much adaption
can be achieved by one hemisphere. It may be speculated for
the reported case that after prenatal insult, formerly left hemi-
spheric functions were successfully organised in the intact
right hemisphere, which might explain his relatively normal
cognitive ability 10 years ago. This is supported by the respec-
tive fMRI and tractography results of our case, indicating
nearly normal functional areas and courses of assessed tracts
in comparison to healthy subjects. The later tumour growth
might have induced additional neuronal reorganisation in this
patient. The formerly good adaption to the missing hemi-
sphere could have provided capacity for additional plasticity.
This might explain the relatively mild cognitive and language
impairments before and after the operation. The divergent
BOLD signal for the fMRI of the left leg near the hand knob
might be regarded as one indication for a divergent functional-
neuroanatomical proportion.
In general, in case of a missing hemisphere, it can be spec-
ulated that this reduces the brain’s ability to compensate for
tumour and treatment-induced cognitive deficits compared to
patients without HHE. In addition, we might observe unique
functional-anatomical relationships which have been formed
during early development and were modulated later by addi-
tional occurrence of a GBM. This draws special attention to a
good balance between a conservative resection and maximal
tumour resection. The operative outcome of our case suggests
that even if only one hemisphere is functioning, a careful
tumour resection can be performed.
Conclusions
Although neurosurgical extirpation of an intracranial tumour
in a patient with HHE has a high risk for permanent neurolog-
ical impairments, this case report documents an almost com-
plete tumour resection (frontal lobe) with a good outcome
regarding language and basic cognitive functions. The results
of our case study support the assumption of a strong potential
for adaptive plasticity in the human brain. Specifically, our
results suggest that even in the absence of the entire left hemi-
sphere, the right hemisphere was able to develop language
functions and reorganise them after occurrence of a GBM.
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4.1 Cognitive screening in patients with intracranial tumors: A vote for a 
comprehensive neuropsychological assessment 
Many neurosurgical acute hospitals cannot afford a comprehensive neuropsychological 
diagnostic for all their patients with intracranial tumors. The same is true for clinical research 
trials which utilize cognitive status as an outcome measure for treatment or side effects 
(Bunevicius et al., 2014; Meyers & Brown, 2006; Meyers, Rock, & Fine, 2012; Taphoorn 
& Klein, 2004). Therefore, cognitive status diagnostic is performed by screening tools such as 
MMSE and MoCA. However, one major drawback is their lack of sensitivity for cognitive 
domains often impaired in patients with brain tumors. This particularly concerns executive 
functions in case of the MMSE and a low overall specificity in case of the MoCA. Most 
important, both tests have a tendency to miss 10-20% of impaired patients (Olson, Tyldesley 
et al., 2011). Despite their limitations, they are frequently used since alternatives are lacking 
to date.  
The goal of the first study (Becker, Steinmann et al., 2016) was to test whether the novel 
screening tool BCSE is a valid and diagnostically more accurate alternative compared to the 
established instruments MoCA and MMSE in patients with intracranial tumors. Despite 
comparable feasibility of the BCSE and the MoCA or MMSE and a sufficient convergent 
validity, we had to conclude that BCSE was no alternative for the established screening tools. 
We assessed the patieŶt’s cognitive status with the three screening tools in a mixed group of 
healthy subjects and patients with intracranial tumors verified by MRI. Our results clearly 
document the lack of the BCSE to distinguish between healthy and ill subjects. We also 
compared the results of the cognitive screening tools with the results of a comprehensive 
test battery in the patient group. Among the three screening tools the BCSE showed the 
lowest concordance with the results of the test battery. Specifically, our results showed that 
the MoCA was the most suitable screening tool for clinical diagnostic in our population of 
patients with intracranial tumors compared to MMSE and BCSE. However, a comprehensive 
test battery is still superior in terms of sensitivity and specificity. 
Sensitivity is influenced by the characteristics of the test population (Kraemer, 1992). One 
could argue that the BCSE was not designed for the application in tumor patients and 
therefore only reached a low sensitivity in our study. However, such limitations are not 
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specified in the test manual by the authors. It should be noted that some of the healthy 
subjects were classified as impaired by the BCSE in our sample, which is particularly critical. 
This misclassification might have resulted from a particularly high sensitivity to detect 
cognitive impairment. However, this explanation is not congruent with the results from the 
comparison to the test batterie in our patients. Here, the BCSE generally failed to accurately 
detect cognitive impairment, in particular those related to visuo-spatial functions. It thus 
remains unclear why the BCSE showed such low categorization accuracy in healthy 
participants. In neuro-oncology, sufficient sensitivity to detect minor cognitive 
deteriorations, which often occur in follow-up test situations, is important (Giovagnoli, 
2012). Additional comparative studies are necessary to verify our findings and further 
investigate the BC“E’s diagnostic characteristic also in different patient populations. 
For clinical purposes, high sensitivity and specificity in a screening tool would be preferable. 
Unfortunately optimizing both at the same time is impossible. A false positive (i.e. impaired 
cognitive status) classification would lead to unnecessary rehabilitative treatment or 
comprehensive testing that might reveal the false classification. In contrast, a false negative 
(i.e. unimpaired cognitive status) classification would lead to a missed chance of 
rehabilitation. Both types of errors are not favorable within the clinical context. Cognitive 
and physical functioning are valid predictors of quality of life (Bunevicius et al., 2014; 
Zucchella, Bartolo, Di Lorenzo, Villani, & Pace, 2013). Furthermore, reintegration in everyday 
life can palliate the already high burden of the disease and prevent depression (Bunevicius et 
al., 2014; Ford, Catt, Chalmers, & Fallowfield, 2012; Zucchella, Bartolo et al., 2013). Thus, at 
first place, the main goal in (awake) craniotomy is preservation of cerebral functions and at 
second place the subsequent rehabilitation (Duffau, 2010; Habets et al., 2014; Satoer, Visch-
Brink, Dirven, & Vincent, 2016). Therefore, our results are congruent with the 
recommendation to use a comprehensive test battery whenever possible (Klein et al., 2001, 
2001; Olson, Iverson et al., 2011).  
A further disadvantage of screening tools is their lack to address the relevant diagnostic 
questions in detail. This concerns in particular preoperative diagnostic in awake surgery. An 
elaborate behavioral observation provides valuable information to estimate the patient’s 
intraoperative compliance. Additionally, on basis of the cognitive profile, intraoperative 
tasks are selected and medical decisions such as eligibility for awake surgery or further 
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rehabilitation are made. All these decision steps are of high importance for the patient and 
should be based on valid diagnostic, which can be achieved only to a limited degree when 
screening tools are applied. The above outlined consequences following a cognitive status 
diagnostic underline the importance of a high diagnostic quality. One important conclusion 
from our results is that a high quality in terms of validity, sensitivity and specificity can only 
be achieved with a test battery so far. The exclusive use of a screening tool can only be 
justified in patients who show exhaustion, severe deceleration or decline the participation in 
a comprehensive test battery. Here, the use of an established screening tool such as the 
MoCA is recommended.  
In research trials the MMSE is often used for repeated cognitive measurements of treatment 
or side effects. The results of our study demonstrated a substantial lack in detecting 
cognitive decline in patients with intracranial tumors by the MMSE, which is in line with 
other studies (Le Rhun, Delbeuck, Devos, Pasquier, & Dubois, 2009; Olson, Iverson et al., 
2011). Accordingly, our results strongly support the replacement of MMSE by MoCA in 
clinical trials involving patients with intracranial tumors. With respect to the already reduced 
life expectancy and impaired health in many patients, it is mandatory to carefully investigate 
any further negative impact. This includes the recommendation to avoid new treatments 
with negative side effects, if their use is not justified by beneficial treatment effects. Due to 
this, one could argue that it is not justified to simply trust screening tools in this context. As a 
compromise in a setting with high time and cost restrictions, one could reduce a 
comprehensive cognitive test battery to the most important tools, as we tried in our study 
and also suggested by Lageman and colleagues (2010). These authors explicitly sought to 
reduce a cognitive test battery (containing standardized neurocognitive tests with a widely 
used format) for research purposes in their study and reported that the assessment of the 
domains of visuo-construction, processing speed, and verbal memory could capture 90% of 
all impaired patients. This approach could improve the results of clinical trials in patients 
with intracranial tumors and prevent risks and side effects on cognitive functions by 
treatment methods such as radiation or new chemotherapeutic agents. For further research, 
it is mandatory to include the patient’s perspective and expectations on cognitive 
assessment. This means that beside the careful selection of cognitive tests for a reduced test 
battery, the ecological validity of the results needs to be assessed. Following this, it is 
mandatory to ask the patients about their subjective cognitive impairments and their impact 
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on everyday life to identify the most severe subjective restraints. The primary goal should be 
the selective inclusion of tests exhibiting a high ecological validity and functions that are 
highlǇ ƌeleǀaŶt fƌoŵ the patieŶt’s suďjeĐtiǀe peƌspeĐtiǀe. 
Beside a qualitatively high status diagnostic regarding cognitive functioning, a respective 
assessment of sensory-motor functions for awake craniotomy is mandatory. Such a scale for 
pre-, intra- and postoperative assessment was established for sensory-motor functions in 
our second study (Becker, Jehna, Steinmann et al., 2016). 
 
4.2 Assessment of sensory-motor function in awake craniotomy  
Awake craniotomies require coordinated teamwork of a multi-professional team consisting 
of neurosurgeons, anesthesiologists, neuroradiologists and neuropsychologists (Talacchi, 
Santini, Casagrande et al., 2013). A substantial part of the surgical success, i.e. avoiding 
permanent postoperative deficits, relies on the intraoperative diagnostic performed by the 
neuropsychologist. As outlined in the second study (Becker, Jehna, Steinmann et al., 2016), 
no standardized tool for intraoperative diagnostic of sensory-motor function was available 
so far. Due to this circumstance, we designed such a tool and investigated its feasibility. 
Awake craniotomy exhibits difficult requirements such as i) high flexibility in task 
composition, ii) task restrictions due to the operation scenario, iii) very short time slots for 
each single task during DCS and iv) an extensive repetition rate of the tasks. To the best of 
our knowledge, our study introduced the first experimental design of a standardized tool for 
awake mapping and monitoring of sensory-motor functions which fulfills all these 
requirements. Further, our results demonstrate the feasibility to implement this tool for 
individually tailored diagnostic in a clinical routine for patients available for awake 
craniotomy.  
Based on these promising results, additional studies with the SMP-a in larger patient 
samples are planned to investigate its psychometric properties. Due to the thorough design, 
the SMP-a meets all basic criteria for implementation objectivity. Yet, the evaluation 
objectivity in terms of interrater concordance needs to be determined. Its clear definition 
and examples for the different rating categories should lead to a high interrater reliability; 
nonetheless the results might encourage a revision of rating examples. To provide a valid 
evaluation of the SMP-a’s interpretation objectivity, future studies on healthy subjects are 
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mandatory. For this population, we would expect no impairments and maximum grade of 
functionality for each task. Further, comparison of healthy subjects and patients should, for 
instance, reveal a significant lower functionality in patients with HGG.  
Of note, our study provided the first detailed characterization of the patient population for 
awake craniotomy in terms of sensory-motor function: These patients showed high sensory-
motor functionality except in fine motor tasks, where medium impairments were 
determined. The mean KPS score of 76.8 in our study group corresponds with the inclusion 
criterion of KPS >70% for awake craniotomy recommended by Santini and colleagues (2012). 
Five out of 17 patients (29.4%) in our study were finally excluded from awake surgery. The 
mean KPS of the excluded patients was 72 (SD=21.68) and did not differ significantly from 
the group which finally underwent awake surgery (Mann-Whitney-Test, U=25.5, p=.63; 
unpublished data). According to the criteria of Santini and colleagues (2012), we 
hypothesized that a group with KPS <70 (relative to the group of KPS >70) would show 
stronger impairments in the SMP-a. In an explorative analysis, we compared the six patients 
with a KPS <70 to the 11 patients with a KPS >70. The former group showed significant lower 
functionality in the following SMP-a tasks: rock (U=10.5, p=.009); paper (U=10.5, p=.009); 
finger tapping (U=14.0, p=.037), rotate wrist (U=16.0, p=.042), adduct foot (U=22.0, p=.048) 
and sensory face (U22.0, p=.048). Further studies should test if these results (convergent 
impairment in KPS and SMP-a) are of relevance for inclusion of patients into awake surgery. 
In particular, it is necessary to investigate whether the exclusion criteria of KPS <70 and 
impairments in the SMP-a predict intraoperative compliance and functional results. 
Contrariwise, a range of the KPS between 40 and 100 in our study indicates that patients 
with lower physical functionality (KPS <70) were able to undergo assessment with the SMP-a 
and were also eligible for awake surgery. The KPS is considered as an adequate measure of 
physical performance (Cheng, Zhang, & Liu, 2009) and widely used as outcome measure, 
although limitations in reliability and validity are reported ;TalaĐĐhi, d’Aǀella et al., ϮϬϭϮͿ. 
However, its predictive value as successful inclusion criteria for awake surgery might be 
limited. Instead, the KPS should be considered as an indicator for inclusion, but not as a sole 
criterion. Other, more specific factors such as cognitive functionality including language 
ability, specific sensory-motor abilities and psychological eligibility might also have high 
predictive values. In a second explorative study, we compared the SMP-a profiles of the five 
excluded patients with that of the included patients. We hypothesized that the excluded 
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patients would exhibit more severe impairments in the SMP-a. Indeed, excluded patients 
showed significantly more severe impairments in the following SMP-a tasks: laughing mouth 
(U=18.0, p=.024), rotate wrist (U=10.0, P=.012), lift shoulder (U=3.5, p=.022) and adduct foot 
(U=18.0, p=.024). It needs to be determined in future studies whether these tasks are 
predictors for a successful inclusion into awake surgery. The same is true for the SMP-a’s 
predictive value for intraoperative compliance and operation outcome. Further research is 
necessary to investigate the differences of included patients in comparison to rejected 
patients, with the ultimate goal to establish guidelines for inclusion and exclusion criteria for 
awake craniotomy in gliomas.  
Future studies for evaluation of the SMP-a’s convergent and divergent validity are planned. 
Validation criteria including routine medical measures for physical health such as KPS, but 
also a general neurological examination could reveal information on the SMP-a’s ability to 
assess similar and complementary information. Moderate to high relationships are expected 
with neurological rating scales for motor function such as mRS, MCSR, CNS and Graded 
neurological scale. Moderately high relationships are expected since some items of the SMP-
a were adapted from the other scales. The results of the exemplary case documented in 
publication two indicate an advantage of the SMP-a over the classical neurological 
examination. For instance, symptoms of disturbed proprioception are easily missed in the 
neurological examination but are explicitly assessed in the sensory section of the SMP-a. 
Additional research is planned to compare the results of a standardized neurological 
examination and the SMP-a to specify the possible advantages of the SMP-a. 
 
Pre-, intra- and postoperative comparison of sensory-motor assessment in awake 
craniotomy 
Talacchi and colleagues (2013) summarized the empirical research in awake craniotomy as 
folloǁs: ͞QualitǇ of eǀideŶĐe foƌ the ďeŶefits of ŵappiŶg is sĐaƌĐe ;ŵostlǇ eǀideŶĐe Đlass II, 
some evidence class III studies) and mainly based on historical control studies, retrospective 
aŶalǇses aŶd eǆpeƌt opiŶioŶ.͞ (p. 216). Their call for a clear terminology and consistency 
between pre-, intra- and post-operative testing for language tasks can be generalized to 
sensory-motor tasks. As one of the basic evaluation principles, the evaluation method for 
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the operative outcome should match the preoperative baseline assessment, otherwise 
information useful for prognosis and interpretation of clinical result is lost (Talacchi, Santini, 
Casagrande et al., 2013). With the SMP-a, we provided a tool for pre-, intra- and 
postoperative testing. Nevertheless, for repeated measurement, the stability of the results 
obtained with the SMP-a (i.e. retest-reliability) needs to be investigated. Based on our 
clinical experience, we would expect higher fluctuation of functionality in patients with 
gliomas due to the nature of the disease, including seizures, edema and tumor progression 
as responsible factors for functional decline. Further, we would expect a higher retest-
reliability for shorter test-retest time spans in this population. For clear estimation on the 
true retest-reliability, which accounts only for the measurement error of the SMP-a and not 
for confounding variables of the disease, future studies should be performed in patients with 
a more stable disease such as stroke patients. 
Despite an agreement on the inclusion of tumor-related outcome criteria as main goal in 
clinical trials, the main focus across the last decades was on medical variables such as 
disease progression and response to radio- or chemotherapy (Shields & Choucair, 2014). 
Improved survival time due to maximum resection may have been achieved at the cost of 
persistent long-term impairments in patients (Talacchi, Taphoorn, & Miceli, 2012). Little is 
known about the patieŶt’s fuŶĐtioŶal status (physical, cognitive, psychological) and health-
related quality of life after treatment (Talacchi, Taphoorn et al., 2012). With the SMP-a, we 
sought to provide an easy tool for long-term evaluation of the relationship of these factors. 
Future study goals should include the connection of medical data such as progression free 
survival and SMP-a data ǁith the patieŶts’ peƌspeĐtiǀe toǁaƌds a ͞patient-related outcome͟ 
(see also Talacchi, Taphoorn et al., 2012). Specifically, the eǀaluatioŶ of so Đalled ͞plaŶŶed 
defiĐits͟, needs to be addressed, i.e. if they are transient or persistent. This aspect was 
outliŶed as ͞oŶe of the ŵajoƌ ĐhalleŶge iŶ the folloǁiŶg Ǉeaƌs͟ by Talacchi and colleagues 
(2012). 
Nowadays, different clinical institutions use different instructions, different items and 
different rating scales for awake craniotomy in sensory-motor eloquent areas. With the 
SMP-a, we also aimed at designing a tool suitable for different institutions. To investigate the 
SMP-a’s aďilitǇ to ďe reliably implemented in different institutions, investigations of its 
interrater reliability between different institutions are necessary (beside analysis of 
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feasibility). For evaluation of the SMP-a’s iŶteƌƌateƌ-reliability, different professional 
backgrounds of the user involved in the assessment of sensory-motor function in awake 
craniotomy have to be considered. Neuropsychologists, medical doctors, clinical linguists 
and neurophysiologists show different experience levels at rating scales and sensory-motor 
assessment. Knowledge about these differences would help to interpret the results of 
sensory-motor assessment in and across different surgical teams. In addition, rules for 
practice could be derived with the goal to converge the institutions’ assessments to a cross-
discipline and cross-institutional standard, as requested by other authors (see for example 
Duffau, 2013, 2014). 
 
Maps of resectability aŶd ͞ŵaps of rehaďility͟ 
Maps of resectability provide preoperative estimations of the ͞expected extent of the 
ƌeseĐtioŶ͟ (Ius et al., 2011, p. 993). Comparing preoperative and postoperative resection 
outcome, they computed the probability of leaving a functional tumoral residuum for each 
voxel of the brain (Ius et al., 2011). For each patient, the preoperative MRI can be 
overlapped by this map. As a result, information of the likelihood of tumor residuals due to 
function in cortical areas and fiber tracts are available before DCS mapping is conducted (Ius 
et al., 2011). For primary motor and somatosensory cortex and the ventral premotor cortex, 
these authors reported a high likelihood of residual tumor for upper and lower limb in both 
hemispheres. However, specifications of the concrete intraoperative assessment and DCS 
elicited events for the residual tumor sites are missing. One could argue that the decision to 
leave a tumor residue in the brain strongly depends on the assessment method. This is why a 
map of resectability strongly depends on the institutional protocol for awake surgery. Using 
a cross-institutional assessment method as provided by the SMP-a, resection maps with a 
higher generalizability can be constructed in the future.  
Application of lesion behavior mapping (LBM) as used by Ius and colleagues (2011), is a 
promising method for future studies including the SMP-a. Here, intraoperative events 
elicited by DCS can be co-registered on MRI and DTI images and help to determine the 
critical regions for single tasks (Rorden, Fridriksson, & Karnath, 2009). The combination of 
LBM with a detailed behavioral assessment by the SMP-a might help to specify expected 
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impairments of specific areas during DCS, especially in areas with medium or low 
resectability as described by Ius and colleagues (2011). Based on these results, the course of 
functionality can be characterized for each residual tumor area in a next step by evaluating 
the relationship between intraoperative grade of impairment and course of postoperative 
impairment. This might result in estimations of the likelihood of recovery for different grades 
of impairment for each task, similar to the above discussed SMA-syndrome that showed a 
high probability of recovery after resection (Duffau, 2011c). Ultimately, this might lead to 
the generation of a ͞map of rehability͟.  
To date, only little is known about tailored rehabilitation for glioma patients (Khan, Amatya, 
Ng, Drummond, & Galea, 2015). With the SMP-a and an evaluation of rehabilitation, one 
might expect to gain helpful information about the impact of rehabilitation on sensory-
motor deficits in glioma patients after awake surgery. As previously described, research on 
the course of planned deficits could support the neurosuƌgeoŶs’ iŶtƌaopeƌatiǀe deĐisions. If 
an intraoperative deficit is known to have good postoperative prognosis, an early cessation 
of resection can be prevented. In addition, future studies should evaluate the ecological 
validity of impairments in single tasks of the SMP-a, particularly its relationship to long-term 
return to work and quality of life. 
Intraoperative decision making is always based on knowledge about the neuroplastic 
potential of the brain. Therefore, basic research studies on the brain’s potential for adaptive 
plasticity in response to lesions such as a glioma are of great value. As discussed above, this 
could be achieved via controlled trials evaluating rehabilitation but also with the help of 
imaging studies. The latter approach is described in the following section.  
 
4.3 Neuroplasticity as a key concept: The ability of the right hemisphere for 
language functions 
The third publication included in this thesis (Becker, Jehna, Larsen et al., 2016) addressed the 
surgical outcome regarding cognitive and language functions in a patient with a congenital 
missing hemisphere and a HGG in the remaining frontal lobe. This extremely rare 
combination of diseases provided a unique opportunity for insights into long- and short-term 
cerebral plasticity.  
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Due to the missing hemisphere during prenatal and later development, it can be assumed 
that this patieŶt’s ďƌaiŶ had to ŵake huge adaptioŶs to achieve a normal range of cognitive 
and motor functions which are normally distributed across two hemispheres. A 
neuropsychological assessment 10 years ago revealed average cognitive performance, no 
aphasia and a spastic hemiparesis of the right arm. These results and the ordinary socio-
professional life of the patient indicated successful large scale neuroplastic reorganization. 
Since the remaining hemisphere was obviously able to provide full functionality, his case can 
be considered as an example for functional compensation by remote homologues. It was 
previously argued that an additional lesion of areas which already compensate lost functions 
is considered to have a large potential for inducing permanent impairment in glioma 
patients (Duffau, Capelle, Denvil, Sichez, Gatignol, Lopes et al., 2003). Therefore, the growth 
of a GBM in the patient’s single right frontal lobe was expected to have a large impact on his 
(cognitive) functioning. However, preoperative assessment showed unexpected high results 
for basic cognitive functions and language abilities, as well as other neurological functions, 
despite the large tumor. This data suggests that further neuroplastic changes triggered by 
the GBM helped to avoid severe cognitive and sensory-motor impairments. The patieŶt’s 
aphasic symptoms 10 years after the last assessment and the symptoms of mild cognitive 
impairment are in concordance with the suggested concept of a threshold between 
compensation and impairment (2007). As argued by these authors ͞sloǁ-growing lesions 
exhaust progressively the plastic potential of the brain, letting us observe cognitive and 
physical deficits if a certain threshold is reached͟ (Desmurget et al., 2007, p. 910) .  
One limitation of the present case report is the absence of long-term standardized data on 
neuropsychological assessment and MR-imaging. Therefore, no conclusions on the specific 
underlying structural neuroplastic changes were drawn. To overcome such limitations and 
gain information on structural plastic changes in glioma patients, we recently designed and 
initiated a bi-centric long-term study. The goal of this study is to determine the relationship 
between cerebral structures for language functions such as the arcuate fascicle (AF) and 
language performance in the long-term course (data acquisition in progress). First results of 
a pilot study investigating the role of the right hemispheric AF for compensation of language 
deficits in brain tumor patients emphasized the supportive value of a bilateral symmetry of 
the AF in these patients. More specific, only laterality of one segment of the AF and the 
tumor grade were significant predictor variables for speech disturbances (Jehna et al., in 
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press). We further hypothesize that glioma patients with bilateral AF show a better 
rehabilitation outcome, as already reported for stroke patients (Forkel et al., 2014). A future 
implementation of our results might lead to the use of preoperative structural imaging in the 
clinical routine, to determine the structure of the contralateral AF. If a sufficient structure on 
the contralateral side is present in the individual patient, tumor resection in the left 
hemisphere might be extended to total or near-total tumor removal instead of subtotal 
extirpation. This might result in a prolonged progression free time without increase of 
language deficits for the patient (see also Shields & Choucair, 2014).  
As another open question, it remains unclear whether laterality might change due to white 
matter alterations in reaction to the tumor growth. In contrast to Duffau’s summary (2009a) 
that there is ͞no evidence for structural white matter plasticity͟, more recent results argue 
in favor of changes in measurements of gray matter density or white matter integrity in 
healthy subjects (Li, Legault, & Litcofsky, 2014; Thomas & Baker, 2013; Zatorre, Fields, & 
Johansen-Berg, 2012). Using a longitudinal study design, we aim to investigate white matter 
plasticity in glioma patients, in whom adaptive plasticity is not initiated by mere learning of a 
new skill but by a lesion. 
 
4.4 An integrative approach of comprehensive neuropsychological assessment in 
glioma patients undergoing awake surgery 
The main goal of the presented research articles was to improve neuropsychological 
diagnostic for patients with intracranial tumors. In summary, the results of the studies 
document i) the superiority of a comprehensive neuropsychological test battery over 
screening tools, ii) successful implementation of a new standardized assessment tool for 
awake surgery and iii) insights into the plastic potential of the brain. In the following 
passages, the results are integrated into a comprehensive model of neuropsychological 
assessment for glioma patients (see Figure 5). 
According to the proposed comprehensive testing approach, neuropsychological care starts 
with the initial diagnosis of a brain tumor and consecutive inpatient stay. Cognitive status 
diagnostic should be conducted with a comprehensive test battery. In contrast to a short 
screening tool, a test battery can detect even subtle cognitive impairments which might not 
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be identified by a standard neurological examination (Duffau, 2014). In addition, it provides 
valuable information on the patient’s cognitive and functional eligibility for awake 
craniotomy (see section Ϯ.Ϯ.ϯ.ϭ.Ϯ PatieŶts’ eligiďilitǇ foƌ aŶ aǁake ĐƌaŶiotoŵǇ). The resulting 
cognitive profile highlights functions likely affected by tumor resection and can help to tailor 
the intraoperative tasks to the patieŶt’s needs and expectations (͞personalized therapeutic 
management͟; see also Duffau, 2014).  
The preparation appointment for the awake surgery will further address factors that 
determine the individual quality of life for each patient, including job, habits, hobbies, and 
planned projects. In addition, possible deficits must be discussed with the patient. Valuable 
information on a patient’s psychological eligibility can further be obtained by discussing his 
fears and concerns with respect to the awake procedure. A preoperative baseline of sensory-
motor functions with the SMP-a should be assessed for further intraoperative comparison 
and outcome evaluation. With this in-depth preoperative protocol, the risk of misclassifying 
a patient as eligible for awake surgery is minimized. Patients with too low cognitive or 
sensory-motor capacity as well as severe aphasic disorders would be assigned for intubation 
narcosis. The preparation appointment also supports the goal of an informed consent for 
awake surgery. Another advantage is the thorough baseline assessment by the SMP-a as well 
as the standardized tests of the test battery, which can both be used for further research 
purposes and intern clinical evaluation of surgical outcome.  
In some cases, patients are too impaired to be assessed with a test battery, even at their first 
inpatient stay. According to the results of our first study, we would suggest the application 
of the MoCA in such cases. An example of a preoperative status diagnostic with an adapted 
test battery in combination with a screening tool (MoCA) in a severely impaired patient is 
provided in our third study. The patieŶt’s status assessment had to be performed at the 
intensive care unit. During the anamnesis, a severe deceleration and low cognitive capacity 
became apparent. For this patient, language was the most important domain to be 
preserved. Therefore, the test battery was reduced to a standardized language assessment. 
Importantly, an awake craniotomy would have focused on language and motor functions. 
Thus, his eligibility for awake surgery needed to be assessed. The necessity to reduce the 
test battery to mere language assessment and a cognitive screening was regarded as an 
indicator for low cognitive functionality. In addition, reliable cortical mapping would have 
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been hindered by the patient’s substantial deceleration. In a similar vein, normal timing of 
DCS would have been too fast for this patient, probably hampering a valid interpretation of 
test results as it was the case in his preoperative fMRI assessment. In combination with the 
low KPS of 30 (unpublished data), which indicates a very low physical functionality, the 
duration of an awake surgery would have been too demanding. Consequently, we did not 
further pursue the preparation for awake surgery with the SMP-a in this patient.  
To date, no general guidelines on exclusion criteria regarding cognitive, sensory-motor and 
psychological functioning for awake craniotomy exist. The proposed comprehensive 
preoperative neuropsychological assessment approach refers to several variables, with a 
potential relationship to intraoperative compliance (e.g. Capacity for test battery given? 
Moderate cognitive impairment? Sufficient language function?) and ability for cognitive 
mapping (e.g. at least moderate functionality in SMP-a tasks?). Future studies are necessary 
to determine their predictive value for intraoperative compliance and surgical success.  
 
 
Figure 5: Integrative approach of comprehensive neuropsychological assessment in glioma patients undergoing 
awake surgery. 
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The objectives of neuropsychological assessment vary with the phase of disease and 
treatment (Giovagnoli, 2012). Directly after surgery, the immediate effects of the operation 
are in the focus. However, especially studies on the benefits of awake craniotomy over 
intubation narcosis still suffer of several shortcomings (Talacchi, Santini, Casagrande et al., 
2013). These limitations include i) a rare assessment of cognitive functions with a 
comprehensive test battery, ii) missing follow-up assessment of postoperative morbidity, iii) 
high variance in the methods used for measurement of degree of deterioration and iv) rarely 
defined quality of deficits (Talacchi, Santini, Casagrande et al., 2013). To overcome these 
limitations in the area of sensory-motor function, the SMP-a was introduced for a 
standardized pre-, intra- and postoperative assessment. In addition, the use of the same test 
battery before and after the operation is suggested in the presented approach of 
neuropsychological assessment. We hope to be able to verify the beneficial influences of 
awake craniotomy compared to intubation narcosis by such a standardized evaluation 
protocol in the future. 
Another objective of comprehensive neuropsychological assessment after surgical tumor 
removal is to plan a specific rehabilitation (Duffau, 2009b). Rehabilitation aims to reduce 
cognitive and physical impairments related to tumor growth and surgery. This in turn 
reduces the patient’s need for assistance in everyday life and supports reintegration into 
working life. On the one hand, costs for rehabilitation of patients are a burden for the social 
health insurance system. On the other hand, an effective rehabilitation helps to ameliorate 
costs due to time absent from work (Hahn et al., 2003). In addition, costs due to 
psychological impairment such as depression are decreased. Cognitive and physical 
functioning are known predictors of quality of life (Bunevicius et al., 2014; Zucchella, Bartolo 
et al., 2013). Participation in normal life can palliate the burden of the disease and prevent 
depression (Bunevicius et al., 2014; Ford et al., 2012; Zucchella, Bartolo et al., 2013). There is 
some evidence that cognitive rehabilitation is effective in patients with high and low grade 
brain tumors (Giovagnoli, 2012). Nevertheless, a lack of control groups, randomized study 
designs and neuropsychological baseline or follow-up evaluation hinder precise assessment 
of the reliability and efficacy of cognitive rehabilitation for patients with intracranial tumors 
(Khan et al., 2015). The future goal should be to determine type, intensity and duration of 
rehabilitation for patients with intracranial tumors (Khan et al., 2015). 
4 GENERAL DISCUSSION AND CONCLUSIONS 
92 
Beside the benefits of comprehensive cognitive testing, there might be a risk of over-testing 
glioma patients. In patients with a severe disease burden and a short life expectancy, time 
consuming assessments may increase fatigue and distress (Giovagnoli, 2012). This might 
especially affect follow-up assessments, where additional treatments such as radio- and 
chemotherapy as well as tumor recurrence might have further reduced the patient’s 
cognitive and physical state. Here, it is recommended to reduce test batteries to tools for 
determining awareness and reliability of informed consent before investigations or 
treatments are initiated (Giovagnoli, 2012). As an alternative to a reduced test battery, the 
method of stepwise evaluation may satisfy clinical indications, patient’s fatigability and staff 
burden (Giovagnoli, 2012). Here, the test protocol is adaptive and ranges from a brief 
screening of dedicated functions to a detailed examination, if impairments are presumed. 
 
4.5 Concluding remarks  
In summary, the present work pointed out various requirements of the neuropsychological 
assessment in the context of glioma patients undergoing awake surgery. Due to the short 
history of this specialized discipline, there are still methodological gaps regarding the 
standardized and goal oriented diagnostic in awake surgery to date. The presented studies 
aimed to fill these gaps, but also generated novel questions for future studies.  
The first study showed that the BCSE cannot be used as valid instrument for cognitive 
screening in patients with intracranial tumors. For screening purposes, the MoCA turned out 
to be the best available tool, in clinical as well as research settings. However, a 
comprehensive test battery could not be replaced by any screening tool. Beside a 
differentiated cognitive performance profile, a test battery in particular provides additional 
information on the patient’s eligibility for an awake craniotomy and information for 
individual composition of intraoperative tasks. The second study outlined the lack of a 
standardized tool for sensory-motor assessment in awake craniotomies. In consequence, the 
SPM-a was introduced as a feasible tool for pre-, intra- and postoperative assessment 
purposes. Its validation with other scales for sensory or motor assessment as well as 
evaluation of its reliability are goals for future multicenter studies. The case report of a HGG 
in a patient with a congenital absent hemisphere in the third study illustrated the large 
potential of the human brain for neuroplastic adaption. The good pre- and postoperative 
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outcome of this patient as well as results of previous works stimulated new hypotheses on 
the brain’s potential for adaptive plasticity. In particular, a long-term study on 
neuroplasticity of language associated brain areas and white matter tracts in glioma patients 
was initiated. Results of the first pilot study indicated the relevance of the right hemispheric 
arcuate fascicle for language performance in patients with tumors in the language dominant 
hemisphere (Jehna et al., in press). After sufficient evaluation of the SMP-a, an analogues 
study on plasticity of sensory-motor networks in glioma patients is planned in the future. 
The long-term objective is an improvement of neuropsychological information supply for 
medical decision making, and in particular the improvement of the protocol for awake 
surgeries.  
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5 SUMMARY 
With only 15 newly diagnosed adults per 100.000 inhabitants per year, the prevalence of 
gliomas (i.e., an intracranial tumor which emanates from neurons and glial supporting tissue) 
is relatively low. However, the disease and its treatment represent a serious medical 
condition (Poeck & Hacke, 1998). Gliomas are classified by the world health organization 
(WHO) in a scheme of four grades of malignancies, according to their histological profile 
(Poeck & Hacke, 2006). It is common to divide gliomas into low and high grade gliomas (LGG, 
respectively HGG) due to their different biological behavior. LGGs tend to grow slowly and 
infiltrate intact brain tissue whereas HGGs grow very fast and more encapsulated (Poeck 
& Hacke, 1998). Removal of the tumor by neurosurgical operation is the first treatment step 
to prevent further tumor growth. Tumor surgery aims at maximizing the resection and 
theƌeďǇ iŶĐƌeasiŶg the patieŶt’s suƌǀiǀal tiŵe. However, surgery can cause severe cognitive 
and neurological deficits upon injuring eloquent areas. These areas are specialized for 
dedicated functions such as language or motor function, and resection bears the risk of 
inducing permanent deficits. Hence, for patients with tumors in eloquent areas a surgery 
under awake conditions is usually recommended (Duffau, 2011a). During an awake 
craniotomy the patient is fully conscious and his motor or cognitive abilities can be assessed 
with diagnostic tasks. With the help of direct cortical stimulation (DCS), maps of cognitive 
and sensory-motor functions for the individual patient can be compiled intraoperatively. 
These maps help the neurosurgeon to identify cortical areas and white matter tracts 
necessary for a specific function (Duffau, 2011a). Therefore, identified eloquent areas will be 
maintained (Duffau & Mandonnet, 2013). For awake surgery the responsibilities of a 
neuropsychologist lie in the ĐoƌƌeĐt eǀaluatioŶ of a patieŶt’s eligiďilitǇ foƌ the pƌoĐeduƌe, a 
valid and reliable pre- and intraoperative assessment of cognitive and sensory-motor 
functions and an evaluation of the direct and long-term operative outcome, including 
planning of target-oriented rehabilitation.  
As outlined above, the tumor itself but also its treatment with surgery and subsequent radio- 
and/or chemotherapy can cause changes in sensory-motor abilities, cognitive functioning, 
personality and affect (Poeck & Hacke, 1998). Indeed, disturbances of language, memory, 
attention, orientation or planning are frequently found in patients with intracranial tumors 
(Klein et al., 2002; Meyers et al., 2000; Murray et al., 2000; Santini, Talacchi, Squintani et al., 
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2012; Satoer et al., 2012; Scheibel et al., 1996; Scotland et al., 2012; Talacchi et al., 2011; 
Taphoorn & Klein, 2004; Tucha et al., 2000). Patients with HGGs show lower preoperative 
cognitive functioning compared to patients with LGGs (Campanella et al., 2015). Data on 
prevalence of impairments regarding memory, attention and executive functioning in 
patients with LGGs range from 19% to 83% (van Loon et al., 2015). The time course 
regarding cognitive deficits can differ significantly depending on tumor type and additional 
treatment. While 60% of LGG patients were able to return to work, this was only the case in 
10-20% of HGG patients in a previous study (Armstrong et al., 2016). Another study (Santini, 
Talacchi, Squintani et al., 2012) reported that 3-6 months after the operation, 45% of 
patients showed a decline in cognitive functioning, whereas improvement was reported in 
5% of the patients. In another 33% of the patients no changes were found (Santini, Talacchi, 
Squintani et al., 2012). However, the amount of surgery-induced cognitive impairments 
cannot be validly estimated since studies on the direct comparison of pre- and postoperative 
cognitive functionality immediately after the resection are rare (Klein et al., 2012). The high 
range of the prevalence data can be traced back to high variance in time point of assessment 
(before/after the operation and course of the disease), different patient samples (first 
diagnosis, recurrence), different neuropsychological assessment methods (selection of tests, 
evaluation focus like test-specific or domain-specific analysis) and different criteria for 
impairment. To date, there is no consensus on how to assess cognitive impairment in 
patients with intracranial tumors (van Loon et al., 2015).  
Prevalence data indicate that a substantial portion of patients has no or only mild cognitive 
and neurological deficits. Some patients even increase in cognitive and physical functioning 
after impairments becoŵe eǀideŶt. This ĐaŶ ďe attƌiďuted to the ďƌaiŶ’s aďilitǇ to 
compensate for lesion induced neuronal malfunctions, so called neuroplasticity (Duffau, 
2011b). Research findings on the ability for neuroplastic changes in the brain have significant 
implications for awake surgery. For instance, with the knowledge about transient 
impairments after resection of an area such as the supplementary motor area that resolve 
due to neuroplastic changes within a few months, the removal of this area could be 
recommended.  
The present work sought to describe and define the requirements for neuropsychological 
diagnostic in emergency hospitals treating patients with intracranial tumors. The aim was to 
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validate current methods and establish a reliable neuropsychological assessment routine for 
patients undergoing awake surgeries. In addition, a specific diagnostic method for the very 
special context of intraoperative diagnostics in awake craniotomy was established and 
evaluated. 
The first study in this thesis mainly focused on cognitive status diagnostic and was motivated 
by the question whether an excellent cognitive screening instrument might be able to 
substitute a comprehensive neuropsychological test battery. Consequently, the first 
publication (Becker, Steinmann et al., 2016) investigated if the recently published screening 
tool ͞Brief Cognitive Status Diagnostic͟ (BCSE) has overcome the limitations of the Mini 
Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) and 
represents a valid tool for patients with intracranial tumors. Particularly, we examined 
whether the BCSE would be more reliable than the older screenings in i) detecting patients 
with intracranial tumors versus healthy subjects and ii) detecting cognitive impaired subjects  
in a patient cohort asserted by the ͞gold standard͟ of a comprehensive neuropsychological 
test battery covering several cognitive domains. 
For the first time, we were able to show that the BCSE has a good feasibility in patients with 
intracranial tumors. However, it did not allow for a valid separation of healthy individuals 
from patients or and was not sensitive enough to reliably detect cognitive impairment in 
patients. As a screening measure, we thus recommend the MoCA instead of BCSE and MMSE 
due to its favorable diagnostic quality. Nevertheless, in good agreement with other studies, 
our results support the view that reliable results could only be obtained with a 
comprehensive neuropsychological test battery, since even the MoCA failed to detect 
cognitive impairment. 
After the first publication clearly indicated the relevance of a comprehensive test battery for 
cognitive status diagnostic, the second study aimed at improving standardized intraoperative 
assessment. A review of the existing literature revealed the following major limitations in 
scales used for sensory-motor functions in the context of awake craniotomy so far: i) lack of 
practicability, ii) lack of assessing highly relevant functions, and iii) lack of precision in item 
phrasing or scoring system. To bridge this gap, we designed a rating scale, the Sensory-
Motor Profile awake (SMP-a) a suitable tool for awake surgery. We aimed at combining the 
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advantages of existing neurological scales used for preoperative and postoperative 
assessment in this setting and evaluated the feasibility of the SMP-a in 17 patients. 
Our results support our assumption that the SMP-a is a feasible tool which can be integrated 
into clinical routine. Furthermore, the SMP-a was applicable even in patients with symptoms 
of mild aphasia or moderate sensory-motor deficits caused by tumor recurrence. The SMP-a 
represents the first flexible rating scale for sensory-motor functions which enables individual 
adaption, but preserves the standardized scoring system. This will allow the comparison 
between assessment dates, patients and institutions in future applications. However, future 
studies aƌe ŵaŶdatoƌǇ to pƌoǀide data oŶ the iŶstƌuŵeŶt’s diagŶostiĐ pƌopeƌties ǁith 
respect to feasibility, objectivity, validity and reliability.  
As outlined above, neuroplasticity is a key concept for awake surgery and influences the 
surgical approach of awake craniotomy considerably (Ius et al., 2011). Since invasive 
experimental lesion approaches cannot be carried out in healthy human participants due to 
ethical concerns, this branch of research is dependent on patients with brain lesions. 
Therefore, results obtained from patients with unique or rare disease constellations 
complement the results of the few empirical studies. Our third publication (Becker, Jehna, 
Larsen et al., 2016), which presents a case report of a HGG in a patient with a congenital 
absent hemisphere, illustrated the huge potential of the human brain for neuroplastic 
adaption. This patient was born with only one hemisphere and developed a HHG in his single 
frontal lobe. Ten years ago, neuropsychological assessment revealed average cognitive 
performance in this patient, without any signs of aphasia but a spastic hemiparesis of the 
right arm. These results and the patieŶt’s ƌelatiǀelǇ Ŷoƌŵal socio-professional life t indicated 
successful large scale neuroplastic reorganization. Due to the fact that his single hemisphere 
was already forced to compensate for the missing one, we expected that this patient would 
now present with severe cognitive deficits due to the tumor. However, in contrast to our 
hypothesis, he showed only a deceleration, moderate deficits in language functions as well 
as mild impairments of basic cognitive functions. We assumed that his single hemisphere 
was able to establish further neuroplastic mechanisms to compensate for the tumor growth. 
The good operative outcome of this patient as well as results of previous works stimulated a 
new hypothesis on the brain’s general potential for plasticity. In particular, neuroplasticity of 
language associated brain areas and white matter tracts is currently investigated in 
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subsequent long-term research in our glioma patients. First results of a pilot study revealed a 
positive relationship between the volume of the right hemispheric arcuate fascicle (AF) 
homologue and a better language performance in patients with glioma in the left sided, 
language dominant hemisphere (Jehna et al., in press). Similar positive relationships were 
reported by Forkel and colleagues (2014) for rehabilitation of language and the bilateral 
symmetrical arrangement of the AF in stroke patients. If additional studies yield similar 
results, a more extensive resection of tumor tissue in the left hemisphere in patients with 
bilateral symmetrical AFs might be implemented in neurosurgical settings in the future. After 
sufficient evaluation of the SMP-a, an analogues study on plasticity of sensory-motor 
networks in glioma patients is planned. 
The results of the studies included in this thesis can be integrated into a comprehensive 
approach for neuropsychological assessment in glioma patients eligible for awake 
craniotomy. The advantages of a comprehensive test battery are reflected in the reduction 
of the risk to miss cognitive impairments. Furthermore, it provides the opportunity to assess 
valuable additional information about a patient’s eligibility for an awake craniotomy such as 
frustration tolerance or compliance under stress. The novel tool SMP-a can be integrated 
into a preparation appointment for awake surgery. Therewith, a baseline assessment of 
sensory-motor function is established for further evaluation. In addition, the SMP-a can 
serve as a base for further discussion of possible intraoperative impairments and the 
patieŶt’s fears. This helps the neuropsychologist to gain information on a patient’s 
emotional stability and estimate his intraoperative compliance. During awake surgery, 
cortical mapping and functional monitoring of sensory-motor functions can be conducted 
with the SMP-a beside individually selected tasks for other functions such as language. The 
same tools as used for preoperative and intraoperative assessment serve as postoperative 
test battery, with the goal to plan a rehabilitation adapted to the patieŶt’s needs and 
evaluate operative short-term and long-term outcome in a standardized fashion. 
In summary, our studies provide novel results that might help clinicians to choose reliable 
and valid methods for a comprehensive assessment of glioma patients undergoing awake 
surgery. In addition, this work outlined the importance of comprehensive 
neuropsychological assessment for research purposes and revealed several areas of missing 
standardization such as surgical long-term evaluation. Future studies are necessary to 
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evaluate the presented tools, especially the SMP-a, and develop guidelines for inclusion and 
exclusion of patients in awake craniotomy. Additionally, research on the ecological validity of 
test results should be intensified with the goal to fuƌtheƌ iŶĐlude the patieŶts’ perspective on 
impairments and quality of life into neurosurgery. The same is true for a precise assessment 
of efficacy of (cognitive) rehabilitation for patients with intracranial tumors. This includes the 
mandatory evaluation of so Đalled ͞planned deficits͟ under awake surgery. One future goal 
should be the compilation of maps including information on resectability and estimated 
rehabilitation success for dedicated brain sites, which can then be integrated into routine 
surgical planning. 
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Die klinische Neuropsychologie ist im 21. Jahrhundert als eigenständige Fachdisziplin der 
kognitiven Neurowissenschaften mit eigenen Universitätslehrstühlen, Vereinigungen und 
Fachzeitschriften etabliert (Goldenberg, 2007). Als wissenschaftliche Disziplin zielt sie drauf 
ab, die zentralnervösen Mechanismen zu verstehen, welche menschlichem Verhalten und 
Erleben zu Grunde liegen (Hartje & Poeck, 2006). Hierfür werden fortlaufend Befunde aus 
der „klassischen͞ Psychologie, Neurologie, Neuroanatomie und Neurophysiologie integriert. 
Als Schnittstelle zwischen Medizin und Psychologie wächst die Bedeutung der klinischen 
Neuropsychologie angesichts des steigenden durchschnittlichen Alters der Bevölkerung und 
der damit einhergehenden wachsenden Zahl an behandlungsbedürftigen Hirnerkrankungen. 
Sowohl für die Prognose als auch für die Therapie der Erkrankungssymptome ist eine valide 
neuropsychologische Diagnostik von hoher Relevanz.  
Infolgedessen stellt die Diagnostik von kognitiven und affektiven Beeinträchtigungen nach 
einem Hirnschaden ein erstes, elementares Tätigkeitsfeld für Neuropsychologen dar. Die 
diagnostischen Fragestellungen umfassen die klassische Status- und Verlaufsdiagnostik wie 
auch die patientenorientierte Erstellung von Behandlungsplänen. Für ein qualitativ 
hochwertiges Vorgehen hilft die Orientierung an Standards aus der klinischen und 
allgemeinpsychologischen Diagnostik. Im Gegensatz zu den vorgenannten Disziplinen 
werden im Rahmen der neuropsychologischen Diagnostik basale und höhere 
Wahrnehmungsleistungen, Gedächtnisfunktionen, Konzentration, Aufmerksamkeit und 
senso-motorische Funktionen wie auch spezifische arbeits- und ausbildungsbezogene 
Funktionen erfasst. Diese werden häufig durch eine Evaluation des Affektes und der 
Persönlichkeit eines Patienten ergänzt (Hartje & Poeck, 2006). Ein zweites 
Haupttätigkeitsfeld für Neuropsychologen liegt in der Therapie von funktionellen 
Beeinträchtigungen nach einem Hirnschaden. Ziel ist hier die Wiedereingliederung des 
Patienten in sein soziales und berufliches Leben (Sturm et al., 2007). 
Die Aufgaben der klinischen Neuropsychologie in der ambulanten Diagnostik und der 
Rehabilitation sind in der bestehenden Literatur bereits gut beschrieben. Es gibt jedoch 
bislang keine umfassenden Arbeiten, welche die externen Anforderungen und spezifischen 
diagnostischen Fragestellungen für die Neuropsychologie im Kontext der Neurochirurgie 
thematisiert. Die vorliegende Arbeit sollten die spezifischen Anforderungen, welche ein 
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Akutkrankenhaus zur Behandlung von Hirntumorpatienten stellt, beschrieben und definiert 
werden. Das Hauptziel war dabei, die derzeit angewendeten Methoden zu validieren und 
eine reliable neuropsychologische Routinediagnostik für Patienten im Rahmen der 
Wachoperation zu etablieren. Im Besonderen wurde eine Methode für die spezielle 
intraoperative Diagnostik für Wachoperationen neu entwickelt und evaluiert.  
Intrakranielle Gliome zählen zu den primären Hirntumoren und wachsen aus Neuronen und 
glialen Stützzellen des Gehirns (Poeck & Hacke, 1998). Sie werden anhand ihrer biologischen 
Eigenschaften in vier Tumorgrade nach WHO (world health organization) eingeteilt (Poeck 
& Hacke, 2006). Die Zellen von niedriggradigen Gliomen (low grade glioma, LGG) mit einem 
WHO-Grad I und II neigen im Laufe der Zeit zur anaplastischen Transformation. Hierdurch 
entstehen höhergradige Tumoranteile (Grad III und IV), welche unter anderem ein 
schnelleres Tumorwachstum mit sich bringen (Shaw et al., 2002). Dies betrifft circa 79% der 
LGG-Patienten (Shaw et al., 2002). Die medizinische Behandlung von Gliomen sieht in den 
meisten Fällen eine chirurgische Entfernung des Tumors vor. Bei bestimmten 
(höhergradigen) Gliomen wird eine Chemo- und/oder Bestrahlungstherapie angeschlossen. 
Im Langzeitverlauf zeigen niedriggradige Tumoren ein längeres Intervall bis zum ersten 
Rezidiv und eine deutlich höhere durchschnittliche Überlebenszeit als höhergradige 
Tumoren (Poeck & Hacke, 2006). Bei höhergradigen Gliomen (high grade glioma, HGG) kann 
trotz wiederholter Operationen und begleitender Radio-Chemotherapie der Verlauf der 
Erkrankung nur um wenige Monate oder Jahre aufgeschoben werden.  
Eine Besonderheit stellen Tumoren mit einer Lokalisation in so genannten eloquenten 
Arealen dar (Chacko et al., 2013). Eloquente Areale bezeichnen Hirnstrukturen, welche auf 
bestimmte Funktionen wie beispielsweise Sprache oder Motorik spezialisiert sind. In solch 
einem Fall kann die Operation zur Entfernung des Tumors als Wachoperation durchgeführt 
werden (Chacko et al., 2013). Bei dieser Operationsform ist der Patient während der 
Tumorresektion bei vollem Bewusstsein und kann mithilfe diagnostischer Tests untersucht 
werden. Ergebnis dieser Diagnostik ist eine intraoperative Kartierung der Funktionen im 
Operationsgebiet. Die erstellte Karte kann die Resektionsentscheidungen des 
Neurochirurgen beeinflussen, da Hirnareale trotz Tumorinfiltration belassen werden, wenn 
sie sich als funktionsrelevant erweisen. Ziel ist es, durch die intraoperative Diagnostik am 
wachen Patienten den Tumor so vollständig, aber schonend wie möglich zu entfernen und 
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dauerhafte Beeinträchtigungen zu vermeiden. Wachoperationen haben bereits in den 
1940ger Jahren ihren Ursprung, als Wilder Penfield das freiliegende Gehirn seiner 
Epilepsiepatienten mit elektrischen Impulsen stimulierte und ihre Reaktionen darauf für 
diagnostische Zwecke studierte (Penfield & Boldrey 1937). Auch heute noch gelten 
Wachoperationen mit direkter kortikaler Stimulation (direct cortical stimulation, DCS) für die 
Gliomchirurgie als Goldstandard (Mandonnet, 2011). Trotz großer technischer 
Entwicklungen in der präoperativen und intraoperativen Bildgebungstechnik stellt die 
Kartierung von zerebralen Funktionen mit Hilfe der DCS derzeit die reliabelste Methode dar, 
um das Risiko eines untersuchten Areals für eine permanenten Beeinträchtigung durch eine 
Resektion abzuschätzen (Ius et al., 2011). DCS kann als Modell für eine transiente virtuelle 
Läsion des stimulierten Areals angesehen werden. Die Funktion von Kortexarealen, aber 
auch verbindenden Faserbahnen der weißen Substanz, wird durch die Applikation eines 
kurzen Stromimpulses unterbrochen oder auch angeregt (Duffau, 2011a). Ist es dem 
Patienten in der Folge beispielsweise nicht mehr möglich, ein Bild zu benennen, wird das 
stimulierte Areal als essentiell für die untersuchte Funktion angenommen und folglich nicht 
reseziert (Duffau, 2011b). Aufgabe der neuropsychologischen Diagnostik im Kontext von 
Wachoperationen ist es, die Eignung eines Patienten für eine Wachoperation fest zu stellen. 
Darüber hinaus müssen kognitive und senso-motorische Funktionen prä- aber auch 
intraoperativ valide und reliabel erfasst werden. Des Weiteren kann das direkte wie auch das 
langfristige Operationsergebnis evaluiert werden, um die eingesetzten Vorgehensweisen 
weiter zu verbessern. Die postoperative Untersuchung umfasst zusätzlich die Planung der 
zielorientierten Rehabilitation. 
Sowohl der Tumor selbst als auch seine Behandlung mit Operationen, Radio- und 
Chemotherapie können Veränderungen in den physiologischen und kognitiven Funktionen, 
der Persönlichkeit und dem Affekt auslösen (Poeck & Hacke, 1998). In der Praxis werden 
Einschränkungen der Sprache, des Gedächtnisses, der Aufmerksamkeit, der Orientierung 
und der Handlungsplanung häufig bei Patienten mit intrakraniellen Tumoren beobachtet  
(Klein et al., 2002; Meyers et al., 2000; Murray et al., 2000; Santini, Talacchi, Squintani et al., 
2012; Satoer et al., 2012; Scheibel et al., 1996; Scotland et al., 2012; Talacchi et al., 2011; 
Taphoorn & Klein, 2004; Tucha et al., 2000). Patienten mit HGG zeigen größere präoperative 
kognitive Einschränkungen als Patienten mit LGG (Campanella et al., 2015). Die 
Prävalenzzahlen zu Einschränkungen im Gedächtnis, der Aufmerksamkeit und den 
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exekutiven Funktionen reichen von 16% bis 83% (van Loon et al., 2015). Der Verlauf der 
kognitiven Einschränkungen bei Hirntumorpatienten unterscheidet sich deutlich zwischen 
den verschiedenen Tumorarten und den zusätzlichen Behandlungen. Beispielsweise kehren 
60% der LGG-Patienten in ihren Beruf zurück, bei HGG-Patienten sind dies lediglich 10-20% 
(Armstrong et al., 2016). 3-6 Monate nach der Operation weisen 45% der Patienten eine 
weitere Verschlechterung der kognitiven Funktionen auf, wohingegen eine Verbesserung für 
nur 5% berichtet wird (Santini, Talacchi, Squintani et al., 2012). Bei einem Drittel der 
Patienten tritt keine Veränderung im Vergleich zum präoperativen Status ein (Santini, 
Talacchi, Squintani et al., 2012). Trotz der genannten Studien kann das Ausmaß der 
operationsinduzierten kognitiven Beeinträchtigungen derzeit noch nicht valide eingeschätzt 
werden, da die Zahl der Studien mit einem direkten Vergleich von prä- und postoperativen 
Ergebnissen noch zu gering ist (Klein et al., 2012). Die hohe Varianz der Prävalenzzahlen kann 
auf deutliche Unterschiede der einzelnen Studien bzgl. des Erhebungszeitpunkts (vor/nach 
der Operation oder im Verlauf), der Patientengruppen (Erstdiagnose, Rezidiv), der 
eingesetzten neuropsychologischen Erhebungsmethoden (Testauswahl, Evaluationsfokus 
Einzeltest oder Domänen bezogen) und der Kriterien für das Vorliegen einer 
Beeinträchtigung zurückgeführt werden. So herrscht bislang kein Konsens bezüglich der 
Erhebung von kognitiven Beeinträchtigungen bei Hirntumorpatienten (van Loon et al., 2015).  
Die genannten Prävalenzzahlen legen nahe, dass ein gewisser Anteil von Patienten vor, aber 
auch nach der Operation keine oder nur geringe kognitive und neurologische Defizite 
aufweist. Andere Patienten wiederum zeigen Verbesserungen in ihrem funktionellen Status , 
nachdem Beeinträchtigungen festgestellt geworden sind. Diese Beobachtungen können auf 
die Fähigkeit des Gehirns zurückgeführt werden, läsionsinduzierte neuronale 
Funktionsstörungen zu kompensieren, die so genannte Neuroplastizität (Duffau, 2011b). 
Hierbei unterscheiden bisherige Untersuchungen kurzzeitige Anpassungen innerhalb von 
Minuten oder Stunden und mittel- bzw. langfristige Veränderungen (Duffau, 2011c). Neben 
der zeitlichen Dimension konnten fMRT-Studien eine hierarchische Strukturierung der durch 
einen (niedriggradigen) Tumor ausgelösten neuronalen Anpassungen belegen (Desmurget et 
al., 2007). So sind in einem ersten Schritt noch funktionelle neuronale Areale innerhalb des 
Tumors auffindbar, in einem zweiten Anpassungsschritt verteilen jedoch neuroplastische 
Mechanismen eloquente Areale um das Tumorgewebe herum um. Sollte die Kompensation 
nach wie vor unzureichend sein, kann eine Funktionsübernahme durch entferntere Areale 
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innerhalb der erkrankten Hirnhemisphäre und/oder durch kontralaterale homologe Areale 
erfolgen (Desmurget et al., 2007). In der präoperativen Erkrankungsphase erlauben LGGs, da 
sie langsam wachsen, eine bessere Anpassung der neuronalen Funktionen als akute Läsionen 
wie bspw. ein Schlaganfall (Desmurget et al., 2007). Dies äußert sich unter anderem in einer 
signifikant geringeren Rate an neurologischen und neuropsychologischen Ausfällen im 
Vergleich zu Schlaganfallpatienten (Desmurget et al., 2007). Darüber hinaus unterscheiden 
sich langsam und schnell wachsende Läsionen in ihrem Muster der Anpassung: langsam 
wachsende Läsionen rekrutieren häufiger ipsilaterale, entfernte Areale und kontralaterale 
homologe Areale (Desmurget et al., 2007). Während der Operation scheint es durch die 
Resektion selbst zu spontanen Veränderungen in funktionalen Netzwerken zu kommen und 
es können, Dank intraoperativer Diagnostik am wachen Patienten, während der Operation 
redundante, jedoch bislang stille Areale identifiziert werden (Duffau, 2011c). Ihr 
tumorinfiltriertes Gegenstück kann reseziert werden und das vormals redundante Areal 
übernimmt die Funktion spontan (Duffau, 2011c). Auch postoperativ können 
neuroplastische Veränderungen durch spezifische Rehabilitation gefördert werden (Duffau, 
2011c; Zucchella, Capone et al., 2013). Die geschilderten Befunde führten bislang zu zwei 
wichtigen therapeutischen Implikationen. Zum Einen konnte die Annahme, dass 
verschiedene Hirnbereiche und Funktionen ein unterschiedliches Potential für plastische 
Veränderungen aufweisen, durch eine Studie von Ius und Kollegen (2011) untermauert 
werden. Sie erstellten mit Hilfe von DCS eine Karte über die Wahrscheinlichkeiten, 
funktionelle Areale innerhalb eines tumorinfiltrierten Areals zu identifizieren. Eine hohe 
Wahrscheinlichkeit hierfür wurde insbesondere für den primären motorischen und 
sensorischen Kortex angegeben. Ergänzend hierzu veröffentlichte Duffau eine Aufzählung 
von Hirnarealen, deren Entfernung oft nur mit einer vorübergehenden Einschränkung 
assoziiert ist, wie bspw. das supplementär motorische Areal (SMA) (Duffau, 2011c). 
Zusammengenommen erlauben beide Forschungsergebnisse durch Anwendung auf den 
individuellen Patienten, das Ausmaß der möglichen Resektion und der unmittelbar 
folgenden Einschränkungen vor der Operation abzuschätzen. Die zweite wichtige 
therapeutische Implikation stellt das Vorgehen der „gestaffelten Operationen͞ (staged 
neurosurgical approach) dar (Talacchi, Santini, Casagrande et al., 2013; Talacchi, Santini, 
Casartelli et al., 2013). Es ist bereits gut belegt, dass Faktoren wie die Resektion selbst, die 
anschließende Rehabilitation und das erneute Tumorwachstum funktionelle Anpassungen 
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im Gehirn auslösen (Duffau, 2011c). Sollten bei einem individuellen Patienten während der 
Operation nach wie vor eloquente Areale innerhalb des Tumors identifiziert werden, können 
diese zum Zweck der Erhaltung der Funktion belassen werden. In diesem Fall kann gewartet 
werden, bis zusätzliche neuroplastische Veränderungen zur Relokalisation der Areale geführt 
haben und eine Folgeoperation Monate oder Jahre später die vollständige Resektion erlaubt 
(Duffau, 2011c). Bedingt durch ethische und strukturelle Hindernisse ist die Untersuchung 
der Neuroplastizität des menschlichen Gehirns schwierig, so dass bislang nur wenig über 
Prädiktoren und Limitationen des plastischen Potentials bekannt ist. Einen limitierenden 
Faktor stellen weiße Faserbahnen dar: eine gewisse Mindestanzahl an verbindenden weißen 
Faserbahnen muss bei der Operation belassen werden, um eine funktionelle Rehabilitation 
zu erlauben (Ius et al., 2011). Dies wird derzeit darauf zurückgeführt, dass das menschliche 
Gehirn keine Möglichkeit hat, neue Faserbahnen in der weißen Substanz zu bilden (Duffau, 
2009a). Vor diesem Hintergrund erscheint eine valide intraoperative Diagnostik zur 
Identifizierung von funktionellen Faserbahnen umso wichtiger.  
Die oben geschilderten Befunde verdeutlichen den hohen Stellenwert von standardisierter 
und valider neuropsychologischer Diagnostik vor wie auch während der Operation. Den 
Fokus der vorliegenden Arbeit bildete daher die Erstellung eines Konzeptes zur 
neuropsychologischen Diagnostik von Patienten für Wachoperationen. Hierfür wurden die 
Ergebnisse dreier Publikationen integriert. 
Die erste Publikation der vorliegenden Arbeit konzentrierte sich auf die neuropsychologische 
Statusdiagnostik bei neurochirurgischen Patienten. Motiviert wurde die Untersuchung durch 
die Frage, ob ein kognitives Screeninginstrument für diesen Zweck ausreichend sein kann. 
Hierfür wurde das neu publizierte Screeninginstrument „Brief Cognitive Status Exam͞ (BCSE) 
mit den beiden in diesem Kontext am häufigsten genutzten Instrumenten, dem Mini Mental 
State Examination (MMSE) und dem Montreal Cognitive Assessment (MoCA), verglichen. 
Untersucht wurde die Fragestellung, ob der BCSE die Limitationen der beiden anderen 
Instrumente bzgl. der diagnostischen Qualität überwunden hat und ein valides 
Screnninginstrument im neurochirurgischen Kontext darstellt. Im Besonderen untersuchten 
wir, ob der BCSE reliabler als die beiden älteren Instrumente i) Patienten mit intrakraniellen 
Tumoren von gesunden Probanden unterscheiden kann und ii) kognitiv eingeschränkte 
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Patienten (erhoben mit dem Goldstandard einer umfassenden neuropsychologischen 
Testbatterie) aus einer Patientenkohorte identifizieren kann. 
Unsere Ergebnisse zeigten erstmalig, dass der BCSE bei Hirntumorpatienten eine 
vergleichbar gute Anwendbarkeit wie der MMSE und der MoCA aufweist. Jedoch erreichte 
er keine zufriedenstellenden Ergebnisse bei der Identifizierung von Patienten unter 
gesunden Probanden und bei der Identifizierung von kognitiven Einschränkungen in einer 
Patientenkohorte. Aufgrund seiner in den meisten Bereichen überlegenen diagnostischen 
Qualität haben wir den MoCA für den Einsatz als Screeninginstrument bei 
Hirntumorpatienten empfohlen. Dennoch zeigten die Ergebnisse auch, dass selbst ein gutes 
Screeninginstrument wie der MoCA einer Testbatterie unterlegen ist, da auch er kognitive 
Einschränkungen nicht immer ausreichend verlässlich identifizierte. Somit konnten wir, in 
Übereinstimmung mit anderen Studien, die Ansicht unterstützen, dass reliable Ergebnisse in 
Bezug auf den kognitiven Status von Hirntumorpatienten nur mit einer umfassenden 
neuropsychologischen Testbatterie erhoben werden können.  
Nachdem in der ersten Publikation gezeigt werden konnte, dass im Rahmen der kognitiven 
Statusdiagnostik eine umfassende neuropsychologische Testbatterie einem guten 
Screeninginstrument nach wie vor überlegen ist, zielte die zweite Untersuchung auf die 
Evaluation der intraoperativen Diagnostik ab. Eine systematische Durchsicht der bisherigen 
Literatur deckte signifikante Mängel der bislang für die Erfassung senso-motorischer 
Funktionen genutzter Ratingskalen bei Wachoperationen auf: a) eine eingeschränkte 
Anwendbarkeit besonders intraoperativ, b) einen Mangel an Erfassung hoch relevanter 
Funktionen wie bspw. Sensorik, sowie c) eine mangelnde Präzision bei der Itemformulierung 
oder des Ratingsystems (Becker, Jehna, Steinmann et al., 2016). Um diese Lücke zu 
schließen, wurde eine Ratingskala für die Anwendung bei Wachoperationen, das Sensory-
Motor Profile awake (SMP-a), entworfen. Ziel war es, die Vorteile der bereits prä- und 
postoperativ genutzten neurologischen Skalen zu kombinieren und die Anwendbarkeit des 
SMP-a zu evaluieren. 
Die Ergebnisse der zweiten Studie unterstützen die Annahme, dass das SMP-a ein geeignetes 
Instrument für den angestrebten Kontext ist und in die klinische Routinediagnostik für 
Wachoperationen integriert werden kann. Darüber hinaus konnte gezeigt werden, dass das 
SMP-a auch bei Patienten mit leichter Aphasie und mittelgradigen senso-motorischen 
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Einschränkungen, wie sie beispielsweise oft durch ein Tumorrezidiv verursacht werden, 
einsetzbar war. Das vorliegende Instrument stellt die erste flexible Ratingskala für senso-
motorische Funktionen dar, welche die individuelle Adaptation an die Patientenbedürfnisse 
gestattet, dabei jedoch ihr standardisiertes Ratingsystem beibehält. Das SMP-a erlaubt damit 
in zukünftigen Studien einen Vergleich von Ergebnissen zwischen unterschiedlichen 
Institutionen, verschiedenen Patienten und Erhebungszeitpunkten. Allerdings sind im 
Vorfeld weitere Studien mit größeren Patientenkollektiven notwendig, um die 
diagnostischen Kennwerte des SMP-a in den Bereichen Anwendbarkeit in anderen Kliniken, 
Objektivität, Validität und Reliabilität zu evaluieren.  
Wie bereits oben angeführt, stellt die Neuroplastizität ein Schlüsselkonzept für 
Wachoperationen dar und beeinflusst das operative Vorgehen maßgeblich. Da sich 
experimentelle Läsionsuntersuchungen am Menschen aus ethischen Gründen verbieten, ist 
dieser Zweig der Forschung auf Patienten mit vorliegenden Hirnläsionen angewiesen. Daher 
ergänzen die Untersuchungsergebnisse von Pateinten mit besonderen Läsionsmustern die 
Ergebnisse der wenigen empirischen Untersuchungen auf wertvolle Weise. Die dritte 
Publikation der vorliegenden Arbeit (Becker, Jehna, Larsen et al., 2016) stellte den Fall eines 
Patienten mit einer fehlenden Hirnhemisphäre und einem späteren HGG vor und gab 
Einblicke in die kurzfristigen und langfristigen neuroplastischen Anpassungen. Bedingt durch 
eine seltene intrauterine Komplikation wurde der vorgestellte Patient mit einer rechten, 
jedoch ohne linke Hirnhemisphäre geboren (Hemihydranencephalie). Jahre später 
entwickelte sich ein HGG in seinem verbleibenden rechten Frontallappen. Eine 
Untersuchung zehn Jahre zuvor belegte durchschnittliche kognitive und sprachliche 
Funktionen, was auf eine sehr gute Anpassungsleistung seines Gehirns an das Fehlen einer 
ganzen Hemisphäre hinweist. Da die rechte Hemisphäre des Patienten in der Lage war, eine 
gute kogŶitiǀe FuŶktioŶalität zu geǁähƌleisteŶ, kaŶŶ sie als „funktionelle Kompensation 
durch homologe Aƌeale͞ füƌ die liŶke Heŵisphäƌe gewertet werden (in Anlehnung an 
Desmurget et al., 2007). Vorherige Befunde legen nahe, dass eine zusätzliche Beschädigung 
von Arealen, welche bereits verloren gegangene Funktionen voll kompensieren, mit hoher 
Wahrscheinlichkeit zu permanenten Funktionseinbußen bei Gliompatienten hervorrufen 
(Duffau, Capelle, Denvil, Sichez, Gatignol, Lopes et al., 2003). Dies führte zu der Annahme, 
dass aufgrund des Tumors nun mit schweren kognitiven Defiziten zu rechnen sei. Im 
Gegensatz dazu zeigte der Patient in einer neuropsychologischen Untersuchung lediglich 
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eine Verlangsamung, mittelgradige sprachliche Einschränkungen und leichte 
Einschränkungen kognitiver Basisleistungen. Als mögliche Erklärung hierfür diskutierten wir 
weitere neuroplastische Anpassungen seiner verbleibenden Hemisphäre, die durch das 
Tumorwachstum induziert wurden. 
Das dargestellte Beispiel der immensen Anpassungsleistung des Gehirns und insbesondere 
der Sprachfunktionen an Läsionen, hat weitere Studien angeregt. Im Besonderen soll die 
Neuroplastizität von sprachassoziierten Kortexarealen und Faserbahnen in einer 
Langzeitstudie an Gliompatienten untersucht werden. Es sollen Faktoren, die zu einer guten 
neuroplastischen Anpassung beitragen, eruiert werden und ihre Bedeutung für die 
zukünftige Patientenbehandlung untersucht werden. Einen Ausblick auf die zu erwartenden 
Ergebnisse lieferten die Ergebnisse der ersten Pilotstudie dieses Projektes. Hier konnten 
Belege dafür gefunden werden, dass das Volumen des homologen rechtsseitigen Fasciculus 
arcuatus (FA) positiv mit einer besseren Sprachfähigkeit bei Patienten mit Gliomen in der 
linken, sprachdominanten Hemisphäre zusammenhängt (Jehna et al., in press). Ähnliche 
positive Einflüsse eines gut ausgeprägten homologen FA konnten Forkel und Kollegen (2014) 
für die Rehabilitation von Sprachfunktionen bei Schlaganfallpatienten dokumentieren. 
Sollten weitere Studien zu einem ähnlichen Ergebnis kommen, kann womöglich in Zukunft 
bei Patienten mit beidseitig angelegtem FA eine vollständigere Resektion von Tumorarealen 
der linken Hemisphäre als bisher erfolgen.  
Nach einer umfassenden Evaluation des SMP-a sind analoge Studien zur Neuroplastizität des 
senso-motorischen Netzwerkes bei Gliompatienten geplant.  
Die Ergebnisse der präsentierten Studien können in ein umfassendes Konzept der 
neuropsychologischen Diagnostik bei Patienten mit Gliomen integriert werden, welche einer 
Wachoperation unterzogen werden sollen. Die Vorteile einer präoperativen Diagnostik mit 
einer umfassenden neuropsychologischen Testbatterie liegen in der deutlich reduzierten 
Wahrscheinlichkeit, kognitive und senso-motorische Einschränkungen zu übersehen. 
Darüber hinaus erlaubt es die Untersuchungssituation einer umfassenden präoperativen 
neuropsychologischen Testung, wertvolle Informationen über die Eignung eines Patienten 
für eine Wachoperation zu erheben. Dies betrifft insbesondere die Verhaltensbeobachtung 
für Frustrationstoleranz und Compliance unter Anforderung. Darüber hinaus können, 
ausgehend vom kognitiven Profil des Patienten und seinen Bedürfnissen, individuell 
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Aufgaben für die Wachoperation ausgewählt werden. Das vorgeschlagene Instrument SMP-a 
kann in das Vorbereitungsgespräch für die Wachoperation integriert werden. Hierdurch 
kann eine standardisierte Erfassung der präoperativen senso-motorischen Funktionen, 
welche für alle weiteren Vergleiche herangezogen werden kann, gewährleistet werden. Des 
Weiteren kann das SMP-a als Grundlage für die Diskussion von möglichen intraoperativen 
Einschränkungen und Befürchtungen des Patienten genutzt werden. Dies liefert weitere 
hilfreiche Informationen bezüglich der emotionalen Stabilität des Patienten und unterstütz 
die Einschätzung der vermuteten intraoperativen Compliance. Während der Wachoperation 
kann das kortikale Mapping und das Monitoring der senso-motorischen Funktionen mit den 
individuell ausgesuchten Aufgaben des SMP-a standardisiert durchgeführt und protokolliert 
werden. Eine Ergänzung findet, sofern dies derzeit möglich ist, durch Aufgaben aus anderen 
Funktionsbereichen wie bspw. der Sprache statt. Postoperativ kann durch den Einsatz 
derselben diagnostischen Instrumente wie zum prä- und intraoperativen Zeitpunkt ein 
standarisierter Vergleich der Funktionen zu Evaluationszwecken erreicht werden. Ziel ist aus 
klinischer Sicht die Planung einer patientenorientierten Rehabilitation. Für 
Forschungszwecke steht die Evaluation des kurz- und langfristigen operativen Outcomes wie 
auch der Zusammenhänge zwischen strukturellen Veränderungen und kognitiven/senso-
motorischen Funktionen an erster Stelle. 
Zusammenfassend haben die skizzierten Studien Ergebnisse hervorgebracht, welche 
Klinikern bei der Auswahl von reliablen und validen Methoden für die umfassende 
Diagnostik von Gliompatienten bei Wachoperation Orientierung bieten. Darüber hinaus hat 
die vorliegende Arbeit die Bedeutung der umfassenden neuropsychologischen Diagnostik für 
wissenschaftliche Zwecke dargelegt und für mehrere Bereiche eine nach wie vor notwendige 
Standardisierung eruiert (bspw. die Evaluation von Wachoperationen im Langzeitverlauf). Es 
sind zukünftig vor allem Studien notwendig, welche die dargestellten Methoden, 
insbesondere das SMP-a, evaluieren und die Entwicklung von Leitlinien für den Einschluss 
und Ausschluss von Patienten für eine Wachoperation initiieren. Darüber hinaus sollten 
Forschungsbemühungen zur ökologischen Validität der Ergebnisse der neuropsychologischen 
Testergebnisse intensiviert werden, mit dem Ziel die subjektive Perspektive der Patienten 
auf ihre Einschränkungen und die damit verbundene Lebensqualität weiter in die 
neurochirurgische Behandlung zu integrieren. Dasselbe gilt für die Evaluation der Effektivität 
von (kognitiver) Rehabilitation bei Gliompatienten. Dies beinhaltet insbesondere die 
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Evaluation so genannter geplanter Defizite bei der Wachoperation. Zukünftiges Ziel sollte die 
Erstellung von zerebralen Karten mit Informationen über Resezierbarkeit und die 
wahrscheinliche Rehabilitierbarkeit eines bestimmten Hirnareals sein, welche in die 
routinemäßige Planung der chirurgischen Eingriffe integriert werden können.  
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Abstract This study presents the ﬁrst validation of the
Brief Cognitive Status Exam (BCSE) against two other
screening tools for cognitive impairment in patients with
intracranial tumors. 58 patients and 22 matched healthy
controls completed the BCSE, the Mini Mental State
Examination (MMSE) and the Montreal Cognitive
Assessment (MoCA). Patients were additionally tested
with a comprehensive neuropsychological battery. Based
on this assessment, they were classiﬁed as cognitively
impaired or unimpaired on ﬁve cognitive domains. Anal-
yses revealed a comparable feasibility of the BCSE relative
to the MoCA and the MMSE, but a smaller range of
assessed functions (e.g., no correlation with the domain
visual-spatial functions). The ability to separate patients
and healthy controls was extremely poor for BCSE and
MMSE (sensitivity of 38.6 % and less), but moderate for
MoCA (sensitivity 68.97 %). Detection of cognitive
impairment in patients was worst with BCSE (sensitivity
37 %; MoCA 92.9 %, MMSE 44.4 %) as compared to
neuropsychological testing. Moreover, prediction of cog-
nitive outcome was also worst for the BCSE (AUC = .713,
NPV = 50 %). An optimal cut-off of 50.5 increased the
results slightly. In summary, the BCSE showed good fea-
sibility but no sufﬁcient results in separating healthy indi-
viduals from patients or detecting cognitive impairment in
patients. Consequently, as a screening measure, we would
recommend the MoCA instead of the BCSE. However,
since even the MoCA failed to detect cognitive impair-
ment, our study supports the view that reliable results could
only be obtained with a comprehensive neuropsychological
battery.
Keywords Screening instrument  Neuropsychological
diagnostic  Intracranial tumor
Introduction
Intracranial tumors refer to any solid neoplasm inside the
bony skull. Their growth can alter normal brain function
and cause symptoms like increased intracranial pressure,
neurological deﬁcits, epileptic seizures and (neuro-) psy-
chological changes. Common treatment for intracranial
tumors includes neurosurgical operations, chemotherapy
and/or radiotherapy. These treatments, as well as the
growth of the intracranial tumor mass and possible inﬁl-
tration of brain tissue are likely to account for the fre-
quently reported reduced cognitive abilities in this patient
group [1–8].
Cognitive performance relies on intact sensory and
motor abilities and several discrete functions. They are
typically assessed during neuropsychological examinations
that consider multiple domains representative for both
hemispheres, including memory, attention, orientation,
speech and executive functions [8]. Precise identiﬁcation of
(even minor) cognitive impairments is on one hand
important for clinical patient management since it
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determines further treatment options like cognitive and
social rehabilitation. Moreover, cognitive impairment is a
predictor of recurrence and survival [3, 9] and is associated
with an overall decrease in quality of life and execution of
activities of daily living [10, 11]. On the other hand,
identiﬁcation of cognitive impairment is particularly
important for research studies that include cognitive status
as an outcome measure, for example in evaluation of
treatment effects and side effects [8, 9, 11, 12]. The current
gold standard recommends a comprehensive neuropsy-
chological test battery with a duration of at least one hour
for assessment of cognitive domains [13]. However, com-
prehensive testing is very costly as it necessitates trained
personal, test rooms, testing materials and time. Therefore,
many clinical trials rely on short screening tools like the
MMSE [12, 14–16]. However, it is questionable whether
cognitive screening instruments represent valid alternatives
to comprehensive neuropsychological test batteries in some
settings and patients [12, 15, 17]. As one of the few studies
considering a comparison of screening tools against the
gold standard of a comprehensive neuropsychological test
battery, Olson and colleagues [18] compared the screening
tools MMSE and MoCA [19] in patients with intracranial
tumors (n = 58). They reported a sensitivity of only
61.9 % for the MoCA and 19 % for the MMSE and a
speciﬁcity of 94.4 % for the MMSE (MoCA 55.6 %) rel-
ative to a 3-4 h neuropsychological assessment battery.
Further analysis failed to reveal any cut-off score where
satisfying detection of cognitive impairment in this popu-
lation was possible and further investigations of the MoCA
in this collective were recommended. Hence, valid alter-
native screening tools for detection of cognitive decline are
desirable. The need for studies involving new, alternative
screening tools was further stressed by the results of a
previous study in acute stroke patients that demonstrated an
underestimation of cognitive impairment for the MoCA
compared to a neuropsychological assessment [20].
The novel screening instrument BCSE [21] might rep-
resent a promising tool for this purpose. However, to the
best of our knowledge, this test has not been compared to
the gold standard of a test battery to date. Consequently,
the validity and diagnostic properties of the BCSE to
identify cognitive impairment in patients with intracranial
tumors remain to be determined.
The primary goal of this study was to explore whether
the BCSE is a superior alternative for neuropsychological
screening as compared with the MoCA and MMSE in
patients with intracranial tumors. A validation of this novel
tool was mandatory since this test has not been used in
patients with intracranial tumors so far. Therefore, our ﬁrst
aim was to examine the feasibility and convergent validity
of the BCSE in comparison to the established screening
instruments MoCA and MMSE.
Secondly, we aimed at providing a comprehensive
comparison of the sensitivity and speciﬁcity and other
diagnostic properties of the BCSE relative to MoCA and
MMSE. Particularly, we examined whether the BCSE
would be more reliable than the older screenings in (i) de-
tecting patients with intracranial tumors versus healthy
subjects and (ii) detecting cognitive impaired subjects in a
patient cohort asserted by the gold standard of a compre-
hensive neuropsychological test battery covering several
cognitive domains.
The neuropsychological test battery in our study was
conceptualized as a German version of the cognitive
domains suggested by Olson and colleagues [18] but was
considerably shorter in terms of assessment time. This was
mandatory to reduce the inﬂuences of exhaustion, selection
bias and split assessment that was reported previously [18].
Thereby, we aimed to reduce the dropout rate and gain
complete neuropsychological proﬁles for each patient.
Methods
Screening-instruments
The BCSE, as part of the Wechsler Memory Scale—Fourth
Edition [21], is a screening tool to assesses basic cognitive
functions: orientation to time, incidental recall, mental
control, planning/visual perceptual processing, inhibitory
control, and verbal productivity. The necessary assessment
time ranges between 7 and 11 min. To the best of our
knowledge, only one previous study evaluated the BCSE
[22] by comparing it with the MMSE in patients with mild
cognitive impairment (MCI) or dementia and healthy
controls. The BCSE provided a better sensitivity in patients
with Alzheimer’s dementia. However, it was less speciﬁc
in correctly distinguishing older adults with MCI from
healthy controls. The present study should thus represent
the ﬁrst validation of the diagnostic properties of the BCSE
in patients with intracranial tumors.
The MoCA evaluates cognitive functions in about
10 min [19]. Current studies show a clear advantage over
the MMSE also in neuro-oncological patients [6, 23, 24].
The MoCA provides a relatively higher sensitivity com-
pared to the MMSE [19, 24–26] and is less affected by
ceiling effects [27] as it includes more demanding tasks
[19]. However, speciﬁcity was lower than in MMSE [19,
23, 25, 26]. It was previously validated in patients with
intracranial tumors [24].
The MMSE [14, 28] assesses cognitive functions also in
about 10 min. The MMSE is often used in patients with
intracranial tumors [2, 29, 30], although it has not been
systematically validated in these patients to date [16, 29].
Moreover, application in patient groups other than
J Neurooncol
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dementia has been criticized [30] as it demonstrated a
relatively low validity [12, 16, 19, 26, 31].
Feasibility analysis
We assessed admission time and subjective perceived tol-
erability and strain for each screening instrument. For the
latter, we modiﬁed the ranges of a visual analogue scale
(VAS) [32] from ‘‘not at all tolerable’’ (0) to ‘‘very toler-
able’’ (10) and respectively from ‘‘not at all exhausting’’
(0) to ‘‘very exhausting’’ (10). In addition, patients had to
state which screening tool they would prefer. For subjec-
tive validity, they were asked which of the screening tools
was best in measuring their perceived changes due to the
disease.
Cognitive domains
Table 1 displays the applied test battery, which was based
on two previous studies (see Online Resource 1 for pro-
cedure of assessment) [7, 10]. Both used comprehensive
neuropsychological test batteries and assigned tests to
particular domains. In the study by Satoer and colleagues
[7], lexical word ﬂuency was assigned to the domain lan-
guage. In contrast, semantic word ﬂuency was assigned to
the domain ‘‘memory’’ in the present study since areas
involved in executive and verbal functions seem to support
semantic word ﬂuency, but contribute less to this task than
temporal (i.e., memory related) regions [33]. Indeed, neu-
roimaging studies revealed stronger activation in the left
hippocampal areas than in the dorsolateral pre-frontal
cortex for semantic word ﬂuency [34].
Subjects
All eligible patients scheduled for routine neuropsycho-
logical examination between April 2013 and July 2014
were pre-screened for study participation. The control
group was recruited among relatives and matched to the
patient group in terms of age, years of education and
gender (for detailed information see Online Resource 1).
Statistical analysis
The data analyses were carried out with the statistical
package for social sciences (SPSS) Version 21…0 and
MedCalc V.12.2.1.0. For a detailed description of the sta-
tistical analysis concerning the preliminary analysis
including feasibility and validity see Online Resource 1.
We referred to the cut-off scores reported in the
respective manuals for group deﬁnition of cognitive status
variables in the screening tools. All subjects reaching lower
scores were labeled as ‘‘cognitively impaired.’’ In case of
the MMSE, we used\26 as cut-off [14]. For the MoCA
and the BCSE, we used the standard cut-off scores of\27
or the percentile rank of\15, respectively [19, 21].
In the test battery, cognitive impairment was assumed
when at least one domain was indicative of impairment [1,
43]. For each domain, we obtained a z-score following the
procedure outlined by two previous studies, for details see
Online Resource 1 [1, 44].
In a ﬁrst step, we calculated sensitivity, speciﬁcity,
positive predictive value (PPV), negative predictive value
(NPV) and diagnostic accuracy (DA) in detecting patients
with intracranial tumors among healthy controls for the
BCSE, MoCA and MMSE. Secondly, we tested these
screening tools against a neuropsychological test battery. In
each case, receiver operating characteristic (ROC) curves
were constructed. The area under the curve (AUC) was
calculated for each ROC curve as a measure of test accu-
racy. Statistical signiﬁcances of the differences between
AUCs were assessed with a non-parametric approach [45].
Optimal cut-off values were derived at ROC coordinate
points where both sensitivity and speciﬁcity were opti-
mized using the Youden Index [46]. In addition, we again
calculated sensitivity, speciﬁcity, PPV, NPV and DA for
the three screenings at these optimal cut-off scores.
Results
Subjects
In this prospective study trial, 58 patients participated before
or after (n = 5) their neurosurgical operation (for details see
Online Resource 2: Flowchart of the recruitment process).
Sample characteristic are shown in Table 2. 58 patients
(50 % female) aged 27–80 (M = 58.03; SD = 13.94)
completed the whole assessment in 75–115 min; two of
them completed only the screening instruments due to fati-
gue and exhaustion (1 of them only MoCA). Results
regarding the prevalence of cognitive impairment are dis-
played in Online Resource 2.
The healthy, matched control subjects (n = 22) did not
reveal any differences in age, gender or education (for
details see Online Resource 2). Overall, the control group
had signiﬁcantly higher scores on each screening tool than
the patient cohort.
Preliminary analysis
Analysis of feasibility
Assessment time for all three tools varied between 2 and
21 min (BCSE: Md = 8, range 4–15; MMSE: Md = 5,
range 2–15, MoCA: Md = 10, range 3–21). The perceived
J Neurooncol
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strain of the BCSE (Md = 3, range 0–9) differed signiﬁ-
cantly from the MMSE (Md = 1, range 0–9; z = -3.817,
p = 0.000). The subjective tolerability was signiﬁcantly
higher for the BCSE (Md = 9.5, range 5–10) than the
MoCA (Md = 9, range 0.5–10; z = -2.053, p = 0.038).
The screening tools were judged as equally appropriate by
the patients (X(2)
2
= 0.304, p = 0.899), but the MoCA was
signiﬁcantly more often rated as the screening tool which
can ‘‘detect actual problems’’ (32.8 %, n = 19), the
MMSE was preferred by 5.2 % (n = 3), the BCSE by
17.2 % (n = 10) (X(2)
2
= 12.063, p = 0.003).
Analysis of validity
The BCSE correlated with the MMSE (r = 0.475,
p = 0.000) and the MoCA (r = 0.485, p = 0.000). It
showed signiﬁcant correlations with the domains speech
(r = 0.388, p = 0.000), attention and visuo-motor speed
(r = 0.302, p = 0.002), memory (r = 0.378, p = .000)
and executive functions (r = 0.351, p = 0.000), but no
correlation with visual-spatial functions (r = 0.070,
p = 0.473). Detailed results for MoCA and MMSE are
displayed in Online Resource 2.
Main analysis: diagnostic properties of BCSE
Distinguishing patients from healthy controls
TheMoCA revealed the highest sensitivity, while speciﬁcity
was higher for MMSE and MoCA. Both tools classiﬁed
100 % of the control group as cognitively unimpaired, as
compared with 81.8 % according to the BCSE. Best PPV
was shown for MMSE and MoCA, best NPV and best
diagnostic accuracy (DA) for the MoCA (Table 3). The
AUC was highest for MoCA (0.848), but signiﬁcant dif-
ferences were only found between MoCA and BCSE.
Table 1 Neuropsychological test battery
Domain/test Cognitive abilities Description
Language
Subtests of the Aachener Aphasie Test (AAT, [35])
Token test Verbal comprehension Pointing to and manipulating geometric forms on verbal
command
Naming Word ﬁnding Naming Objects, colors and complex activities
Written language Verbal academic skills Writing to dictation and reading aloud
Language comprehension Auditory and reading
comprehension
Finding the object/scene out of three distracting stimuli
Lexical word ﬂuency [36] Phonological ﬂuency Producing words beginning with a given letter within 2 min
Attention and visuo- motor speed
Digit Span [37] Attention and working memory Immediate repetition of digits forward and in reverse order
Trail-making test part A (TMT-A, [38]) Visuo-motor speed Connecting 25 encircled numbers
Memory
Memo-test [39] Immediate and delayed verbal
memory
Learning 10-item wordlist within ﬁve repetitions, recall after
15 min
Rey-Complex-Figure-Test (CFT, [40])
delayed recall
Implicit visual–spatial memory Reproduction of the copied ﬁgure from memory
Semantic word ﬂuency [36] Semantic memory Naming animals within two minutes
Executive functions
Five-point test (FPT, [41]) sub score
productivity
Figural ﬂuency Production of patterns by connecting dots within rectangles
within three minutes
Trail-making test part B (TMT-B, [38]) Cognitive ﬂexibility, visuo-
motor speed
Connecting 25 encircled numbers and letters in alternating
order
Semantic alternating categorical word
ﬂuency [36]
Flexibility of verbal ﬂuency Naming sports and fruits alternating within two minutes
Visuo-spatial functions
Visual Object and Space Perception battery (VOSP, [42])
Object decision Object perception Detecting silhouettes of a real object among fantasy drawings
CFT [40] copy Visual–spatial processing Copying a complex ﬁgure
AAT Aachener aphasie test; CFT Rey-complex-ﬁgure-test; FPT Five-point test; TMT-A Trail-making test part A; TMT-B Trail-making test part
B; VOSP Visual object and space perception battery
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Table 2 Sample characteristics
patient cohort (N = 58)
Variable n %
Mean age in years M = 58.03 (SD = 13.94)
range = 27–80
Sex
Female 29 50
Male 29 50
Education (highest level)
Elementary school 26 44.8
Junior high school 17 29.3
University entrance diploma 11 19.0
University degree 3 5.2
No graduation 1 1.7
Current employment status
Currently employed/in education 37 64.0
Retired 17 29.3
Housekeeper/unemployed 4 6.9
Pre-morbid intellectual level/IQa M = 110.25 (SD = 10.80)
range = 82–137
Karnofsky Performance Status 0-100 (n = 47) M = 87.13 (SD = 13.54)
range = 50–100
Previous neurosurgical treatment
None 47 58.8
First recurrence after initial operation 10 12.5
Second recurrence 1 1.3
WHO grading
WHO I 15 29.9
WHO II 9 15.5
WHO III 7 12.1
WHO IV 20 34.5
No WHO grading
Malignant tumor (Metastases) 4 6.9
Benign tumor (Schwannoma) 1 1.7
No histopathological reportb 2 3.4
Tumor-histological diagnosis
Meningioma 15 25.9
Astrocytoma 10 17.2
Glioblastoma multiforme 20 34.5
Other 11 19.0
No histopathological report 2 3.4
Tumor-lateralization
Right 23 39.7
Left 24 41.4
Other (e.g. multiple or medial) 11 19.0
Main tumor-localization
Frontal 20 34.5
Temporal 11 19.0
Parietal 11 19.0
Occipital 2 3.4
Multiple 8 14.0
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Distinguishing patients with cognitive decline
from unimpaired patients
The full protocol could not be applied to all patients: Pri-
ority was given to tests that were most relevant to the
preparation and evaluation of the operative procedure,
which accounts for ﬂuctuating number of patients per
domain (see [1]). 48.1 % (n = 26) of the patients were
classiﬁed as unimpaired and 51.9 % (n = 28) as impaired
in at least one domain (see Online Resource 2).
MoCA showed better sensitivity than MMSE at the
respective cut-off scores, indicating higher speciﬁcity
(Table 4). At the optimal cut-off score, sensitivity was
highest for MoCA and speciﬁcity was highest for MMSE.
Regarding cognitive impairment in the neuropsychological
test battery, the AUC for MoCA was highest. A signiﬁcant
difference between two ROC curves was found for MoCA
and BCSE.
Discussion
This is the ﬁrst study comparing the BCSE with the MoCA
and the MMSE in terms of feasibility and diagnostic
properties in patients with intracranial tumors. With respect
to the feasibility of the BCSE in patients with intracranial
tumors, we experienced that assessment time of the BCSE
was similar to the estimated time provided in the manual
and lay between MMSE and MoCA. All screening tools
were perceived as hardly straining, highly tolerable and
equally appropriate. The signiﬁcantly higher strain of
BCSE and MoCA in comparison with MMSE probably
reﬂects higher demands on executive functions and mem-
ory in both tests. Additionally, the BCSE was rated as more
tolerable than the MoCA, which might explain why the
MoCA, as the subjectively most difﬁcult tool, was signif-
icantly more often judged as the screening tool that could
‘‘detect the actual problems’’.
As expected, we found medium but signiﬁcant correla-
tions between the BCSE and the two other screening tools
(r = 0.475–0.485). While the BCSE was the only screen-
ing that failed to show a signiﬁcant relationship with visuo-
spatial functions, this test showed low signiﬁcant correla-
tions with all other domains. This can be explained by the
lack of the BCSE in assessing visuo-spatial functions. As
this is the ﬁrst study investigating the BCSE in the popu-
lation of patients with intracranial tumors, our results
remain to be replicated in future studies. A detailed dis-
cussion of the results of MoCA and MMSE can be found in
Online Resource 3.
Distinguishing patients and healthy controls
One of our main goals was to examine the BCSE‘s ability
to correctly distinguish patients with an intracranial tumor
from healthy individuals. It should be kept in mind, how-
ever, that the screening tools were not constructed to
address this speciﬁc issue.
Regarding the speciﬁcity of the tools, it should be noted
that the control group was correctly classiﬁed as
Table 2 continued
Variable n %
Basal ganglia, cerebellum and adjacent structures 6 10.3
M arithmetic mean; SD standard deviation; WHO World health organization
a Estimated via the socio-demographic equation [47, 48]
b One patient suffered from a meningioma of the falx cerebri (radiological report), but died under the
surgery. One patient declined a surgery and was diagnosed with gliomatosis cerebri (radiological report)
Table 3 Diagnostic properties
distinguishing patients from
healthy controls (manual
cut-off)
AUC SD P Sensitivity Speciﬁcity PPV NPV DA
BCSE 0.699 0.0638 0.0018 38.6 81.82 84.6 34.0 50.6
MoCA 0.848 0.0409 \0.0001 68.97 100 100 55.3 77.5
MMSE 0.826 0.0463 \0.0001 28.07 100 100 33.9 47.4
Comparison of AUC z p
MoCA-BCSE 1.966 .0493*
MMSE-BCSE 1.611 0.1072
MMSE-MoCA -0.356 0.7218
AUC area under the curve; BCSE Brief Cognitive Status Exam; DA diagnostic accuracy; MMSE Mini
Mental State examination; MoCA Montreal cognitive assessment; NPV negative predictive value; P prob-
ability; PPV positive predictive value; SD standard deviation;  test statistic: z value; * signiﬁcant with
P\ .05
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unimpaired with 100 % by MMSE and MoCA. Surpris-
ingly, the BCSE considered four of them as impaired. With
respect to the very low speciﬁcity in detecting cognitive
impairment (see below), we assume that this outcome is a
false positive classiﬁcation. The ability to correctly identify
those individuals who have been classiﬁed as tumor
patients (i.e., the sensitivity) was extremely poor for BCSE
(38.6 %), but also for the MMSE with even less sensitivity.
The best, but still moderate sensitivity was achieved for the
MoCA (68.97 %). Better results were obtained for the
probability that the tested person was a patient (i.e.,
impaired) based upon a positive score (PPV), which was
considerably higher for all screenings (BCSE 84.6 %,
MoCA 100 %, MMSE 100 %). In contrast, the NPV
probability of a valid negative test result (i.e., unimpaired)
was very low (B55.3 %). Overall, diagnostic accuracy
favored the MoCA. ROC-analysis revealed low AUC for
BCSE, while AUCs for MMSE and MoCA were good
(0.826 and 0.848). Although no signiﬁcant differences
(only in tendency) were found between the AUCs of
MoCA and MMSE, our results suggest that the MoCA
seems to be the best alternative in clinical screening situ-
ations because it demonstrated the highest sensitivity.
However, it should be noted that it still misses one third of
ill patients, indicating that it should not serve as the sole
criterion for assuming a brain disease and initiating further
diagnostic.
Detecting cognitively impaired patients
Our second main goal was to examine the ability of the
BCSE to correctly identify those patients who have been
classiﬁed as cognitively impaired according to the current
gold standard of a comprehensive neuropsychological test
battery. When the cut-offs provided by the manuals were
used, the BCSE showed extremely low abilities to detect
impaired individuals (37 %). The best alternative screening
tool was the MoCA (92.9 %). Considering the speciﬁcity,
the BCSE’s ability to detect cognitively unimpaired indi-
viduals among patients with an intracranial tumor was
moderate but similar to the results of the MoCA (MoCA
61.5 %; BCSE 65.4 %). The best alternative screening for
this purpose was the MMSE (92.3 %). Converging results
were reported by other authors comparing MMSE and
MoCA in different and similar patient populations [18, 19,
26, 49]. For the BCSE, the poor results need to be further
explored in future studies.
Finally, prediction of cognitive outcome was worst for
the BCSE (AUC = 0.713) compared to the other screening
tools. Hence, with respect to the negative predictive value
(NPV), results from BCSE were in poor agreement with the
neuropsychological test battery as patients with a BCSE
score above PR 15 were likely to meet neuropsychological
criteria for cognitive impairment after comprehensive
evaluation (NPV = 50 %). Conversely, patients classiﬁed
as impaired by the BCSE (score\ PR15) had a probability
of 52.6 % to be diagnosed as impaired by the test battery.
The best alternative screening tool here againwas theMoCA
with clearly superior results (NPV = 88.9; PPV = 72.2).
Importantly, examination of different cut-off scores lead
to the conclusion that only in case of the BCSE the use of
an optimal cut-off increased both sensitivity and speci-
ﬁcity, indicating that the use of the stratiﬁed norms leads to
substantial misclassiﬁcation of patients with intracranial
tumors. Despite this improvement, the values remained far
below the diagnostic ability of MMSE and MoCA.
In summary, the BCSE is as feasible as the MoCA or the
MMSE in patients with intracranial tumors, but seems to
Table 4 Diagnostic properties
of cognitive impairment
according to
neuropsychological test battery
AUC SD P Manuals cut-off J sens spec PPV NPV DA
BCSE 0.713 0.0747 0.003 PR 15 % 37.0 65.4 52.6 50.0 50.9
MoCA 0.895 0.0412 \0.000 \26 0.503 92.9 61.5 72.2 88.9 77.8
MMSE 0.845 0.0547 \0.000 \26 0.516 44.4 92.3 85.7 61.5 67.9
Comparison of AUC z p
MoCA-BCSE 2.133 0.033*
MMSE-BCSE 1.426 0.154
MMSE-MoCA -0.730 0.47
Optimal cut-off
BCSE \51/50.5 0.439 59.3 84.6 80.0 66.7 72.7
MoCA \24/23.5 0.632 78.6 84.6 84.6 78.5 81.5
MMSE \28/27.5 0.625 74.1 88.5 87.0 76.7 81.1
AUC area under the curve; BCSE Brief Cognitive Status Exam; DA diagnostic accuracy; J Youden’s J;
MMSE Mini Mental State examination; MoCA Montreal cognitive assessment; NPV negative predictive
value; p probability; PPV positive predictive value; PR percentile rank; SD standard deviation; sens
sensitivity; spec speciﬁcity;  test statistic: z value; * signiﬁcant with p\ .05
J Neurooncol
123
Author's personal copy
lack the assessment of visuo-spatial functions. In addition,
compared to MoCA and MMSE, it showed the lowest
diagnostic qualities in several areas and therefore cannot be
recommended as a screening tool for cognitive status in
these patients. This also holds true for clinical trials, as our
results identiﬁed the MoCA as the screening tool with best
PPV and NPV and again did not favor the BCSE. Never-
theless, for clinical as well as research settings it should be
kept in mind that screening tools usually underestimate the
amount of cognitive deﬁcits and the effect of treatment on
cognition in comparison with a comprehensive neuropsy-
chological test battery.
Acknowledgments We would like to thank the Familie Mehdorn
Stiftung for funding this study. We thank Rajka Matthiesen and Lea
Schmitz for the excellent assistance in data acquisition, and Yumiko
Nakai for her helpful comments on the manuscript. This manuscript
or parts of it have not been published previously and have not been
submitted simultaneously for publication in another source.
Funding Juliane Becker and Elisabeth Steinmann were receiving a
grant from the Familie Mehdorn Stiftung. None of the other authors
received any ﬁnancial or material support.
Compliance with ethical standards
Disclosure of potential conflicts of interest The authors declare
that they have no conﬂict of interest.
Ethical approval All procedures performed in this study involving
human participants were in accordance with the ethical standards of
the institutional research committee and with the 1964 Helsinki
declaration and its later amendments.
Informed consent Informed consent was obtained from all indi-
vidual participants included in the study.
References
1. Talacchi A, Santini B, Savazzi S et al (2011) Cognitive effects of
tumour and surgical treatment in glioma patients. J Neurooncol
103(3):541–549. doi:10.1007/s11060-010-0417-0
2. Murray KJ, Scott C, Zachariah B et al (2000) Importance of the
Mini-Mental Status Examination in the treatment of patients with
brain metastases: a report from the radiation therapy oncology
group protocol 91-04. J Radiat Oncol Biol Phys 48:59–64
3. Meyers CA, Hess KR, Yung WKA et al (2000) Cognitive func-
tion as a predictor of survival in patients with recurrent malignant
glioma. J Clin Oncol 18:646–650
4. Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of
radiotherapy and other treatment-related factors on mid-term to
long-term cognitive sequelae in low-grade gliomas: a compara-
tive study. Lancet 360(9343):1361–1368. doi:10.1016/S0140-
6736(02)11398-5
5. Santini B, Talacchi A, Squintani G et al (2012) Cognitive out-
come after awake surgery for tumors in language areas. J Neu-
rooncol 108(2):319–326. doi:10.1007/s11060-012-0817-4
6. Olson RA, Chhanabhai T, McKenzie M (2008) Feasibility study
of the Montreal Cognitive Assessment (MoCA) in patients with
brain metastases. Support Care Cancer 16(11):1273–1278.
doi:10.1007/s00520-008-0431-3
7. Satoer D, Vork J, Visch-Brink E et al (2012) Cognitive func-
tioning early after surgery of gliomas in eloquent areas. J Neu-
rosurg 117:831–838
8. Taphoorn MJB, Klein M (2004) Cognitive deﬁcits in adult
patients with brain tumours. Lancet Neurol 3(3):159–168. doi:10.
1016/S1474-4422(04)00680-5
9. Meyers CA, Rock EP, Fine HA (2012) Reﬁning endpoints in
brain tumor clinical trials. J Neurooncol 108(2):227–230. doi:10.
1007/s11060-012-0813-8
10. Zucchella C, Bartolo M, Di Lorenzo C et al (2013) Cognitive
impairment in primary brain tumors outpatients: a prospective
cross-sectional survey. J Neurooncol 112(3):455–460. doi:10.
1007/s11060-013-1076-8
11. Bunevicius A, Tamasauskas S, Deltuva V et al (2014) Predictors
of health-related quality of life in neurosurgical brain tumor
patients: focus on patient-centered perspective. Acta Neurochir
(Wien) 156(2):367–374. doi:10.1007/s00701-013-1930-7
12. Meyers CA, Brown PD (2006) Role and relevance of neurocog-
nitive assessment in clinical trials of patients with CNS tumors.
J Clin Oncol 24(8):1305–1309. doi:10.1200/JCO.2005.04.6086
13. Papagno C, Casarotti A, Comi A et al (2012) Measuring clinical
outcomes in neuro-oncology. A battery to evaluate low-grade
gliomas (LGG). J Neurooncol 108(2):269–275. doi:10.1007/
s11060-012-0824-5
14. Folstein MF, Folstein SE, McHugh PR (1975) ‘‘Mini-Mental
State’’A practical method for grading the cognitive state of
patients for the clinican. J Psychiatr Res 12(3):189–198. doi:10.
1016/0022-3956(75)90026-6
15. Patel RR, Mehta MP (2007) Targeted therapy for brain metas-
tases: improving the therapeutic ratio. Clin Cancer Res
13(6):1675–1683. doi:10.1158/1078-0432.CCR-06-2489
16. Meyers CA, Wefel JS (2003) The use of the Mini-Mental State
Examination to assess cognitive functioning in cancer trials: no
ifs, ands, buts, or sensivity. J Clin Oncol 21(19):3557–3558
17. Vardy J, Wong K, Yi Q et al (2006) Assessing cognitive function
in cancer patients. Support Care Cancer 14(11):1111–1118.
doi:10.1007/s00520-006-0037-6
18. Olson RA, Iverson GL, Carolan H et al (2011) Prospective
comparison of two cognitive screening tests: diagnostic accuracy
and correlation with community integration and quality of life.
J Neurooncol 105:337–344
19. Nasreddine ZS, Phillips NA, Bedirian V et al (2005) The Mon-
treal Cognitive Assessment, MoCA: a brief screening tool for
mild cognitive impairment. J Am Geriatr Soc 53(4):695–699
20. Chan E, Khan S, Oliver R et al (2014) Underestimation of cog-
nitive impairments by the Montreal Cognitive Assessment
(MoCA) in an acute stroke unit population. J Neurol Sci
343(1–2):176–179. doi:10.1016/j.jns.2014.05.005
21. Petermann F, Lepach AC (eds) (2012) Wechsler Memory Scale-
Fourth Edition (WMS-IV). Manual zur Durchfu¨hrung und
Auswertung. Always learning, 4th edn. Pearson, Frankfurt
22. Bouman Z, Hendriks, Marc PH, Aldenkamp AP et al. (2014)
Clinical validation of the WMS-IV-NL brief cognitive status
exam (BCSE) in older adults with MCI or dementia. Int Psy-
chogeriatr, 1–9, doi: 10.1017/S1041610214001471
23. Olson RA, Iverson GL, Parkinson M, Carolan H, Ellwood A,
McKenzie M (2009) Investigation of cognitive screening mea-
sures in patients with brain tumors: Diagnostic accuracy and
correlation with quality of life.: Meeting Abstract e13000. J Clin
Oncol, 27
24. Olson RA, Tyldesley S, Carolan H et al (2011) Prospective
comparison of the prognostic utility of the Mini Mental State
Examination and the Montreal Cognitive Assessment in patients
J Neurooncol
123
Author's personal copy
with brain metastases. Support Care Cancer 19(11):1849–1855.
doi:10.1007/s00520-010-1028-1
25. Gauthier S, Reisberg B, Zaudig M et al (2006) Mild cognitive
impairment. Lancet 367:1262–1270
26. Smith T, Gildeh N, Holmes C (2007) The Montreal Cognitive
Assessment: validity and utility in a memory clinic setting. Can J
Psychiatry 52:329–332
27. Wong GKC, Lam S, Ngai K et al (2012) Evaluation of cognitive
impairment by the Montreal Cognitive Assessment in patients
with aneurysmal subarachnoid haemorrhage: prevalence, risk
factors and correlations with 3 month outcomes. J Neurol Neu-
rosurg Psychiatry 83(11):1112–1117. doi:10.1136/jnnp-2012-
302217
28. Kessler J, Denzler P, Markowitsch HJ (1990) Der mini-mental-
status-test. Beltz, Weinheim
29. Brown PD, Buckner JC, O’Fallon JR et al (2003) Effects of
radiotherapy on cognitive function in patients with low-grade
glioma measured by the folstein mini-mental state examination.
J Clin Oncol 21(13):2519–2524. doi:10.1200/JCO.2003.04.172
30. Malloy PF, Cummings JL, Coffey CE et al (1997) Cognitive
screening instruments in neuropsychiatry: a report of the Com-
mittee on Research of the American Neuropsychiatric Associa-
tion. J Neuropsychiat Clin Neurosci 9(2):189–197
31. Shibamoto Y, Baba F, Oda K et al (2008) Incidence of brain
atrophy and decline in Mini-Mental State Examination score after
whole-brain radiotherapy in patients with brain metastases: a
prospective study. Int J Radiat Oncol Biol Phys 72(4):1168–1173
32. NCCN (2003) Distress management Clinical practice guidelines.
J Natl Compr Cancer Netw 1(3):344–374
33. Baldo JV, Schwartz S, Wilkins D et al (2006) Role of frontal
versus temporal cortex in verbal ﬂuency as revealed by voxel-
based lesion symptom mapping. J Int Neuropsychol Soc
12(6):896–900. doi:10.1017/S1355617706061078
34. Pihlajama¨ki M, Tanila H, Ha¨nninen T et al (2000) Verbal ﬂuency
activates the left medial temporal lobe: a functional magnetic
resonance imaging study. Ann Neurol 47(4):470–476. doi:10.
1002/1531-8249(200004)47:4\470:AID-ANA10[3.0.CO;2-M
35. Huber W, Poeck K, Weniger D, Willmes K (1983) Aachener
Aphasie Test (AAT). Hogrefe, Go¨ttingen
36. Aschenbrenner A, Tucha O, Lange K (2000) Regensburger
Wortﬂu¨ssigkeits-Test (RWT), Handanweisung. Hogrefe,
Go¨ttingen
37. von Aster M, Neubauer A, Horn R (2006) Wechsler- Intelligen-
ztest fu¨r Erwachsene WIE. Manual. U¨bersetzung und Adaption
der WAIS-III von David Wechsler. Hartcourt Test Services,
Frankfurt am Main
38. Tombaugh T (2004) Trail making test A and B: normative data
stratiﬁed by age and education. Arch Clin Neuropsychol
19(2):203–214. doi:10.1016/S0887-6177(03)00039-8
39. Schaaf A, Kessler J, Grond M, Fink GR (1992) Memo-test
manual. Beltz Testgesellschaft, Weinheim
40. Rey A, Osterrieth PA (1998) Rey-Complex Figur Test (CFT). In:
Spreen O, Strauss E (eds) A compendium of neuropsychological
tests: administration, norms, and commentary, 2nd edn. Oxford
University Press, New York, pp 341–363
41. Goebel S, Fischer R, Ferstl R et al (2009) Normative data and
psychometric properties for qualitative and quantitative scoring
criteria of the Five-point Test. Clin Neuropsychol 23(4):675–690.
doi:10.1080/13854040802389185
42. Warrington EK, James M. (1992) Testbatterie fu¨r visuelle
Objekt- und Raumwahrnehmung (VOSP). Burry St Edmunds,
Thames Valley Test Company
43. Vardy J, Tannock I (2007) Cognitive function after chemotherapy
in adults with solid tumours. Crit Rev Oncol/Hematol
63(3):183–202. doi:10.1016/j.critrevonc.2007.06.001
44. Correa DD, Shi W, Thaler HT et al (2008) Longitudinal cognitive
follow-up in low grade gliomas. J Neurooncol 86(3):321–327.
doi:10.1007/s11060-007-9474-4
45. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing
the areas under two or more correlated receiver operating char-
acteristic curves: a nonparametric approach. Biometrics
44(3):837. doi:10.2307/2531595
46. Youden WJ (1950) Index for rating diagnostic tests. Cancer
3(1):32–35
47. Leplow B, Friege L (1998) Eine Sozialformel zur Scha¨tzung der
pra¨morbiden Intelligenz. Zeitschrift fu¨r Klinische Psychologie
27: 1–8
48. Jahn T, Beitlich D, Hepp S et al (2013) Drei Sozialformeln zur
Scha¨tzung der (pra¨morbiden) Intelligenzquotienten nach Wech-
sler. Zeitschrift fu¨r Neuropsychologie 24(1):7–24. doi:10.1024/
1016-264X/a000084
49. Le Rhun E, Delbeuck X, Devos P et al (2009) Troubles cognitifs
dans les gliomes de grade II et III de l’adulte: A` propos d’une
se´rie de 15 patients (Cognitive disorders and adult grade II and III
gliomas: analysis of a series of 15 patients). Neurochirurgie
55(3):303–308. doi:10.1016/j.neuchi.2008.08.111
J Neurooncol
123
Author's personal copy
Online Resource 1: Additional material section methods 
 
1 
 
Cognitive screening in patients with intracranial tumors: 
Validation of the BCSE 
Journal of Neuro-Oncology  
 
Authors: 
Juliane Becker 
1
, MA; Elisabeth Steinmann 
1
, MA; Maria Könemann 
1
, MA; Sonja Gabske
 1
, MA; Hubertus 
Maximilian Mehdorn 
1
, MD; Michael Synowitz 
1
, MD; Gesa Hartwigsen 
2
, PhD, MA; Simone Goebel 
1
, PhD, MA 
 
1 Department of Neurosurgery, University Hospital Schleswig–Holstein, Kiel, Germany 
2 Department of Psychology, University of Kiel, Kiel, Germany 
 
Address correspondence to Juliane Becker, E-Mail: juliane.becker@uksh.de 
  
Online Resource 1: Additional material section methods 
 
2 
 
Subjects 
Inclusion and exclusion criteria for all patients 
Online Resource 1 table 1 displays the Inclusion and exclusion criteria of this study. We excluded 
patient with a hemiplegia of the dominant arm, because this would have impeded their participation 
in most of the tests used in this study (i.e., paper and pencil tests). The same holds true for a neglect, 
which would cause patients to work only on one side of a given test sheet. A complete hemianopsia 
reduĐes the speed of ǀisual eǆploratioŶ aŶd therefore reduĐes the patieŶt’s perforŵaŶĐe iŶ ǀisual-
motor speed dependent tasks.   
 
Online Resource 1 table 1: Detailed Information about inclusion and exclusion criteria 
Inclusion criteria  
 diagnosis of an intracranial tumor (primary brain tumor, meningioma or metastasis); 
 age between 20 and 80 years;  
 native language German  
Exclusion criteria  
 severe aphasia (defined as less of 30% correct items in elected subtests of the AAT [1]) 
 serious physical/medical conditions like hemiplegia of the dominant arm, deficient 
orientation in terms of person and/or situation; being bedbound (Karnofsky Performance 
Scale <50) [2] 
 known dementia or cognitive impairment prior to diagnosis of an intracranial tumor 
 known history of drug abuse   
 known medication with anesthetics (like Morphine or Diazepam) or antipsychotics (like 
Haloperidol) at the day of the assessment 
 severe deficits in eyesight like diplopic images, complete hemianopsia, neglect or visual 
hallucinations (examination of eyesight [3]) 
AAT = Aachener Aphasie Test 
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Procedure of assessment  
PatieŶt’s assessŵeŶt took plaĐe 1-5 days prior or 4-5 days after the operation during in-patient stay 
as part of the patieŶts’ diagŶostiĐ routiŶe. PartiĐipaŶts did Ŷot reĐeiǀe aŶǇ reimbursement. None of 
the patients were institutionalized. Socio-demographic and medical data were obtained via a semi-
structured interview and the medical history. The pre-morbid intellectual level of functioning was 
estimated via the socio-demographic equation [4, 5]. First, eligible patients were asked to 
participate, familiarized with the procedure and gave their written informed consent. This was 
followed by comprehensive exploration, estimation of premorbid intelligence and AAT. If patients 
were further included, the three screening-instruments were given in pseudo-randomized order 
including the VASs for tolerability and strain as well as questions for subjective preference and 
validity. The neuropsychological test battery was performed in the following order: CFT copy, 
immediate verbal memory, digit span, verbal and figural fluency, VOSP, TMT, CFT delay, delayed 
verbal memory. Total assessment time was 75-115 min for each patient. The control group 
completed a shortened demographic interview and the screenings in pseudo-randomized order. 
 
Statistical analysis  
Preliminary analysis 
Patient characteristics and raw test scores were presented using descriptive statistics. A difference 
with a p value < .05 was regarded as statistically significant (two tailed test) unless otherwise 
specified. To match patient data with healthy controls, categorical data were analyzed using the 
Fisher’s eǆaĐt test or ² test, with ORs and 95% confidence interval (CI) where appropriate. For direct 
comparison of age and test scores, Mann-Whitney-U-Test was calculated. Median comparison of 
subjective data for strain, tolerability, preference and subjective validity was done with Wilcoxon 
signed-rank test. Correlations between screening tools, domains and risk factors were assessed using 
KeŶdal’s raŶk ĐorrelatioŶ.  
Main Analysis: Defining cognitive impairment  
We first transformed raw test scores of the neuropsychological test battery into z-scores, based on 
the normative data of each subtest. Afterwards, we summed up the z-scores for all tests of a specific 
domain for each patient separately and calculated his mean z-score for each domain. For definition 
of cognitive impairment, we followed Vardy and colleagues [6] and determined moderate cognitive 
impairment as more than 1.5 standard deviations (SD) below the mean which corresponds to a z-
score of <-1.5 [7]. Patients who met this criterion for cognitive impairment in at least one cognitive 
doŵaiŶ ǁere laďeled as ͞ĐogŶitiǀelǇ iŵpaired͟.  
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Online Resource 2 figure 1: Flowchart of patient recruitment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AAT = Aachener Aphasie Test; KPS = Karnofsky Performance Scale 
 
135 patients eligible for routine 
neuropsychological assessment 
50 patients without an intracranial tumor 
4 patients with German not being their first language 
14 patients with KPS < 50% 
4 patients with less than 50% correct performance in one 
subscale of the AAT 
2 with known dementia or severe psychiatric 
impairment prior to diagnosis of the brain tumor 
2 known histories of drug abuse  
2 known medication with anesthetics (Morphine or 
Diazepam) or antipsychotics (like Haloperidol) at the 
day of the assessment  
1 unable to cooperate for cognitive assessments (not 
obeying command) 
63 patients 
1 patient declined to participate before admission 
62 patients completed 
screening tools and test battery 
Complete datasets of 58 
patients (5 postoperative) 
4 patients were excluded due to histopathological finding 
(cavernoma, gliosis) 
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Prevalence of cognitive impairment in patients with intracranial tumors 
According to the screening tools, 28.1% up to 69.0% of the patients were classified as cognitively 
impaired. For details see table 1. 51.9% (n = 28) of the patients were classified as impaired in at least 
one cognitive domain. Most frequently, cognitive impairment was found in only one domain. 
Patients showed most often deficits in memory and visuo-spatial functions. 
Online Resource 2 table 1: Cognitive impairment in patients  
Screening tools° Md range  n   %  
BCSE  (n=57) 52 16-58  22 37.9  
MoCA  (n=58) 23 11-30  40 69.0  
MMSE  (n=57) 28 18-30  16 28.1  
No. of impaired domains ^ (N=54)   n   % cumulative % 
0 26 48.1 100 
1 15 27.8 51.9 
2 9 16.7 24.0 
3 3 5.6 7.4 
4 1 1.9 1.9 
 z-scores                   z < -1.5  
Domain M   SD  n   %  
Language (n = 55) 0.18  1.12  3 5.6  
Attention and  
   visuo-motor speed (n = 53) 
-0.39  1.31  6 11.3  
Memory (n = 53) -0.75  1.10  15 28.3  
Executive functions (n = 50) -0.62  1.24  9 18.0  
Visuo-spatial functions (n = 54) -1.19  1.82  15 27.8  
BCSE = Brief Cognitive Status Exam; M = arithmetic mean; Md = Median; MMSE = Mini Mental State 
examination; MoCA = Montreal cognitive assessment; n = number; SD = standard deviation; °classification on 
basis of the manuals (MMSE cut-off: <26, MoCA cut-off <26, BCSE 15% percentile rank); ^ full protocol could 
not be applied to all patients: Priority was given to tests that were most relevant to the preparation and 
evaluation of the operative procedure (see [1]). 
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Sample characteristics healthy control group  
Online Resource 2 table 2: Sample characteristics healthy control group (N= 22) 
   test statistics³ 
Mean age in years 
 
M = 55.00 (SD= 15.37) 
          range = 23-83 
U = 589.0 ,  
p = .602 
Sex 
   Female 
   Male 
n % 
²(1) = 2.130 ,  
p = .209 
15 
7 
68.2 
31.8 
Education (highest level) 
   Elementary school 
   Junior high school 
   University entrance diploma 
   University  degree 
   no graduation 
 
8 
8 
6 
0 
0 
 
36.4 
36.4 
27.3 
0 
0 
²(4) =2.231 , 
p = .738 
  cognitively impaired°  
 Md range n %  
BCSE (n = 22) 56   42-58 4 18.2 U=377.0; p=.003 
MoCA (n = 22) 28  26-30 0 0.0 U=194.5; p=.000 
MMSE (n = 21) 30  27-30 0 0.0 U=208.0; p=.000 
BCSE = Brief Cognitive Status Exam; M = arithmetic mean; Md = Median; MMSE = Mini Mental State 
examination; MoCA = Montreal cognitive assessment; n = number; p = probability; SD = standard deviation; U = 
Test statistic for Mann-Whitney-U-Test; ² = test statistic chi-square test; ³ in comparison with the patient 
group; °classification on basis of the manuals (MMSE cut-off: <26, MoCA cut-off <26, BCSE 15% percentile rank) 
 
Results preliminary analysis 
Analysis of feasibility: Additional results 
The subjective strain differed significantly between MMSE (Md= 10, range =0-10) and MoCA (Md= 3, 
range= 0-8) (z=-3.838, p=.000). The subjective tolerability of MMSE had a median of 10 and a range 
of 0-10. The screening tools were judged as appropriate by the patients (MMSE 24.1%, n=14; MoCA 
25.9%, n=15; BCSE 29.3% n=17).  
Analysis of validity: Additional results 
Correlation of MMSE and MoCA was slightly higher than for BCSE and both other tools (table 3). 
MMSE and MoCA sum scores correlated significantly with each of the five domains (r=.192 to .539). 
For details see table 4. 
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Online Resource 2 table 3: Correlational analysis of the screening 
tools (Kendall-Tau-b) 
 BCSE MoCA 
MMSE (n=78) .475** p=.000 .641** p=.000  
MoCA (n=79) .485** p=.000    
BCSE = Brief Cognitive Status Exam; MMSE = Mini Mental State examination; MoCA = Montreal cognitive 
assessment; p = probability; * significant with p < .05 (two-tailed); ** significant with p < .01 (two-tailed) 
 
 
Online Resource 2 table 4: Correlational analysis of screening tools (sum score) and domains (mean 
z-score) (Kendall-Tau-b) 
 Domain 
speech 
attention and 
visuo-motor speed 
memory 
executive 
functions 
visual-spatial 
functions 
screening  
(sum score) 
BCSE 
.388** .302** .378** .351** .070 
(n=54) (n=52) (n=52) (n=50) p=.473 (n=53) 
MoCA 
      
 .473** .389** .539** .385** .192* 
 (n=55) (n=53) (n=53) (n=50)  (n=54) 
MMSE 
      
 .447** .395** .499** .333** .213* 
 (n=54) (n=52) (n=52) (n=50)  (n=53) 
BCSE = Brief Cognitive Status Exam; MMSE = Mini Mental State examination; MoCA = Montreal cognitive 
assessment; n = number; *higher values indicating higher strain; °higher values indicating higher tolerability; * 
significant with p < .05 (two-tailed); ** significant with p < .01 (two-tailed) 
Several risk factors showed significant relationship with the sum scores of the screening tools: higher 
age was correlated with lower sum scores in each screening tool (r=-.46 to -.36; p=.000), male 
patients showed lower sum scores for MoCA and BCSE (U=271.5 respective U=259.5; p=.019 
respective .018), higher educational status was correlated with higher sum scores (r=.287 to .304; 
p=.004 to .006) and higher WHO-grade was correlated with lower sum scores (r=-.338 to -.197; 
p=.001 to .059). No relationship was found for lesion side (hemisphere) and premorbid IQ.  
 
References 
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Prevalence of cognitive impairment  
Screenings 
Comparison of healthy individuals with patients who were diagnosed with an intracranial tumor 
showed significantly higher scores in each screening tool for the healthy group. Depending on the 
screening tool used, 28.1% (MMSE) to 69.0% (MoCA) of the patients were classified as cognitively 
impaired when the published cut-off scores were used. We are not aware of any previous 
classification studies on cognitive impairment in a comparable collective. However, similar rates of 
30% were found for the MMSE in patients with an intracranial tumor after radiotherapy [1]. The high 
rate of 69% of MoCA defined cognitive impairment corresponds roughly to the findings of Olson and 
colleagues [1] who studied patients with intracranial tumors after radiation and reported cognitive 
impairment in 80% of their sample. However, these findings need to be interpreted with caution 
since a later study by the same group reported different prevalence rates in patients after resection 
of intracranial tumors and chemo-/radiotherapy (MMSE 12.8% and MoCA 53.8% both with cut-offs 
<26) [2]. Finally, 37.9% of our patients showed BCSE-defined cognitive impairment. These findings 
need to be replicated in other samples as there are no previous studies on the application of the 
BCSE in a similar collective. 
 
Domains 
According to the comprehensive neuropsychological test battery applied in our study, 51.9% of the 
patients demonstrated cognitive impairment in at least one cognitive domain. This is in line with 
previous findings of defining cognitive impairment as a z-score of -2 in at least one domain and 
comparable reported rates of 38% and 37% impaired patients with intracranial tumors [3, 4]. 
Cognitive impairment in only one domain was prevalent in 27.8% of the patients, only 24.2% showed 
impairment in two or more domains. This also matches previous reports of cognitive impairment in 
only one domain in 24 % [3] or 32 % [4] of the tested collective, while 14% [3] or 5% [4] had two or 
more impaired domains. Among the most frequently affected domains were memory, visuo-spatial 
functions and executive functions, which is also in line with previous studies [3–5]. Note that 
discrepancies in prevalence between the different studies can be explained by different tests applied 
in each domain and different definitions of impairment (i.e., z-scores ranging from -1 to -2, all tests in 
one domain impaired) or selection biases in the study sample. For instance, Santini and Satoer [4, 5] 
restricted their study sample to patients undergoing awake surgery. In most of their patients, tumors 
were localized in the left hemisphere, which might have produced a higher prevalence of speech 
impairment than usually reported in the population of patients with intracranial tumors.  
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Preliminary analysis  
 
Validity of MMSE and MoCA  
Similar correlations of r=.641 between MMSE and MoCA were found in previous studies [6, 7], while 
iŶǀestigatioŶs iŶ iŶdiǀiduals ǁith ŵild cogŶitiǀe iŵpairŵeŶt aŶd ŵild Alzheiŵer’s disease [8] or 
patients with brain metastasis after surgery and radiotherapy demonstrated higher correlations 
(r=.74, [9]). 
The MMSE showed low, but significant correlation with each of the five domains, which was 
unexpected because executive functions were not assessed and other studies reported a poor 
sensitivity to detect visuo-spatial deficits [10]. In our sample, the visuo-spatial domain yielded the 
smallest correlation compared to other domains, which might be explained by the fact that the 
visuo-spatial items of the MMSE and the neuropsychological tests for the respective domain are 
similar (copy a figure). The correlation with the executive domain might be explained by the fact that 
executive functions contribute to almost all cognitive functions [11]. The MoCA also demonstrated a 
significant low to medium relationship with all five cognitive domains, indicating that each domain is 
roughly assessed by this test.  
As expected, correlations between age, education, WHO grading and cognitive performance were 
found for healthy adults and, as formerly reported by other authors, also for patients with 
intracranial tumors [1, 10, 12–14]. Additionally, male patients showed worse cognitive performance 
in the MoCA and BCSE. Notably, while both tools include a word fluency task which usually reveals 
better performance in females [12], this test is not included in the MMSE. This might explain the 
observed differences in our patient sample. The missing relationship between intelligence and 
cognitive performance might be attributed to the measure of intelligence via estimation of a 
premorbid status. No relationship was found between tumor-affected hemisphere and performance 
in the screening tools.  
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Objectives: Awake  craniotomy is  a  well-established  procedure in surgery of intracranial tumors  in
eloquent areas.  However,  sufficiently standardized  instruments  for the  assessment  of sensory-motor
function  before,  during  and  after  the  operation  are currently  lacking, despite  their importance  for  eval-
uation  of operative outcome.
Patients and methods:  To address  this issue,  we designed a  standardized  assessment  tool  (the “sensory-
motor profile awake  scale”;  SMP-a). The final scale consists  of three motor sections  (face,  arm  and  leg)
assessing  both  gross and fine motor skills and  one  sensory  section.  It  differentiates  between six  grades
of impairment  and  its tasks are  applicable  for intraoperative  continuous  monitoring  of  sensory-motor
functions  and supporting  processes.  We analyzed  the  data  of 17 patients  with  intracranial tumors  eligible
for  awake  craniotomy who  were  preoperatively  assessed with  the  SMP-a.  In addition, we present an
exemplary  case.
Results:  Our  data  support  the  assumption  that the SMP-a  is feasible  in patients  eligible  for  awake  cran-
iotomy, even in patients with  symptoms  of mild  aphasia  or  more  severe  sensory-motor  deficits  caused  by
tumor recurrence.  The exemplary  case  demonstrates  the  feasibility of repeated  measures  with  the  SMP-a
in a  tumor  patient, including  the  adaption  of tasks to  the  individual requirements  of an intraoperative
setting.
Conclusion:  This  exploratory  study  suggests that  the  SMP-a  might  be  a feasible  rating  scale in patients
with  intracranial  tumors.  The flexibility  of the  scale  enables individual adaption,  but preserves  the  stan-
dardized scoring system to allow  comparison between assessment  dates,  patients  and,  hopefully  in the
future,  institutions.  However,  future  studies  are  mandatory  to provide data  on the  instrument’s diagnostic
properties  with  respect  to feasibility, objectivity,  validity  and  reliability.
©  2016  Elsevier B.V.  All  rights  reserved.
1. Introduction
Awake craniotomies are usually considered in  patients with
intracranial tumors located in  or near motor areas to prevent
cortical and/or subcortical damage which might lead  to perma-
nent neurologic deficits [1–5].  Direct cortical stimulation (DCS)
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and mapping supports the surgeon with real-time intraoperative
information and this way accounts for individual variability of
cortical organization and neuroplastic changes [2,6]. The neuro-
surgeon must be aware of a  wide range of possible intraoperative
changes (e.g. slowing of movements, weakness, dysarthria or
delayed response) since they guide the decision for resection [7].
A suitable tool for intraoperative monitoring should account for
all these changes and support the neurosurgeon with valid and
standardized that is, easy-to-interpret information during the oper-
ation.
So far, the available literature on  awake craniotomy in motor
eloquent areas provides either no information on the methods used
to  monitor endangered functions, or  is  restricted to the assessment
of somatosensory and motor evoked potentials or  unstandard-
http://dx.doi.org/10.1016/j.clineuro.2016.05.022
0303-8467/© 2016 Elsevier B.V. All rights reserved.
40 J.  Becker et al. /  Clinical Neurology and Neurosurgery 147 (2016) 39–45
Table  1
Rating scale for the assessment of complex sensory-motor functions in brain tumor patients undergoing awake craniotomy (sensory-motor profile awake; SPM-a).
SMP-a  preoperative  intraoperative  postoperative
face severe impairment medium impairment no/slight impairment notes
frown  forehead 0 1 2 3 4 5
blink  eyes 0 1 2 3 4 5
wrinkle nose 0 1 2 3 4 5
kissing  lips 0 1 2 3 4 5
laughing  mouth 0 1 2 3 4 5
mouthwash 0 1 2 3 4 5
poke  tongue out 0 1 2 3 4 5
hand  and arm
hand:
fine
motor
skills
rock 0 1 2 3 4 5
scissor 0 1 2 3 4 5
paper 0 1 2 3 4 5
well 0 1 2 3 4 5
finger tapping (oscillating) 0 1 2 3 4 5
strength: shake hands 0 1 2 3 4 5
rotate  wrist 0 1 2 3 4 5
flex  elbow 0 1 2 3 4 5
lift  shoulder 0 1 2 3 4 5
leg
lift  knee slightly 0 1 2 3 4 5
adduct  and abduct foot 0 1 2 3 4 5
move  toes 0 1 2 3 4 5
strength: press foot against hand (io) 0 1 2 3 4 5
sensory
face  0 1 2 3 4 5
fingers  0 1 2 3 4 5
arm  0 1 2 3 4 5
leg  0 1 2 3 4 5
toes  0 1 2 3 4 5
(io): first baseline in the operating room.
ized behavioral monitoring [1,8–16]. Evoked potentials provide
only limited reliability and impairments of non-monitored mus-
cles could not be avoided in previous studies [2,13,17–19].  Another
limitation of this technique is  that evoked potentials provide
no information on the direct effects of the DCS as reflected in
continuous voluntary movement during awake craniotomy [2].
The above-cited limitations probably partly result from the fact
that sensory-motor function is  a complex and integrated process,
comprising mobilization itself and several adaptation processes
[20–24]. This might explain why registration of simple muscle
contractions alone is  insufficient for obtaining optimal evalua-
tion [18,25,26]. Behavioral monitoring as alternative assessment
strategy during DCS  might increase the reliability and validity of
sensory-motor assessment [25,27–30]. However, previous studies
solely applied non- standardized or  semi-standardized approaches
of instructing their patients. Moreover, it remains unclear, if and
how baseline assessment of the patients’ functions was done and
how the surgery-induced alterations were rated and reported.
Therefore, inter-study comparability is hardly existent. In addition,
for evaluation of the surgical outcome, previous approaches often
assessed very different functions on variable scales compared to the
monitored and this way protected functions under surgery [29,30] .
Consequently, a valid conclusion on the value of awake craniotomy
appears to be difficult at this time.
Hence, a standardization of the monitoring procedure would be
mandatory to improve intraoperative assessment of sensory-motor
function and provide reliable postsurgical evaluation. However, to
the best of our knowledge, no attempts have been made to adapt
the existing neurological scales for the application in  awake cran-
iotomy so far.
To bridge this gap, we designed a rating scale suitable for this
purpose. By this, we aimed at combining the advantages of existing
neurological scales used for preoperative and postoperative evalu-
ation in this setting (i.e., the Modified Rankin Scale (mRS) [31],  the
British Medical Council Research Scale (MCRS) [32,33],  the Cana-
dian neurological scale (CNS) [34] and the Graded neurologic scale
[35]). Furthermore we  tried to  overcome the following limitations
of the previous scales: (a) lack of practicability: mRS, CNS and Graded
neurologic scale provide rating sections not suitable for intraoper-
ative setting (e.g., flexion of thighs toward trunk with knees flexed
at 90◦; activities of daily living; gait), (b) lack of highly relevant func-
tions: missing fine motor skills and/or sensory functions in  all four
scales, (c) lack of precision in item phrasing or scoring system: i. e. mix-
ing motor and sensory functions (mRS), vague phrasings in scoring
system like “moderate disability, requiring some help” (mRS) or
limitation to  strength (MCRS) and no qualitative assessment of
deceleration or imprecise movements (CNS).
2. Material and methods
The result of our efforts is the “sensory-motor profile awake
scale” (SMP-a) as displayed in Table 1. Whenever possible, we
adopted suitable items and scoring schedules from existing scales
and adapted them for intraoperative settings.
Somatosensory function can be assessed with the SMP-a by
touching the face and extremities and recording the respective
description of the sensation by the patient. The same holds true
for cortical stimulation-elicited dysesthesia reported by  the patient
(see also 11,19,30). Our standardized scoring system (including
an explanation of the grades) is shown in Table 2.  It  consists of
six points covering three steps of impairment. For assessment of
strength and sensory function, the numbers follow a continuum
similar to the MCRS.
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Table 2
Scoring system for  assessment of complex sensory-motor functions with the SPM-a.
Grade of functionality Classification of impairment
severe moderate slight/no
grade 0 grade 1 grade 2 grade 3  grade 4  grade 5
Motor functions no contraction or
muscle
movement
trace of
contraction
visible or
palpable, but no
movement at the
joint
hint towards a
purposeful
movement
visible
uncoordinated
execution of a
purposeful
movement
visible
purposeful
movement
visible, but
deceleration or
imprecise
execution
no deficit,
purposeful
movement
visible, normal
strength
Sensory  functions numbness, no
sensory function
isolated
dysesthesia, but
rest numb
more severe
dysesthesia,
transposed
assignment of
fingers
dysesthesia slight dysesthesia no deficit,
normal sensory
function
2.1. Recommendation for patient preparation and intraoperative
monitoring
In accordance with other authors [36,37], we recommend an in-
depth preparation of the patient to enhance her/his intraoperative
compliance. Special attention should be paid to functions that are
highly important for the patient’s professional and social life [38].
The total number of tasks during surgery might be decreased if
deficits are tolerated or  specific functions are not  endangered. For
a precise baseline assessment, the patient executes the demanded
movements after a  verbal command with and without visual
control and if necessary by imitation (f.  e. aphasic patients or non-
native speakers). In addition, the patient’s report of any changes
during the operation is  explicitly encouraged [39–41]. In our expe-
rience, one should keep in  mind that some tasks might be not
feasible due to restrictions in the operating theater. For instance,
“frown forehead” is  often hindered by  the Mayfield head holder
and local anesthesia and “lift shoulder” might be impossible due to
the positioning of the patient. A well-trained examiner can do  the
whole preparation within 20 min.
Intraoperatively, the baseline-profile or the last noted profile
changes enable a  fast judgment of any alterations at one glance. The
SMP-a is used in  our clinic in  a  surgery mode following the DCS pro-
tocol introduced by Duffau et al. for stimulation of cortical as well as
subcortical areas without additional measurement’ of somatosen-
sory or motor evoked potentials (SSEP/MEP) [42].  For mapping
purposes the cortical stimulation is done simultaneously with the
execution of one task at a  time. The intraoperative selection of the
tasks for each stimulated site strongly depends on the patient’s
individual neuroanatomical structure and the tumors relationship
to functional areas. For  example, during the mapping of areas with
specified functions like motor areas of the hand, the assessment can
focus only on finger tapping. For areas with negative DCS results,
resection can be initiated and a  selection of tasks can be performed
repeatedly until impairments emerge. Then, again, the monitor-
ing may  focus on the altered functions. In accordance with other
authors, we prefer a continuous monitoring of the selected tasks
during mapping and resection [7,25,27,28,30,43].  To date, intraop-
erative data acquisition is  performed in two ways. The first part of
data acquisition focuses on  several time points of interest, including
pre-stimulation assessment, measurement after change of resec-
tion site, before an intraoperative MRI  or at the end of the resection.
This data can be  recorded with different colors or  symbols on the
SMP-a sheet. As extensive mapping as well as continuous monitor-
ing may  generate a lot of information beyond the time points of
interest mentioned above, this additional data is currently noted
on an extra sheet with exact test time and results. This extra data
can  be condensed in a  postoperative neuropsychological operation
report.
Postoperatively, the tasks of the SMP-a can be assessed at dif-
ferent follow-up dates.
2.2. Subjects
We  retrospectively analyzed the data of patients eligible for
undergoing an awake craniotomy (from 2012 to 2015) at the Uni-
versity Hospital, Kiel. We  included patients whose preoperative
assessments took place within one to  five days before surgery
by a  neuropsychologist (J. B.  and E. S.)  with the assessment scale
introduced here. Additional data on language ability and medical
information was taken from the records. Permission for study par-
ticipation was  routinely obtained from all patients during inpatient
stay.
3. Results
3.1. Group analysis
Table 3 displays the subjects’ characteristics (n  = 17, 9 female).
29.4% of the assessed patients had language impairments: all of
these had difficulties in comprehension, four of them in naming
objects. 47.1% of our patients underwent an operation due to tumor
recurrence. All patients were able to  complete the baseline assess-
ment of the SMP-a sufficiently. The results on the preoperative
SMP-a baseline are displayed in Fig. 1. Preoperatively sensory-
motor functions showed no or only slight impairments except for
finger tapping with a medium functional impairment.
3.2. Exemplary case
The 40 year old patient was hospitalized with a  recurrence of an
oligodendroglioma WHO ◦II  in  the left central region (see Fig. 2  part
B). A former partial resection under general anesthesia two years
earlier had induced a spastic hemiparesis of her right body side that
was treated with intensive rehabilitation training.
She was prepared for an awake craniotomy with the SMP-a as
displayed in Fig. 2 on the left side. The assessment revealed con-
siderable deficits in the gross and fine motor functions of  the right
arm and leg. Additionally, corresponding to functional-anatomical
location of the lesions, the patient experienced impairments in sen-
sory functions and reported a lack of “feeling the extremities in the
deep”. The same assessment without visual control (closed eyes)
showed a strong deceleration of the motor functions of the right
hand.
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Table  3
Sample characteristics (N  =  17).
Variable n  %
Mean age in years M =  50.7 (SD =  10.87)
range  =  32–68
Karnofsky Performance Status 0–100 [52] M =  76.8 (SD = 10.9)
range =  40–100
Operation due to tumor recurrence
No  9 52.9
Yes  8 47.1
Tumor-lateralization
Right 5 29.4
Left 12 70.6
Main tumor-localization
Frontal lobe 7 41.2
Central sulcus 2 11.8
Temporal lobe 1 5.9
Parietal lobe 6 35.3
Insula 1 5.9
Tumor-histological diagnosis
Anaplastic Astrocytoma 3 17.6
Glioblastoma 8 47.1
Oligodendroglioma 2 11.8
Diffuse fibrillary Astrocytoma 1 5.9
Anaplastic Oligoastrocytoma 1 5.9
Oligoastrocytoma 1 5.9
Metastases 1 5.9
WHO  classification (n = 16)[53]
Grade 2 4 23.5
Grade 3 4 23.5
Grade 4 8 47.1
Language abilitya
Impaired 5 29.4
Naming impaired 4 23.5
Comprehension impaired 5 29.4
a assessed with the Aachener Aphasie Test (AAT; [54]).
4. Discussion
The existing literature on awake craniotomy provides either no
information on the methods used to monitor endangered func-
tions during the operation, or is  restricted to the assessment of
somatosensory and motor evoked potentials or unstandardized
behavioral monitoring [1,8–16].  While mRS, MCSR, CNS and Graded
neurological scale were used for evaluation of motor functions
before and/or after the operation [17,18,25,27–30,39–41,44–46]
none of them seem to be generally suitable for intraoperative
assessment. These instruments were originally designed for other
clinical cohorts and include impractical tasks like gait. Moreover,
they lack important tasks like  fine motor skills, mix  functional sec-
tions and do not provide a sufficient scoring system for qualitative
changes in motor functions. With the SMP- a, we aimed to over-
come these limitations and combine their benefits like valuable
items and a template for the scoring system. To the best of our
knowledge, our study represents the first attempt to adapt the
existing formal neurological scales for awake craniotomies.
The strengths of the SMP-a are  its standardization of the intra-
operative tasks and its use in the preoperative phase with an in
depth-preparation of the patient and a detailed baseline assess-
ment. This enhances the patient’s intraoperative compliance and
ensures valid data to compare intraoperative and postoperative
changes. Previous studies frequently reported that tumor-induced
impairment of proprioception and/or fine motor skills often allows
normal movements under visual control but reveals deficits with
closed eyes [47].  Such differences can be  assessed with the SMP-a
baseline by comparing task performance with and without visual
control. Thereby, the possibility of missing preoperative impair-
Fig. 1. Grade of functionality measured on the SMP-a for patients eligible for awake
craniotomy (0/1 = severe impairment, 2/3 =  medium impairment, 4/5 = slight/no
impairment; data obtained from 17 patients).
ments might be substantially reduced, which could otherwise
easily be  mistaken for operation outcomes. Since the SMP-a enables
rating of separate functions instead of providing summary scores,
it is  possible to  reduce the intraoperatively used tasks to  the indi-
vidually requirements of the patient’s social and professional life,
while still preserving a  standardized rating (see  also [38,48]). In
addition, the tasks are doable with minimum effort and there-
fore are repeatedly performable. The simple profile character of
the data and repetition of the same task during the operation
(continuous monitoring) allows to notice any changes like posi-
tive and negative effects of DCS as well as short term plasticity
[49].  Given that the SMP-a includes all motor tasks reported in the
main literature on awake craniotomy [7,25,27,28,30] the neuro-
surgeon can be confident to probe all functions located along the
“human homunculus” of one hemisphere [47,50].  Specific intra-
operative events like deceleration or imprecise execution of the
motor tasks [7] are represented in the rating scale of the SMP-a.
The repeated measure of the same tasks after the operation allows
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Fig. 2. Exemplary case. (A) Grade of functionality measured on the SMP-a with and without visual control. The assessment revealed a  considerable latency for movements
requiring an opening of the hand, despite visual control. Additionally, the patient reported numbness of the right side of the forehead as well as a strongly disturbed
proprioception of the right sided extremities. Assessment with closed eyes (dotted line) revealed a  strong increase in deceleration of fine motor skills (0/1 = severe impairment,
2/3 = medium impairment, 4/5 =  slight/no impairment). (B) Preoperative sagittal T2-weighted MRI showing a tumor recurrence in  the (post-) central region. (C) Preoperative
fiber tracking of the pyramidal tract running in close vicinity to  the  tumor.
drawing a differentiated picture of the recovery of the intraopera-
tively monitored functions. By this, a survey of the intraoperative
resection decisions and a  comparison across patients and institu-
tions becomes possible for the first time.
Our preliminary feasibility analysis shows the successful use of
the SMP-a in 17 patients, 8 of them were operated due to  tumor
recurrence and 5 showed aphasic symptoms. Aphasic symptoms
seem to be tolerable for the assessment of motor functions with
the  SMP-a, as it allows imitation of the tasks in case of compre-
hension deficits. For sensory functions, these impairments might
have greater impact as for rating of these functions a reliable
self-disclosure of the patient is  necessary. Future studies should
evaluate the influence of aphasic symptoms on the SMP-a.
Our preliminary data shows more severe impairments in fine
motor tasks especially finger tapping than in facial motor functions
or sensory functions in a cohort of patients eligible for awake cran-
iotomy. These exploratory findings need to be reassessed in future
studies. The presented exemplary case provides an illustration of
the successful implementation of the SMP-a assessment during
the inpatient stay in a patient with preoperative impairments.
Compared to the neurological examination, the SMP-a baseline
assessment revealed additional information useful for the awake
craniotomy, i.e., the impact of visual control and proprioception
on motor functions.” In addition, it shows the applicability of the
SMP-a in a  patient with a  tumor recurrence and thus more severe
impairments as compared to the average awake patient. Future
studies should address observations like a  possible dissociation of
motor function with or without visual control as well as the subjec-
tive feeling of weight before hemiparesis becomes apparent [39] as
potentially useful information for awake craniotomy.
Although our proposed scale is  more structured and compre-
hensive than the available ones, its ease of use during DCS needs to
be  evaluated beyond our subjective experience. A first hint that the
SMP-a might be suitable for continuous monitoring without caus-
ing high exhaustion mimicking paresis is  provided by the study
of Goebel et al. [51] where monitoring was performed with the
tasks of the SMP-a. In addition, a  feasibility study carried out by
an institution not familiar with this scale would be of great value
and might help to improve the SMP-a significantly. Since a  very
limited number of patients is available for awake craniotomies, we
were not  able to provide data on objectivity (inter-rater reliability),
validity (comparison with other neurological scales) or stability
(test-retest reliability) to date. Additionally, the registration of  the
intraoperative monitoring data beyond specific time points via  a  pc
and its collection in  a database would enable further data analysis
on relationships between standardized behavioral monitoring and
different intraoperative variables like stimulation method (e.g., dif-
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ferent electrode arrangements, frequency and amplitude), changes
in blood pressure or other assessment methods like SSEP and MEP.
We hope that this preliminary study might encourage other
centers to use this scale and provide data for a  multi-center eval-
uation of its quality criteria. Because of the benefits of the SMP-a
mentioned above, we  are confident that the SMP-a represents a sig-
nificant improvement as compared to previous techniques used in
clinical settings so far. Nevertheless, further studies are necessary
to evaluate the clinical relevance of a comprehensive tool like the
SMP-a. These studies should test whether the SMP-a could serve
the ultimately goal to  evaluate outcome in  awake craniotomy and
compare data between institutions.
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Abstract We present the first case report describing a craniot-
omy for a glioblastoma in a patient with hemihydranencephaly
(HHE). Ten years ago our patient had average cognitive and
language functions, indicating very good adaption of his
single right hemisphere. Due to the tumour he developed a
deceleration, deficits in language functions and mild impair-
ments of basic cognitive functions. Further neuroplastic
reorganisations of his right hemisphere in response to the tu-
mour growth are discussed. The favourable postoperative out-
come supported the decision for careful tumour resection in
this patient with HHE.
Keywords Neuropsychological diagnostic .
Hemihydranencephaly . Neurosurgery . Brain tumour .
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Introduction
Hemihydranencephaly (HHE) describes the condition of one
brain hemisphere being absent due to prenatal vascular com-
plications. So far, only nine cases have been reported in the
literature [10]. The space of the missing hemisphere is filled
with a cyst containing cerebrospinal fluid, minimal residual
neurons, glial tissue and remaining blood vessels [7]. Central
nervous structures fed by the vertebra-basiliar blood system
like the basal ganglia, pons, medulla, cerebellum, meninges
and falx are not affected [10]. Glioblastoma multiforme
(GBM) represents a malignant primary brain tumour affecting
only about 3 of 100,000 adults per year [3]. The growth of a
GBM causes multiple physical and cognitive symptoms and
its treatment with surgery is the first line therapy [2]. The case
we report is the first illustration of a treatment of a GBM in
HHE so far and a follow-up on the probably oldest patient
alive with HHE [12].
Case report
The 48-year-old patient with a known history of HHE
[12] was diagnosed with a GBM in the right frontal lobe
(Fig. 1). The tumour size was about 5.2 × 6.1 cm with
cystic and solid portions and surrounded by oedema in
the apical direction to the tumour. Despite a considerable
deceleration, the patient was awake, oriented and compli-
ant in the neurological examination. He only presented the
formerly diagnosed spastic hemiparesis of the right side.
The patient complained about a loss of physical strength
within the last 4 weeks, but no recent alteration of the
hemiparesis. He had to wear varifocal glasses for about
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4 years. A semi-structured interview for eyesight revealed
new impairments of basic and spatial visual functions af-
ter approximately 2 years [9].
Functional magnetic resonance imaging (fMRI) of the
left foot showed BOLD-signal alterations in areas similar
to that observed in healthy subjects (Fig. 2) [11]. However,
abnormal activation for foot movement was found near the
hand knob in the precentral gyrus. A deterministic
tractography reconstructed the pyramidal tracts in distance
to the tumour-induced oedema (Fig. 2 middle and bottom
rows). The fMRI of language could not be interpreted due
to the patient’s deceleration.
Preoperative cognitive and language ability
The patient complained of perceived personality changes in
the last 7 weeks. Additionally, he reported a decline in mem-
ory functions and recently occurring problems in pronuncia-
tion for the last 3 months. His pre-morbid cognitive functional
level was estimated to be 90 IQ points [6]. A cognitive screen-
ing tool, the Montreal Cognitive Assessment (MoCA) [8],
revealed an overall result of 17 out of 30 points, indicating
mild cognitive impairment (for details, see Table 1). In sum-
mary, the patient showed preoperative impairments in tasks
involving executive functions, attention, verbal fluency, ab-
straction and memory.
In contrast to a previous assessment 10 years previously
[12], the standardised diagnostic of aphasia [5] revealed clear
symptoms of an aphasic disorder and signs of dysarthria (see
Table 2). His spontaneous speech was repeatedly slurred, but
showed no neologisms, semantic or phonematic paraphasic
errors or repeated speech. In summary, the patient had mild
impairments of receptive, expressive and academic verbal
skills.
Surgical procedure
The strategy for microsurgical removal of the mass was to
minimise frontal lobe alteration and associated risk of
neurological deterioration. Therefore, a right-sided supra-
orbital approach was chosen. Insufficient compliance of
the patient prevented an awake craniotomy. After opening
the dura the tumour appeared clearly distinct from the
Fig. 1 Preoperative magnetic resonance imaging (MRI) scans in
transverse and sagittal views showing the defect of the left hemisphere
and the GBM in the right frontal lobe surrounded by oedema (frontal
midline shift about 1.7 cm). Top row: T1-weighted images (voxel size,
1 × 1 × 2 mm ; TR = 7 . 3 7 m s ; TE = 3 . 5 7 6 m s ; f i e l d o f
view= 224 × 224 mm2, flip angle, 8). Middle row: T2-weighted images
(voxel size, 0.43× 0.43× 2.60 mm; TR=5,501 ms; TE= 80 ms; field of
view= 512 × 512 mm2, flip angle, 90). Bottom row: T2-weighted FLAIR
images (voxel size, 0.45× 0.45 × 3 mm; TR= 12,000 ms; TE= 160 ms;
field of view= 512 × 512 mm2, flip angle, 90)
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brain tissue in a grey-bluish (livid) discoloration. The tu-
mour resection proceeded without complications: solid
masses were resected completely and all cystic structures
were opened. No resection beyond the tumour borders
was performed to avoid the high risk of permanent neu-
rological impairment in this patient. There were no intra-
operative pictures available.
Postoperative surgical outcome
MRI with contrast agent revealed minor contrast enhance-
ments at the margin dorso-laterally to the resection cavity
and a bold ring-like enhancement at the right frontal base
indicating small residual tumour parts (Fig. 3). Postoperative
diffusion tensor imaging (DTI) showed that the pyramidal
tracts were passing the rear corona radiate (Fig. 4). The
capsula interna as well as the cingulum were visually intact
on MRI. The right hemispheric arcuate fasciculus and the
inferior fronto-occipital fasciculus (IFOF) could not be
followed to their origin in anterior direction due to oedema.
Our Supplementary Material (ESM 1) displays additional
probabilistic tractography results of main fibre tracts. Aside
from slight subjectively reported postoperative physical weak-
ness (circulatory disturbances, balance), the neurological ex-
am revealed no novel postoperative sensory-motor deficits.
The patient reported no alteration of the hemiparesis in com-
parison to the preoperative impairment and no changes in
hearing and vision [9]. In addition, there were no more signs
of deceleration.
Postoperative cognitive and language ability
Six days after the resection, the patient no longer reported
problems in memory or pronunciation. It also negated
changes in the patient’s ability to concentrate. With 19
Fig. 2 Top row: Functional MRI for movement of the left foot (t-test,
MC) showing BOLD-signal alterations (red) in the cerebellum (bilateral),
right thalamus, right anterior cingulate cortex, right precentral gyrus, and
the right supplementary motor cortex (block designwith six active and six
passive conditions, 96 volumes; voxel size, 3.3 × 3.3 × 3 mm;
TR=2,500 ms; TE= 33 ms; field of view= 224 × 224 mm2; flip angle,
90). Middle and bottom rows: Deterministic tractography results from
diffusion-weighted images for the pyramidal tracts (green; seed: inferior
cerebellar peduncle) in transverse and coronal views (FA-colour-coded
MRI regis tered onto a T1-TFE scan with TR/TE: 7/3.4,
1 × 1 × 1 mm3 voxel size covering 104 slices (field of view, 224 × 224;
32 directions; b value = 1,000 s/mm2; 52 slices; voxel size, 2 × 2 × 2 mm,
no gap; TR= 5,234 ms; TE= 69 ms; field of view= 512 × 512 mm2; flip
angle, 90)
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of 30 points, the postoperative MoCA (alternative version
2) [8] still indicated mild cognitive impairment (Table 1).
In contrast to the preoperative assessment, the patient was
not able to solve the visual-constructive item. On the con-
trary, the clock-drawing-task was easily carried out this
t ime. One er ro r was made in the naming task
Table 1 Preoperative and postoperative assessment results for basic cognitive functioning with the MoCA [7]
Items
preoperative
raw score
postoperative
raw score
max.
Visual-spatial and executive functions 
alternating Trail Making
0 0 = 1
visuo-construction (rectangle)
1 0 1
clock drawing test
2 3 3
Naming 3 2 3
Attention digit span 2 2 = 2
vigilance 0 1 1
serial 7s 2 2 = 3
Language sentence repetition 0 0 = 2
verbal fluency 0 0 = 1
Abstraction 0 2 2
Memory: Delayed recall
free recall 0 1
cued recalla (0) (2) 5
multiple choicea (1) (2)
Orientation 5 5 = 6
wrong item exact date day of the week
Sum Score 
+1 for education fewer than 12 years
17 19 30
Δ pre-post comparison; max. (achievable) maximum score; a not relevant for final sum score
Table 2 Preoperative and postoperative language functions assessed with the Aachener Aphasie Test (AAT [5])
Subtest of AAT Preoperative Postoperative Δ max.
Raw score Classificationa Raw score Classificationa
Token test 35 Impaired 48 Unimpaired ↑ 50
Reading 27 Marginal 29 Unimpaired ↑ 30
Writing to dictation 28 Unimpaired 30 Unimpaired ↑ 30
Naming 106 Impaired 114 Unimpaired ↑ 120
Auditory comprehension 43 Impaired 41 Impaired ↓ 60
Reading comprehension 49 Impaired 47 Impaired ↓ 60
Δ pre-post comparison, max. (achievable) maximum score
a In comparison to other aphasic patients according to the manual of the AAT
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postoperatively. In contrast to the preoperative results, the
patient was able to solve the vigilance item correctly, in-
dicating clear improvement of the deceleration. In addi-
tion, he showed better performance on the assessment of
abstraction and memory. Moreover, the patient exhibited
no more symptoms of dysarthria (spontaneous speech was
no longer slurred and no new aphasic symptoms oc-
curred). Improvements in expressive and academic verbal
skills occurred. Mild impairments of receptive language
were still present (Table 2).
Fig. 3 Comparison of preoperative and postoperative MRI scans Top
row: Preoperative T1-weighted MRI with contrast agents (voxel size,
0.43 × 0.43 × 5). Bottom row: Postoperative T1-weighted MRI with
contrast agents (voxel size, 0.43 × 0.43 × 5) 1 day after the operation
displaying the slightly regressive midline shift. The resection cavity
exhibited hemorrhagic areas, was partially filled with fluid and showed
slight infarctions at the cavity margins (not displayed here)
Fig. 4 Postoperative deterministic
tractography. Top row: Pyramidal
tract (blue, coronal view) and
inferior fronto-occipital fasciculus
(IFOF) (green, transverse view)
displayed on the background of the
colour-coded FA map and selected
by slice filtering. Bottom row, left:
Display of pyramidal tracts (blue)
and IFOF (green) (selected by slice
filtering) in coronal and transverse
view from posterior overlaid on a
T1-weighted MRI scan registered
to the DTI native space. Bottom
row, right: Reconstruction of the
tumour volume (rosy), the
cingulum (pink), pyramidal tracts
(blue) and the right hemispheric
arcuate fasciculus (green). The
tracts were selected by slice
filtering and are marked by arrows
Acta Neurochir
Immediately after the patient’s release, radio-chemotherapy
according to the Stupp regimen was started [11]. The treat-
ment is not yet completed, but to date well tolerated by the
patient without major changes in cognitive or physical
status.
Discussion
Here, we present the first report of a craniotomy of a right
frontal GBM in a patient with HHE. Despite the high risk
of causing permanent neurological deficits during an intra-
cranial tumour resection in HHE, this case documents an
almost complete tumour resection with a good outcome
regarding language and basic cognitive functions. In con-
trast to the patient’s normal cognitive functionality 10 years
earlier [12], he presented preoperatively with a severe de-
celeration, mild impairments in basic cognitive functions
(memory, attention, executive functions) and mild impair-
ments in receptive, expressive and academic verbal skills.
One might speculate that these new symptoms were tu-
mour induced. The deceleration vanished after tumour re-
section and some basic cognitive functions including lan-
guage functions improved. No severe cognitive deficits
emerged postoperatively.
Cognitive performance in HHE is generally judged as rel-
atively normal, independent of which hemisphere is affected
[1, 10]. This is explained by the fact that already in utero, no
corresponding hemisphere is present for a longer time period
and the full Bfunctional potential of a single cerebral
hemisphere^ might be able to develop [4, 10]. HHE can be
considered as the earliest time point for a cerebral lesion in-
ducing neuroplastic changes, which likely differ from the ob-
served reorganisations in patients with hemispherectomy [10]
or patients with intracranial tumours. To date, however, it
remains unclear whether patients with HHE show further plas-
tic changes after additional lesions and how much adaption
can be achieved by one hemisphere. It may be speculated for
the reported case that after prenatal insult, formerly left hemi-
spheric functions were successfully organised in the intact
right hemisphere, which might explain his relatively normal
cognitive ability 10 years ago. This is supported by the respec-
tive fMRI and tractography results of our case, indicating
nearly normal functional areas and courses of assessed tracts
in comparison to healthy subjects. The later tumour growth
might have induced additional neuronal reorganisation in this
patient. The formerly good adaption to the missing hemi-
sphere could have provided capacity for additional plasticity.
This might explain the relatively mild cognitive and language
impairments before and after the operation. The divergent
BOLD signal for the fMRI of the left leg near the hand knob
might be regarded as one indication for a divergent functional-
neuroanatomical proportion.
In general, in case of a missing hemisphere, it can be spec-
ulated that this reduces the brain’s ability to compensate for
tumour and treatment-induced cognitive deficits compared to
patients without HHE. In addition, we might observe unique
functional-anatomical relationships which have been formed
during early development and were modulated later by addi-
tional occurrence of a GBM. This draws special attention to a
good balance between a conservative resection and maximal
tumour resection. The operative outcome of our case suggests
that even if only one hemisphere is functioning, a careful
tumour resection can be performed.
Conclusions
Although neurosurgical extirpation of an intracranial tumour
in a patient with HHE has a high risk for permanent neurolog-
ical impairments, this case report documents an almost com-
plete tumour resection (frontal lobe) with a good outcome
regarding language and basic cognitive functions. The results
of our case study support the assumption of a strong potential
for adaptive plasticity in the human brain. Specifically, our
results suggest that even in the absence of the entire left hemi-
sphere, the right hemisphere was able to develop language
functions and reorganise them after occurrence of a GBM.
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S-Fig. 1 Probabilistic tractography of main fibre tracts following the procedure outlined by Behrens et al. [1]  
First row (a): cortico-spinal tract (blue) Second row (b): cingulum (pink) Third row (c): inferior fronto-occipital 
fasciculus (red) Fourth row (d): arcuate fasciculus (green) Fifth row (e): uncinate fasciculus (yellow); A = 
anterior, P = posterior, L = left, R = right, S = superior, I = inferior 
 
 
Additional information on methods and graphics programs used to create the artwork 
The following programs were used to create the figures: Philips-Software from Phillips MRI-Scanner 
(“View Bold”), MRICron for Fig. 1, (http://www.mccauslandcenter.sc.edu/mricro/mricron/), ImageJ 
for Fig. 2 (http://imagej.nih.gov/ij/), MRICro for Fig. 3 (http://www.mccauslandcenter.sc.edu/mricro/), 
Diffusion Toolkit and TrackVis for Fig. 4 (http://trackvis.org/), and BedpostX, ProbtrackX, and 
fslview from fsl for Fig. S-Fig. 1 (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/fsl),  
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